MST4
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0MZ66 | T455 | Sugiyama | SHTN1 KIAA1598 | KPESSKGCEsAVDELKGILGtLNKSTSSRsLKsLDPENsEt |
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| B2RPK0 | S15 | Sugiyama | HMGB1P1 HMG1L1 HMGB1L1 | ______MGKGDPKKPRGKMssyAFFVQtCREEHKKKHSDAS |
| B2RPK0 | T22 | Sugiyama | HMGB1P1 HMG1L1 HMGB1L1 | GKGDPKKPRGKMssyAFFVQtCREEHKKKHSDASVNFSEFS |
| O00267 | T709 | Sugiyama | SUPT5H SPT5 SPT5H | GGSGGMSRGRGRRDNELIGQtVRISQGPYKGYIGVVKDATE |
| O00303 | T119 | Sugiyama | EIF3F EIF3S5 | LASIVDSYERRNEGAARVIGtLLGtVDKHSVEVTNCFSVPH |
| O00303 | T123 | Sugiyama | EIF3F EIF3S5 | VDSYERRNEGAARVIGtLLGtVDKHSVEVTNCFSVPHNEsE |
| O00429 | S44 | Sugiyama | DNM1L DLP1 DRP1 | QLPQIVVVGTQSSGKSsVLEsLVGRDLLPRGTGIVTRRPLI |
| O00506 | S149 | Sugiyama | STK25 SOK1 YSK1 | DYLHsERKIHRDIKAANVLLsEQGDVKLADFGVAGQLtDtQ |
| O00506 | T166 | Sugiyama | STK25 SOK1 YSK1 | VLLsEQGDVKLADFGVAGQLtDtQIKRNtFVGTPFWMAPEV |
| O00506 | T168 | Sugiyama | STK25 SOK1 YSK1 | LsEQGDVKLADFGVAGQLtDtQIKRNtFVGTPFWMAPEVIK |
| O00584 | T120 | Sugiyama | RNASET2 RNASE6PL | VIHSFPNRSRFWKHEWEKHGtCAAQVDALNSQKKYFGRSLE |
| O14744 | T80 | Sugiyama | PRMT5 HRMT1L5 IBP72 JBP1 SKB1 | KNRPGPQTRSDLLLSGRDWNtLIVGKLSPWIRPDSKVEKIR |
| O14818 | T147 | Sugiyama | PSMA7 HSPC | FGISALIVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGAKS |
| O14818 | T152 | Sugiyama | PSMA7 HSPC | LIVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGAKSVREFL |
| O14818 | Y145 | Sugiyama | PSMA7 HSPC | RPFGISALIVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGA |
| O14829 | S6 | Sugiyama | PPEF1 PPEF PPP7C | _______________MGCSSsSTKTRRSDTSLRAALIIQNW |
| O14908 | T238 | Sugiyama | GIPC1 C19orf3 GIPC RGS19IP1 | FDMISQRsAGGRPGsGPQLGtGRGtLRLRsRGPAtVEDLPs |
| O14908 | T242 | Sugiyama | GIPC1 C19orf3 GIPC RGS19IP1 | SQRsAGGRPGsGPQLGtGRGtLRLRsRGPAtVEDLPsAFEE |
| O14950 | T160 | Sugiyama | MYL12B MRLC2 MYLC2B | DELyREAPIDKKGNFNyIEFtRILKHGAKDKDD________ |
| O15212 | T75 | Sugiyama | PFDN6 HKE2 PFD6 | VVFKLLGPVLVKQELGEARAtVGKRLDyItAEIKRYESQLR |
| O15371 | T49 | Sugiyama | EIF3D EIF3S7 | PyQPFsKGDRLGKVADWtGAtyQDKRYTNKYSSQFGGGSQY |
| O43290 | T430 | Sugiyama | SART1 | RKKEKEVVVRADDLLPLGDQtQDGDFGsRLRGRGRRRVsEV |
| O43390 | T137 | Sugiyama | HNRNPR HNRPR | ESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYS |
| O43390 | T141 | Sugiyama | HNRNPR HNRPR | GPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYSGVQP |
| O43399 | T146 | Sugiyama | TPD52L2 | yKKTQETLsQAGQKtsAALstVGsAIsRKLGDMRNsAtFKs |
| O43707 | T443 | Sugiyama | ACTN4 | sIHEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEsDL |
| O43707 | T445 | Sugiyama | ACTN4 | HEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEsDLAA |
| O43707 | T69 | Sugiyama | ACTN4 | EKQQRKTFTAWCNsHLRKAGtQIENIDEDFRDGLKLMLLLE |
| O43852 | T196 | Sugiyama | CALU | FtAFLHPEEyDyMKDIVVQEtMEDIDKNADGFIDLEEyIGD |
| O43852 | T89 | Sugiyama | CALU | sKERLGKIVSKIDGDKDGFVtVDELKDWIKFAQKRWIyEDV |
| O60231 | T110 | Sugiyama | DHX16 DBP2 DDX16 KIAA0577 PRP2 | LLEKNRSYRLLEDsEEssEEtVsRAGsSLQKKRKKRKHLRK |
| O60361 | S107 | Sugiyama | NME2P1 | GtIRGDFCIQVGRNIIHGsDsVKsAEKEISLRFKPEELVDY |
| O60361 | T88 | Sugiyama | NME2P1 | VVKTGRVMLGEtNPADsKPGtIRGDFCIQVGRNIIHGsDsV |
| O60506 | T134 | Sugiyama | SYNCRIP HNRPQ NSAP1 | DSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYS |
| O60506 | T138 | Sugiyama | SYNCRIP HNRPQ NSAP1 | GPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYSGQQP |
| O60716 | S230 | Sugiyama | CTNND1 KIAA0384 | PDGysRHyEDGyPGGsDNyGsLsRVtRIEERyRPsMEGyRA |
| O60716 | S232 | Sugiyama | CTNND1 KIAA0384 | GysRHyEDGyPGGsDNyGsLsRVtRIEERyRPsMEGyRAPs |
| O60814 | S39 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| O60927 | T75 | Sugiyama | PPP1R11 HCGV TCTE5 | RRssKCCCIyEKPRAFGEsstEsDEEEEEGCGHtHCVRGHR |
| O75347 | S103 | Sugiyama | TBCA | ENEKDLEEAEEyKEARLVLDsVKLEA_______________ |
| O75369 | T907 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | PLPGDAVKDLDIIDNyDysHtVKYtPtQQGNMQVLVTYGGD |
| O75390 | T335 | Sugiyama | CS | LQKEVGKDVSDEKLRDYIWNtLNSGRVVPGyGHAVLRKTDP |
| O75534 | T761 | Sugiyama | CSDE1 D1S155E KIAA0885 NRU UNR | GPKAVAAPRPDRLVNRLKNItLDDAsAPRLMVLRQPRGPDN |
| O75821 | S217 | Sugiyama | EIF3G EIF3S4 | PGELEPVQAtQNKtGKYVPPsLRDGAsRRGESMQPNRRADD |
| O75821 | T240 | Sugiyama | EIF3G EIF3S4 | DGAsRRGESMQPNRRADDNAtIRVtNLSEDTRETDLQELFR |
| O75822 | T33 | Sugiyama | EIF3J EIF3S1 PRO0391 | sWDADAFsVEDPVRKVGGGGtAGGDRWEGEDEDEDVKDNWD |
| O95071 | T119 | Sugiyama | UBR5 EDD EDD1 HYD KIAA0896 | GRTSRPGRTSDsPWFLsGSEtLGRLAGNTLGSRWSsGVGGs |
| O95255 | S66 | Sugiyama | ABCC6 ARA MRP6 | VLGPIYLLFIHHHGRGYLRMsPLFKAKMVLGFALIVLCTSS |
| O95678 | S162 | Sugiyama | KRT75 K6HF KB18 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| O95707 | T62 | Sugiyama | POP4 RPP29 | MsPQAREDQLQRKAVVLEyFtRHKRKEKKKKAKGLSARQRR |
| O95714 | S2928 | Sugiyama | HERC2 | ILLGRIRAEEEDLAAVPFLAsDNEEEEDEKGNSGsLIRKKA |
| O95757 | S587 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | RLNQTLKKGKVKsIDLPIQssLCRQLGQDLLNsyIENEGKM |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00338 | S167 | Sugiyama | LDHA PIG19 | AWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVHPLSCHG |
| P00338 | T322 | Sugiyama | LDHA PIG19 | DLVKVTLtsEEEARLKKsADtLWGIQKELQF__________ |
| P00390 | T507 | Sugiyama | GSR GLUR GRD1 | MLQGFAVAVKMGATKADFDNtVAIHPtssEELVtLR_____ |
| P00390 | T520 | Sugiyama | GSR GLUR GRD1 | TKADFDNtVAIHPtssEELVtLR__________________ |
| P00492 | S123 | Sugiyama | HPRT1 HPRT | KsYCNDQsTGDIKVIGGDDLstLTGKNVLIVEDIIDTGKTM |
| P00492 | T124 | Sugiyama | HPRT1 HPRT | sYCNDQsTGDIKVIGGDDLstLTGKNVLIVEDIIDTGKTMQ |
| P00558 | T168 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | EAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGF |
| P00558 | Y161 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | KAEPAKIEAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNL |
| P02538 | S176 | Sugiyama | KRT6A K6A KRT6D | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWT |
| P02786 | T143 | Sugiyama | TFRC | yWDDLKRKLsEKLDstDFTGtIKLLNENsyVPREAGsQKDE |
| P02786 | T336 | Sugiyama | TFRC | FNHTQFPPSRSSGLPNIPVQtISRAAAEKLFGNMEGDCPSD |
| P04040 | S517 | Sugiyama | CAT | LDKYNAEKPKNAIHtFVQsGsHLAAREKANL__________ |
| P04040 | T125 | Sugiyama | CAT | KKTPIAVRFStVAGEsGSADtVRDPRGFAVKFYTEDGNWDL |
| P04040 | T434 | Sugiyama | CAT | QQPSALEHSIQYSGEVRRFNtANDDNVtQVRAFyVNVLNEE |
| P04040 | T511 | Sugiyama | CAT | SHIQALLDKYNAEKPKNAIHtFVQsGsHLAAREKANL____ |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | T119 | Sugiyama | ALDOA ALDA | KsKGGVVGIKVDKGVVPLAGtNGEtttQGLDGLsERCAQYK |
| P04083 | S173 | Sugiyama | ANXA1 ANX1 LPC1 | NRVYREELKRDLAKDItsDtsGDFRNALLsLAKGDRsEDFG |
| P04083 | T223 | Sugiyama | ANXA1 ANX1 LPC1 | ARALyEAGERRKGtDVNVFNtILttRSyPQLRRVFQKYTKY |
| P04083 | T226 | Sugiyama | ANXA1 ANX1 LPC1 | LyEAGERRKGtDVNVFNtILttRSyPQLRRVFQKYTKYSKH |
| P04083 | T64 | Sugiyama | ANXA1 ANX1 LPC1 | PssDVAALHKAIMVKGVDEAtIIDILtKRNNAQRQQIKAAY |
| P04083 | T70 | Sugiyama | ANXA1 ANX1 LPC1 | ALHKAIMVKGVDEAtIIDILtKRNNAQRQQIKAAYLQEtGK |
| P04259 | S176 | Sugiyama | KRT6B K6B KRTL1 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P04406 | S321 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsKE______ |
| P04406 | T211 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | PsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtGM |
| P04406 | T237 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | VGKVIPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDD |
| P04406 | T246 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKVVKQAS |
| P04632 | T143 | Sugiyama | CAPNS1 CAPN4 CAPNS | ILNKVVTRHPDLKTDGFGIDtCRSMVAVMDSDTTGKLGFEE |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05187 | T185 | Sugiyama | ALPP PLAP | VGVVTTTRVQHAsPAGtyAHtVNRNWysDADVPASARQEGC |
| P05455 | S325 | Sugiyama | SSB | VLEGEVEKEALKKIIEDQQEsLNKWKSKGRRFKGKGKGNKA |
| P05787 | S104 | Sugiyama | KRT8 CYK8 | IQAVRTQEKEQIKTLNNKFAsFIDKVRFLEQQNKMLETKWS |
| P05787 | S410 | Sugiyama | KRT8 CYK8 | TYRKLLEGEESRLEsGMQNMsIHtKTTSGYAGGLSSAYGGL |
| P06703 | S46 | Sugiyama | S100A6 CACY | KHTLSKKELKELIQKELtIGsKLQDAEIARLMEDLDRNKDQ |
| P06703 | T43 | Sugiyama | S100A6 CACY | EGDKHTLSKKELKELIQKELtIGsKLQDAEIARLMEDLDRN |
| P06733 | S349 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | AKAVNEKsCNCLLLKVNQIGsVTEsLQACKLAQANGWGVMV |
| P06733 | S353 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | NEKsCNCLLLKVNQIGsVTEsLQACKLAQANGWGVMVsHRs |
| P06733 | S37 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | NPtVEVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRY |
| P06733 | T100 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | KKLNVtEQEKIDKLMIEMDGtENKsKFGANAILGVsLAVCK |
| P06733 | T19 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | __MSILKIHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGA |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P06733 | T26 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | IHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEA |
| P06733 | T41 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKG |
| P06733 | T55 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | VPsGAstGIyEALELRDNDKtRYMGKGVSKAVEHINKtIAP |
| P06748 | S125 | Sugiyama | NPM1 NPM | GsGPVHIsGQHLVAVEEDAEsEDEEEEDVKLLsIsGKRsAP |
| P06748 | S260 | Sugiyama | NPM1 NPM | GPssVEDIKAKMQAsIEKGGsLPKVEAKFINyVKNCFRMtD |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S168 | Sugiyama | LDHB | TWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIHPSSCHG |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | T302 | Sugiyama | LDHB | YGIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsAD |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07205 | T168 | Sugiyama | PGK2 PGKB | EAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNLPHKASGF |
| P07205 | Y161 | Sugiyama | PGK2 PGKB | KAEPDKIEAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNL |
| P07355 | S184 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | sGDFRKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVK |
| P07437 | S75 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | tGGKyVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| P07686 | T474 | Sugiyama | HEXB HCC7 | ISYGQDWRKyyKVEPLDFGGtQKQKQLFIGGEACLWGEYVD |
| P07737 | T65 | Sugiyama | PFN1 | PAEVGVLVGKDRssFyVNGLtLGGQKCsVIRDsLLQDGEFs |
| P07814 | S335 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | PIEKNLQMWEEMKKGsQFGQsCCLRAKIDMSSNNGCMRDPt |
| P07814 | T1506 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | LCELQPGAKCVCGKNPAKyytLFGRsy______________ |
| P07858 | T95 | Sugiyama | CTSB CPSB | TEDLKLPAsFDAREQWPQCPtIKEIRDQGSCGSCWAFGAVE |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07864 | S167 | Sugiyama | LDHC LDH3 LDHX | VWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVHPTSCHG |
| P07900 | S165 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | AEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGEPMGRGTK |
| P07900 | S476 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | RKKLsELLRyytsAsGDEMVsLKDYCTRMKENQKHIyyItG |
| P07900 | S505 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KENQKHIyyItGETKDQVANsAFVERLRKHGLEVIyMIEPI |
| P07900 | S641 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DNstMGyMAAKKHLEINPDHsIIEtLRQKAEADKNDKSVKD |
| P07900 | T109 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LtIVDtGIGMTKADLINNLGtIAKSGtKAFMEALQAGADIS |
| P07900 | T317 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | WtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P07900 | T624 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | yGWTANMERIMKAQALRDNstMGyMAAKKHLEINPDHsIIE |
| P07900 | T645 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MGyMAAKKHLEINPDHsIIEtLRQKAEADKNDKSVKDLVIL |
| P08195 | S292 | Sugiyama | SLC3A2 MDU1 | VAQtDLLQIDPNFGsKEDFDsLLQsAKKKSIRVILDLTPNY |
| P08195 | T321 | Sugiyama | SLC3A2 MDU1 | SIRVILDLTPNYRGENSWFStQVDtVATKVKDALEFWLQAG |
| P08195 | T325 | Sugiyama | SLC3A2 MDU1 | ILDLTPNYRGENSWFStQVDtVATKVKDALEFWLQAGVDGF |
| P08238 | S160 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | AEKVVVITKHNDDEQyAWEssAGGsFtVRADHGEPIGRGTK |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S468 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItG |
| P08238 | T104 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LtLVDtGIGMtKADLINNLGtIAKSGtKAFMEALQAGADIS |
| P08238 | T309 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | WtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P08238 | T616 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | yGWTANMERIMKAQALRDNstMGyMMAKKHLEINPDHPIVE |
| P08238 | T637 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MGyMMAKKHLEINPDHPIVEtLRQKAEADKNDKAVKDLVVL |
| P08238 | T85 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LDsGKELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtI |
| P08238 | T89 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtIAKSG |
| P08238 | Y457 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LKLGIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMK |
| P08708 | T22 | Sugiyama | RPS17 RPS17L | GRVRTKTVKKAARVIIEKyytRLGNDFHtNKRVCEEIAIIP |
| P08729 | S104 | Sugiyama | KRT7 SCL | LQRVRQEESEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWT |
| P08758 | T40 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | DAEtLRKAMKGLGtDEEsILtLLtsRsNAQRQEISAAFKTL |
| P08758 | T43 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | tLRKAMKGLGtDEEsILtLLtsRsNAQRQEISAAFKTLFGR |
| P08758 | T8 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | _____________MAQVLRGtVtDFPGFDERADAEtLRKAM |
| P09104 | S37 | Sugiyama | ENO2 | NPtVEVDLyTAKGLFRAAVPsGAstGIyEALELRDGDKQRY |
| P09211 | T62 | Sugiyama | GSTP1 FAEES3 GST3 | GsLKASCLyGQLPKFQDGDLtLyQsNtILRHLGRTLGLYGK |
| P09211 | T68 | Sugiyama | GSTP1 FAEES3 GST3 | CLyGQLPKFQDGDLtLyQsNtILRHLGRTLGLYGKDQQEAA |
| P09211 | Y64 | Sugiyama | GSTP1 FAEES3 GST3 | LKASCLyGQLPKFQDGDLtLyQsNtILRHLGRTLGLYGKDQ |
| P09382 | T58 | Sugiyama | LGALS1 | DsNNLCLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVF |
| P09429 | S15 | Sugiyama | HMGB1 HMG1 | ______MGKGDPKKPRGKMssyAFFVQtCREEHKKKHPDAs |
| P09429 | T22 | Sugiyama | HMGB1 HMG1 | GKGDPKKPRGKMssyAFFVQtCREEHKKKHPDAsVNFsEFs |
| P09651 | S368 | Sugiyama | HNRNPA1 HNRPA1 | FAKPRNQGGyGGssssssyGsGRRF________________ |
| P09923 | T182 | Sugiyama | ALPI | VGVVTTTRVQHAsPAGtyAHtVNRNWysDADMPASARQEGC |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P10412 | S55 | Sugiyama | H1-4 H1F4 HIST1H1E | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P10646 | S237 | Sugiyama | TFPI LACI TFPI1 | CLTPADRGLCRANENRFyyNsVIGKCRPFKYSGCGGNENNF |
| P10646 | Y235 | Sugiyama | TFPI LACI TFPI1 | SWCLTPADRGLCRANENRFyyNsVIGKCRPFKYSGCGGNEN |
| P10809 | T231 | Sugiyama | HSPD1 HSP60 | LEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAyVLLsEKKI |
| P11142 | S340 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | ALRDAKLDKsQIHDIVLVGGstRIPKIQKLLQDFFNGKELN |
| P11142 | T163 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtAAAIAy |
| P11142 | T226 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFIAEFK |
| P11142 | T425 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | TAGGVMTVLIKRNtTIPTKQtQtFttysDNQPGVLIQVyEG |
| P11142 | T427 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | GGVMTVLIKRNtTIPTKQtQtFttysDNQPGVLIQVyEGER |
| P11142 | T47 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | EIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPtNtV |
| P11142 | T66 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQsD |
| P11586 | T527 | Sugiyama | MTHFD1 MTHFC MTHFD | PTTLtDEEINRFARLDIDPEtITWQRVLDTNDRFLRKITIG |
| P11940 | T379 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | AtKPLyVALAQRKEERQAHLtNQyMQRMASVRAVPNPVINP |
| P12035 | S211 | Sugiyama | KRT3 | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWN |
| P12268 | S416 | Sugiyama | IMPDH2 IMPD2 | APGEYFFSDGIRLKKyRGMGsLDAMDKHLssQNRyFsEADK |
| P12814 | T424 | Sugiyama | ACTN1 | sIHEAWtDGKEAMLRQKDyEtAtLsEIKALLKKHEAFEsDL |
| P12814 | T426 | Sugiyama | ACTN1 | HEAWtDGKEAMLRQKDyEtAtLsEIKALLKKHEAFEsDLAA |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13639 | S38 | Sugiyama | EEF2 EF2 | NIRNMsVIAHVDHGKStLtDsLVCKAGIIAsARAGEtRFtD |
| P13639 | S732 | Sugiyama | EEF2 EF2 | DAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQCP |
| P13639 | T34 | Sugiyama | EEF2 EF2 | DKKANIRNMsVIAHVDHGKStLtDsLVCKAGIIAsARAGEt |
| P13639 | T5 | Sugiyama | EEF2 EF2 | ________________MVNFtVDQIRAIMDKKANIRNMsVI |
| P13639 | T735 | Sugiyama | EEF2 EF2 | HRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQCPEQV |
| P13647 | S181 | Sugiyama | KRT5 | IQRVRTEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P13667 | S379 | Sugiyama | PDIA4 ERP70 ERP72 | QPEKFQSKYEPRSHMMDVQGstQDsAIKDFVLKyALPLVGH |
| P13667 | T139 | Sugiyama | PDIA4 ERP70 ERP72 | KIDAtsAsVLAsRFDVsGyPtIKILKKGQAVDyEGsRtQEE |
| P13674 | T140 | Sugiyama | P4HA1 P4HA | YFPNDEDQVGAAKALLRLQDtyNLDTDtIsKGNLPGVKHKS |
| P13674 | T147 | Sugiyama | P4HA1 P4HA | QVGAAKALLRLQDtyNLDTDtIsKGNLPGVKHKSFLTAEDC |
| P13929 | S37 | Sugiyama | ENO3 | NPtVEVDLHtAKGRFRAAVPsGAstGIyEALELRDGDKGRY |
| P13987 | T76 | Sugiyama | CD59 MIC11 MIN1 MIN2 MIN3 MSK21 | AGLQVYNKCWKFEHCNFNDVtTRLRENELtyyCCKKDLCNF |
| P14314 | T469 | Sugiyama | PRKCSH G19P1 | WGsWIGPDHDKFSAMKyEQGtGCWQGPNRstTVRLLCGKEt |
| P14618 | S202 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | SLQVKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVs |
| P14618 | S205 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | VKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVsEKD |
| P14618 | T45 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | TFLEHMCRLDIDsPPItARNtGIICtIGPAsRsVEtLKEMI |
| P14618 | T50 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | MCRLDIDsPPItARNtGIICtIGPAsRsVEtLKEMIKsGMN |
| P14618 | T87 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | sGMNVARLNFsHGtHEyHAEtIKNVRtAtEsFAsDPILyRP |
| P15153 | T161 | Sugiyama | RAC2 | QGLALAKEIDSVKyLECsALtQRGLKtVFDEAIRAVLCPQP |
| P15170 | T315 | Sugiyama | GSPT1 ERF3A | NRSVDGPIRLPIVDKYKDMGtVVLGKLESGSICKGQQLVMM |
| P15311 | T567 | SIGNOR|EPSD|PSP | EZR VIL2 | RTHNDIIHNENMRQGRDKYKtLRQIRQGNTKQRIDEFEAL_ |
| P15531 | S122 | Sugiyama | NME1 NDPKA NM23 | GtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELVDy |
| P15531 | T103 | Sugiyama | NME1 NDPKA NM23 | VVKTGRVMLGEtNPADsKPGtIRGDFCIQVGRNIIHGsDsV |
| P15880 | T230 | Sugiyama | RPS2 RPS4 | PKKLLMMAGIDDCytsARGCtAtLGNFAKATFDAISKTysy |
| P15880 | T232 | Sugiyama | RPS2 RPS4 | KLLMMAGIDDCytsARGCtAtLGNFAKATFDAISKTysyLt |
| P15880 | T285 | Sugiyama | RPS2 RPS4 | PyQEFtDHLVKtHtRVsVQRtQAPAVATt____________ |
| P15924 | T61 | Sugiyama | DSP | YYSRRGVITDQNsDGyCQtGtMsRHQNQNTIQELLQNCSDC |
| P16070 | T76 | Sugiyama | CD44 LHR MDU2 MDU3 MIC4 | FNSTLPTMAQMEKALsIGFEtCRyGFIEGHVVIPRIHPNSI |
| P16402 | S56 | Sugiyama | H1-3 H1F3 HIST1H1D | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16403 | S55 | Sugiyama | H1-2 H1F2 HIST1H1C | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P17066 | T228 | Sugiyama | HSPA6 HSP70B' | DVSVLSIDAGVFEVKAtAGDtHLGGEDFDNRLVNHFMEEFR |
| P17066 | T49 | Sugiyama | HSPA6 HSP70B' | EILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHNtV |
| P17844 | T438 | Sugiyama | DDX5 G17P1 HELR HLR1 | yPNSsEDyIHRIGRTARSTKtGtAytFFtPNNIKQVSDLIS |
| P17844 | T443 | Sugiyama | DDX5 G17P1 HELR HLR1 | EDyIHRIGRTARSTKtGtAytFFtPNNIKQVSDLISVLREA |
| P17987 | S35 | Sugiyama | TCP1 CCT1 CCTA | EtIRsQNVMAAAsIANIVKssLGPVGLDKMLVDDIGDVTIT |
| P18124 | T17 | Sugiyama | RPL7 | ____MEGVEEKKKEVPAVPEtLKKKRRNFAELKIKRLRKKF |
| P18124 | T170 | Sugiyama | RPL7 | VNELIyKRGYGKINKKRIALtDNALIARSLGKyGIICMEDL |
| P18621 | T79 | Sugiyama | RPL17 | PFRRYNGGVGRCAQAKQWGWtQGRWPKKSAEFLLHMLKNAE |
| P18669 | S152 | Sugiyama | PGAM1 PGAMA CDABP0006 | FysNIsKDRRyADLtEDQLPsCEsLKDtIARALPFWNEEIV |
| P18669 | S155 | Sugiyama | PGAM1 PGAMA CDABP0006 | NIsKDRRyADLtEDQLPsCEsLKDtIARALPFWNEEIVPQI |
| P18669 | T146 | Sugiyama | PGAM1 PGAMA CDABP0006 | MEPDHPFysNIsKDRRyADLtEDQLPsCEsLKDtIARALPF |
| P18669 | T159 | Sugiyama | PGAM1 PGAMA CDABP0006 | DRRyADLtEDQLPsCEsLKDtIARALPFWNEEIVPQIKEGK |
| P19105 | T159 | Sugiyama | MYL12A MLCB MRLC3 RLC | DELyREAPIDKKGNFNyIEFtRILKHGAKDKDD________ |
| P19338 | S458 | Sugiyama | NCL | TEADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKN |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P19338 | S595 | Sugiyama | NCL | FVKGLsEDttEEtLKEsFDGsVRARIVTDRETGssKGFGFV |
| P19338 | T452 | Sugiyama | NCL | AyIEFKTEADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQD |
| P19338 | T464 | Sugiyama | NCL | KTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWsGE |
| P19338 | T587 | Sugiyama | NCL | RSQPSKTLFVKGLsEDttEEtLKEsFDGsVRARIVTDRETG |
| P19338 | Y463 | Sugiyama | NCL | EKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWsG |
| P20618 | S157 | Sugiyama | PSMB1 PSC5 | IIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLL |
| P20674 | T105 | Sugiyama | COX5A | EPKIIDAALRACRRLNDFAstVRILEVVKDKAGPHKEIYPY |
| P22090 | S204 | Sugiyama | RPS4Y1 RPS4Y PRO2646 | IGGANLGRVGVITNRERHPGsFDVVHVKDANGNSFATRLSN |
| P22392 | S122 | Sugiyama | NME2 NM23B | GtIRGDFCIQVGRNIIHGsDsVKsAEKEISLWFKPEELVDy |
| P22392 | T103 | Sugiyama | NME2 NM23B | VVKTGRVMLGEtNPADsKPGtIRGDFCIQVGRNIIHGsDsV |
| P22626 | T140 | Sugiyama | HNRNPA2B1 HNRPA2B1 | KEDTEEHHLRDyFEEYGKIDtIEIItDRQsGKKRGFGFVtF |
| P23193 | T256 | Sugiyama | TCEA1 GTF2S TFIIS | MRKNLTKEAIREHQMAKTGGtQTDLFtCGKCKKKNCTYTQV |
| P23246 | S283 | Sugiyama | SFPQ PSF | GPGGRsEEKIsDsEGFKANLsLLRRPGEKTyTQRCRLFVGN |
| P23381 | S358 | Sugiyama | WARS1 IFI53 WARS WRS | TFFPALQGAQTKMsAsDPNssIFLtDtAKQIKTKVNKHAFs |
| P23381 | T364 | Sugiyama | WARS1 IFI53 WARS WRS | QGAQTKMsAsDPNssIFLtDtAKQIKTKVNKHAFsGGRDtI |
| P23381 | T383 | Sugiyama | WARS1 IFI53 WARS WRS | DtAKQIKTKVNKHAFsGGRDtIEEHRQFGGNCDVDVSFMYL |
| P23396 | S104 | Sugiyama | RPS3 OK/SW-cl.26 | VELyAEKVAtRGLCAIAQAEsLRyKLLGGLAVRRACyGVLR |
| P23526 | S183 | Sugiyama | AHCY SAHH | NLyKMMANGILKVPAINVNDsVtKsKFDNLyGCRESLIDGI |
| P23528 | T63 | Sugiyama | CFL1 CFL | DKKNIILEEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyA |
| P23528 | T70 | Sugiyama | CFL1 CFL | EEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAtyE |
| P23528 | T91 | Sugiyama | CFL1 CFL | FVKMLPDKDCRyALyDAtyEtKESKKEDLVFIFWAPESAPL |
| P23528 | Y89 | Sugiyama | CFL1 CFL | AtFVKMLPDKDCRyALyDAtyEtKESKKEDLVFIFWAPESA |
| P24752 | S218 | Sugiyama | ACAT1 ACAT MAT | ENTAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNEVIPV |
| P24752 | T220 | Sugiyama | ACAT1 ACAT MAT | TAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNEVIPVtV |
| P24941 | T160 | Sugiyama | CDK2 CDKN2 | AIKLADFGLARAFGVPVRtytHEVVtLWyRAPEILLGCKYY |
| P25705 | S198 | Sugiyama | ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM | GIIPRIsVREPMQTGIKAVDsLVPIGRGQRELIIGDRQTGK |
| P25786 | T11 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | __________MFRNQyDNDVtVWsPQGRIHQIEYAMEAVKQ |
| P25789 | T9 | Sugiyama | PSMA4 HC9 PSC9 | ____________MSRRyDsRttIFsPEGRLYQVEYAMEAIG |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P26373 | S181 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | YKKEKARVItEEEKNFKAFAsLRMARANARLFGIRAKRAKE |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26373 | T24 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | SRNGMVLKPHFHKDWQRRVAtWFNQPARKIRRRKARQAKAR |
| P26583 | S15 | Sugiyama | HMGB2 HMG2 | ______MGKGDPNKPRGKMssyAFFVQtCREEHKKKHPDss |
| P26583 | T22 | Sugiyama | HMGB2 HMG2 | GKGDPNKPRGKMssyAFFVQtCREEHKKKHPDssVNFAEFS |
| P26639 | T700 | Sugiyama | TARS1 TARS | EKISGTVNIRTRDNKVHGERtIsEtIERLQQLKEFRSKQAE |
| P26641 | T287 | Sugiyama | EEF1G EF1G PRO1608 | EQALAAEPKAKDPFAHLPKstFVLDEFKRKysNEDtLsVAL |
| P27348 | S45 | Sugiyama | YWHAQ | CMKAVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSI |
| P27348 | T205 | Sugiyama | YWHAQ | PELACTLAKTAFDEAIAELDtLNEDsyKDstLIMQLLRDNL |
| P27695 | S66 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | EDPPDQKtsPsGKPAtLKICsWNVDGLRAWIKKKGLDWVKE |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P28340 | S1064 | Sugiyama | POLD1 POLD | LNALEERFSRLWTQCQRCQGsLHEDVICTSRDCPIFyMRKK |
| P29401 | T444 | Sugiyama | TKT | DGPSQMALEDLAMFRsVPtstVFyPsDGVAtEKAVELAANT |
| P29401 | T454 | Sugiyama | TKT | LAMFRsVPtstVFyPsDGVAtEKAVELAANTKGICFIRTsR |
| P29692 | S162 | Sugiyama | EEF1D EF1D | AKKPAtPAEDDEDDDIDLFGsDNEEEDKEAAQLREERLRQY |
| P29692 | S44 | Sugiyama | EEF1D EF1D | RFyEQMNGPVAGAsRQENGAsVILRDIARARENIQKsLAGs |
| P29692 | S60 | Sugiyama | EEF1D EF1D | ENGAsVILRDIARARENIQKsLAGssGPGAssGtsGDHGEL |
| P30041 | T48 | Sugiyama | PRDX6 AOP2 KIAA0106 | FLGDSWGILFSHPRDFtPVCttELGRAAKLAPEFAKRNVKL |
| P30041 | T49 | Sugiyama | PRDX6 AOP2 KIAA0106 | LGDSWGILFSHPRDFtPVCttELGRAAKLAPEFAKRNVKLI |
| P30043 | T199 | Sugiyama | BLVRB FLR SCAN | HDLGHFMLRCLttDEyDGHstyPsHQyQ_____________ |
| P30050 | T135 | Sugiyama | RPL12 | QMRHRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDI |
| P30086 | S52 | Sugiyama | PEBP1 PBP PEBP | AAVDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPD |
| P30086 | S60 | Sugiyama | PEBP1 PBP PEBP | VLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPK |
| P30086 | S99 | Sugiyama | PEBP1 PBP PEBP | PKYREWHHFLVVNMKGNDIssGtVLsDyVGsGPPKGtGLHR |
| P30086 | T167 | Sugiyama | PEBP1 PBP PEBP | GKFKVAsFRKKyELRAPVAGtCyQAEWDDyVPKLyEQLsGK |
| P30086 | T65 | Sugiyama | PEBP1 PBP PEBP | QVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREWH |
| P30086 | Y64 | Sugiyama | PEBP1 PBP PEBP | tQVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREW |
| P30101 | T102 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KVDCTANTNTCNKyGVsGyPtLKIFRDGEEAGAyDGPRtAD |
| P30626 | T130 | Sugiyama | SRI | IsFDTDRSGTVDPQELQKALttMGFRLsPQAVNSIAKRYst |
| P30626 | T131 | Sugiyama | SRI | sFDTDRSGTVDPQELQKALttMGFRLsPQAVNSIAKRYstN |
| P31942 | S298 | Sugiyama | HNRNPH3 HNRPH3 | GGsGMGGYGRDGMDNQGGyGsVGRMGMGNNysGGyGtPDGL |
| P31946 | S47 | Sugiyama | YWHAB | AMKAVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P31947 | S45 | Sugiyama | SFN HME1 | FMKGAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsI |
| P31948 | T243 | Sugiyama | STIP1 | KQALKEKELGNDAYKKKDFDtALKHYDKAKELDPtNMtyIT |
| P31949 | T33 | Sugiyama | S100A11 MLN70 S100C | CIESLIAVFQKYAGKDGyNytLsKtEFLsFMNTELAAFTKN |
| P32119 | T142 | Sugiyama | PRDX2 NKEFB TDPX1 | EGIAYRGLFIIDGKGVLRQItVNDLPVGRsVDEALRLVQAF |
| P32929 | T372 | Sugiyama | CTH | AIMtHASVLKNDRDVLGISDtLIRLsVGLEDEEDLLEDLDQ |
| P33121 | T695 | Sugiyama | ACSL1 FACL1 FACL2 LACS LACS1 LACS2 | KAKRPELRNYFRSQIDDLyStIKV_________________ |
| P33991 | T854 | Sugiyama | MCM4 CDC21 | AITKDMFEEALRALADDDFLtVtGKtVRLL___________ |
| P33991 | T859 | Sugiyama | MCM4 CDC21 | MFEEALRALADDDFLtVtGKtVRLL________________ |
| P34931 | T228 | Sugiyama | HSPA1L | DVSILTIDDGIFEVKAtAGDtHLGGEDFDNRLVsHFVEEFK |
| P34931 | T49 | Sugiyama | HSPA1L | EIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPQNTV |
| P35269 | T154 | Sugiyama | GTF2F1 RAP74 | AFEAFPVHNWYNFTPLARHRtLtAEEAEEEWERRNKVLNHF |
| P35269 | T41 | Sugiyama | GTF2F1 RAP74 | NTTKKyNIMAFNAADKVNFAtWNQARLERDLSNKKIyQEEE |
| P35579 | S1892 | Sugiyama | MYH9 | LKQLKRQLEEAEEEAQRANAsRRKLQRELEDAtEtADAMNR |
| P35579 | T1151 | Sugiyama | MYH9 | EKQKRDLGEELEALKtELEDtLDstAAQQELRSKREQEVNI |
| P35579 | T1208 | Sugiyama | MYH9 | QEMRQKHsQAVEELAEQLEQtKRVKANLEKAKQtLENERGE |
| P35658 | T860 | Sugiyama | NUP214 CAIN CAN KIAA0023 | LEQKKKQRHLLVPERETLFNtLANNREIINQQRKRLNHLVD |
| P35908 | S191 | Sugiyama | KRT2 KRT2A KRT2E | IQNVKAQEREQIKTLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| P36578 | S66 | Sugiyama | RPL4 RPL1 | KNNRQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGGGtHR |
| P36578 | S87 | Sugiyama | RPL4 RPL1 | WGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAPTKT |
| P36578 | T62 | Sugiyama | RPL4 RPL1 | TNLRKNNRQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGG |
| P36578 | T69 | Sugiyama | RPL4 RPL1 | RQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGGGtHRsGQ |
| P36578 | T84 | Sugiyama | RPL4 RPL1 | AEsWGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAP |
| P36871 | S483 | Sugiyama | PGM1 | DKVYtVEKADNFEysDPVDGsIsRNQGLRLIFTDGSRIVFR |
| P37108 | S25 | Sugiyama | SRP14 | EsEQFLtELTRLFQKCRTSGsVyItLKKYDGRTKPIPKKGt |
| P37108 | T29 | Sugiyama | SRP14 | FLtELTRLFQKCRTSGsVyItLKKYDGRTKPIPKKGtVEGF |
| P37108 | T45 | Sugiyama | SRP14 | sVyItLKKYDGRTKPIPKKGtVEGFEPADNKCLLRATDGKK |
| P37108 | Y27 | Sugiyama | SRP14 | EQFLtELTRLFQKCRTSGsVyItLKKYDGRTKPIPKKGtVE |
| P37802 | T180 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | RNFsDNQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL_ |
| P37802 | T190 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | GKNVIGLQMGtNRGAsQAGMtGyGMPRQIL___________ |
| P38117 | T172 | Sugiyama | ETFB FP585 | QVTLEGDKLKVEREIDGGLEtLRLKLPAVVTADLRLNEPRy |
| P38646 | T116 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | DGERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKD |
| P38646 | T120 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | LVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIKNV |
| P38646 | T398 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | SDIGEVILVGGMTRMPKVQQtVQDLFGRAPsKAVNPDEAVA |
| P38646 | T86 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | CVAVMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAK |
| P38646 | T94 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | QAKVLENAEGARttPsVVAFtADGERLVGMPAKRQAVtNPN |
| P38646 | Y118 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | ERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIK |
| P39019 | S59 | Sugiyama | RPS19 | LAKHKELAPyDENWFytRAAstARHLYLRGGAGVGsMTKIY |
| P39019 | S93 | Sugiyama | RPS19 | GsMTKIYGGRQRNGVMPsHFsRGsKsVARRVLQALEGLKMV |
| P39019 | T55 | Sugiyama | RPS19 | DtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGsM |
| P39019 | T60 | Sugiyama | RPS19 | AKHKELAPyDENWFytRAAstARHLYLRGGAGVGsMTKIYG |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P39023 | S265 | Sugiyama | RPL3 OK/SW-cl.32 | HRGLRKVACIGAWHPARVAFsVARAGQKGYHHRTEINKKIY |
| P40429 | T155 | Sugiyama | RPL13A | FAYLGRLAHEVGWKyQAVtAtLEEKRKEKAKIHYRKKKQLM |
| P41091 | T22 | Sugiyama | EIF2S3 EIF2G | AGGEAGVtLGQPHLsRQDLttLDVtKLTPLSHEVISRQAtI |
| P41091 | T41 | Sugiyama | EIF2S3 EIF2G | ttLDVtKLTPLSHEVISRQAtINIGtIGHVAHGKSTVVKAI |
| P41091 | T430 | Sugiyama | EIF2S3 EIF2G | sLstGGRVSAVKADLGKIVLtNPVCtEVGEKIALSRRVEKH |
| P41091 | T435 | Sugiyama | EIF2S3 EIF2G | GRVSAVKADLGKIVLtNPVCtEVGEKIALSRRVEKHWRLIG |
| P41091 | T46 | Sugiyama | EIF2S3 EIF2G | tKLTPLSHEVISRQAtINIGtIGHVAHGKSTVVKAISGVHt |
| P41091 | T9 | Sugiyama | EIF2S3 EIF2G | ____________MAGGEAGVtLGQPHLsRQDLttLDVtKLT |
| P42677 | S11 | Sugiyama | RPS27 MPS1 | __________MPLAKDLLHPsPEEEKRKHKKKRLVQsPNsy |
| P42677 | S78 | Sugiyama | RPS27 MPS1 | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| P42766 | T59 | Sugiyama | RPL35 | GAASKLsKIRVVRKSIARVLtVINQtQKENLRKFYKGKKyK |
| P42766 | T64 | Sugiyama | RPL35 | LsKIRVVRKSIARVLtVINQtQKENLRKFYKGKKyKPLDLR |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P46060 | T247 | Sugiyama | RANGAP1 KIAA1835 SD | ALAQAFAVNPLLRVINLNDNtFTEKGAVAMAETLKTLRQVE |
| P46108 | S41 | Sugiyama | CRK | QEAVALLQGQRHGVFLVRDsstsPGDyVLSVSENSRVSHYI |
| P46776 | T72 | Sugiyama | RPL27A | yFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRVNAAK |
| P46777 | S176 | Sugiyama | RPL5 MSTP030 | GNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHR |
| P46777 | S230 | Sugiyama | RPL5 MSTP030 | yLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAHAAIREN |
| P46777 | T177 | Sugiyama | RPL5 MSTP030 | NKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHRK |
| P46778 | T29 | Sugiyama | RPL21 | RGTRYMFSRPFRKHGVVPLAtyMRIYKKGDIVDIKGMGTVQ |
| P46779 | T80 | Sugiyama | RPL28 | VVVVIKRRSGQRKPAtsyVRttINKNARAtLsSIRHMIRKN |
| P46779 | T81 | Sugiyama | RPL28 | VVVIKRRSGQRKPAtsyVRttINKNARAtLsSIRHMIRKNK |
| P46781 | S160 | Sugiyama | RPS9 | QVVNIPSFIVRLDsQKHIDFsLRsPYGGGRPGRVKRKNAKK |
| P46783 | S146 | Sugiyama | RPS10 | TYRRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ_ |
| P46937 | S94 | PSP | YAP1 YAP65 | NPKtANVPQtVPMRLRKLPDsFFKPPEPKsHsRQAstDAGt |
| P46937 | T110 | PSP | YAP1 YAP65 | KLPDsFFKPPEPKsHsRQAstDAGtAGALtPQHVRAHssPA |
| P46937 | T41 | PSP | YAP1 YAP65 | SQPPQGQGPPSGPGQPAPAAtQAAPQAPPAGHQIVHVRGDs |
| P46937 | T77 | PSP | YAP1 YAP65 | VRGDsEtDLEALFNAVMNPKtANVPQtVPMRLRKLPDsFFK |
| P46937 | T83 | PSP | YAP1 YAP65 | tDLEALFNAVMNPKtANVPQtVPMRLRKLPDsFFKPPEPKs |
| P47756 | T186 | Sugiyama | CAPZB | HYKLTSTVMLWLQTNKSGsGtMNLGGsLtRQMEKDEtVsDC |
| P48643 | T47 | Sugiyama | CCT5 CCTE KIAA0098 | RLMGLEALKSHIMAAKAVANtMRtsLGPNGLDKMMVDKDGD |
| P48643 | T50 | Sugiyama | CCT5 CCTE KIAA0098 | GLEALKSHIMAAKAVANtMRtsLGPNGLDKMMVDKDGDVtV |
| P48668 | S176 | Sugiyama | KRT6C KRT6E | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P48741 | T228 | Sugiyama | HSPA7 HSP70B | DVSVLSIDAGVFEVKAtAGDtHLGGEDFDNRLVNHFMEEFR |
| P48741 | T49 | Sugiyama | HSPA7 HSP70B | EILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHNtV |
| P49368 | T459 | Sugiyama | CCT3 CCTG TRIC5 | AVAQALEVIPRTLIQNCGAstIRLLtSLRAKHtQENCEtWG |
| P49368 | T484 | Sugiyama | CCT3 CCTG TRIC5 | tSLRAKHtQENCEtWGVNGEtGtLVDMKELGIWEPLAVKLQ |
| P49411 | T433 | Sugiyama | TUFM | LRQPMILEKGQRFTLRDGNRtIGTGLVTNTLAMTEEEKNIK |
| P49589 | S34 | Sugiyama | CARS1 CARS | VQPQWsPPAGtQPCRLHLyNsLtRNKEVFIPQDGKKVTWYC |
| P49590 | S127 | Sugiyama | HARS2 HARSL HARSR HO3 | KYGEDSGLMYDLKDQGGELLsLRYDLTVPFARYLAMNKVKK |
| P49773 | T17 | Sugiyama | HINT1 HINT PKCI1 PRKCNH1 | ____MADEIAKAQVARPGGDtIFGKIIRKEIPAKIIFEDDR |
| P49840 | Y279 | Sugiyama | GSK3A | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P49841 | Y216 | Sugiyama | GSK3B | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P50402 | T43 | Sugiyama | EMD EDMD STA | HGPVVGstRRLyEKKIFEyEtQRRRLsPPsssAAssysFsD |
| P50613 | S164 | Sugiyama | CDK7 CAK CAK1 CDKN7 MO15 STK1 | LLDENGVLKLADFGLAKsFGsPNRAytHQVVtRWYRAPELL |
| P50613 | T170 | Sugiyama | CDK7 CAK CAK1 CDKN7 MO15 STK1 | VLKLADFGLAKsFGsPNRAytHQVVtRWYRAPELLFGARMY |
| P50613 | Y169 | Sugiyama | CDK7 CAK CAK1 CDKN7 MO15 STK1 | GVLKLADFGLAKsFGsPNRAytHQVVtRWYRAPELLFGARM |
| P50990 | T374 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | EVGDTQVVVFKHEKEDGAIstIVLRGstDNLMDDIERAVDD |
| P50990 | T398 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | RGstDNLMDDIERAVDDGVNtFKVLTRDKRLVPGGGAtEIE |
| P50991 | S51 | Sugiyama | CCT4 CCTD SRB | AQIRFsNISAAKAVADAIRtsLGPKGMDKMIQDGKGDVtIt |
| P50991 | T50 | Sugiyama | CCT4 CCTD SRB | PAQIRFsNISAAKAVADAIRtsLGPKGMDKMIQDGKGDVtI |
| P50991 | T69 | Sugiyama | CCT4 CCTD SRB | RtsLGPKGMDKMIQDGKGDVtItNDGAtILKQMQVLHPAAR |
| P51116 | S601 | Sugiyama | FXR2 FMR1L2 | RPQRRNRSRRRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQ |
| P51116 | T610 | Sugiyama | FXR2 FMR1L2 | RRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQsRQRPPLER |
| P51149 | T168 | Sugiyama | RAB7A RAB7 | NIPyFEtSAKEAINVEQAFQtIARNALKQETEVELyNEFPE |
| P51532 | S1382 | Sugiyama | SMARCA4 BAF190A BRG1 SNF2B SNF2L4 | EEEKMFGRGSRHRKEVDYsDsLTEKQWLKAIEEGtLEEIEE |
| P51991 | S375 | Sugiyama | HNRNPA3 HNRPA3 | ssGsPyGGGyGsGGGsGGyGsRRF_________________ |
| P52272 | T68 | Sugiyama | HNRNPM HNRPM NAGR1 | KRKEKNIKRGGNRFEPyANPtKRYRAFITNIPFDVKWQsLK |
| P52948 | S872 | Sugiyama | NUP98 ADAR2 | LEAVSRKQGAQFKEyRPEtGsWVFKVSHFSKYGLQDsDEEE |
| P53621 | T821 | Sugiyama | COPA | IMPLDTNWPLLTVSKGFFEGtIAsKGKGGALAADIDIDTVG |
| P53634 | T431 | Sugiyama | CTSC CPPI | GYGTDSASGMDYWIVKNsWGtGWGENGyFRIRRGtDECAIE |
| P54652 | T164 | Sugiyama | HSPA2 | VITVPAYFNDSQRQATKDAGtITGLNVLRIINEPtAAAIAy |
| P54652 | T229 | Sugiyama | HSPA2 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLAEEFK |
| P54652 | T48 | Sugiyama | HSPA2 | EIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPTNTI |
| P55036 | S358 | Sugiyama | PSMD4 MCB1 | VLENLPGVDPNNEAIRNAMGsLAsQATKDGKKDKKEEDKK_ |
| P55209 | S69 | Sugiyama | NAP1L1 NRP | LAALQERLDGLVEtPtGyIEsLPRVVKRRVNALKNLQVKCA |
| P55854 | S27 | Sugiyama | SUMO3 SMT3A SMT3H1 | KEGVKTENDHINLKVAGQDGsVVQFKIKRHTPLSKLMKAYC |
| P56192 | S812 | Sugiyama | MARS1 MARS | GHQIGTVSPLFQKLENDQIEsLRQRFGGGQAKtsPKPAVVE |
| P56537 | T91 | Sugiyama | EIF6 EIF3A ITGB4BP OK/SW-cl.27 | LVPNNTTDQELQHIRNSLPDtVQIRRVEERLSALGNVTTCN |
| P57053 | S39 | Sugiyama | H2BC12L H2BFS H2BS1 | VTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P58876 | S39 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P60174 | S204 | Sugiyama | TPI1 TPI | EVHEKLRGWLKsNVsDAVAQstRIIyGGsVtGAtCKELASQ |
| P60174 | S21 | Sugiyama | TPI1 TPI | MAPSRKFFVGGNWKMNGRKQsLGELIGtLNAAKVPADtEVV |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60174 | T205 | Sugiyama | TPI1 TPI | VHEKLRGWLKsNVsDAVAQstRIIyGGsVtGAtCKELASQP |
| P60174 | T214 | Sugiyama | TPI1 TPI | KsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGG |
| P60174 | T217 | Sugiyama | TPI1 TPI | VsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGGAsL |
| P60174 | T28 | Sugiyama | TPI1 TPI | FVGGNWKMNGRKQsLGELIGtLNAAKVPADtEVVCAPPtAy |
| P60174 | T38 | Sugiyama | TPI1 TPI | RKQsLGELIGtLNAAKVPADtEVVCAPPtAyIDFARQKLDP |
| P60174 | T46 | Sugiyama | TPI1 TPI | IGtLNAAKVPADtEVVCAPPtAyIDFARQKLDPKIAVAAQN |
| P60174 | T90 | Sugiyama | TPI1 TPI | VTNGAFtGEIsPGMIKDCGAtWVVLGHsERRHVFGEsDELI |
| P60660 | T103 | Sugiyama | MYL6 | QGtyEDyVEGLRVFDKEGNGtVMGAEIRHVLVtLGEKMTEE |
| P60660 | T85 | Sugiyama | MYL6 | LDFEHFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVM |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S300 | Sugiyama | ACTB | NSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItAL |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | S60 | Sugiyama | ACTB | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P60709 | T201 | Sugiyama | ACTB | AGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVAL |
| P60709 | T202 | Sugiyama | ACTB | GRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALD |
| P60709 | T297 | Sugiyama | ACTB | TTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEI |
| P60709 | T303 | Sugiyama | ACTB | MKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPs |
| P60709 | T304 | Sugiyama | ACTB | KCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPst |
| P60709 | T318 | Sugiyama | ACTB | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P60709 | T324 | Sugiyama | ACTB | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P60709 | Y53 | Sugiyama | ACTB | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P60763 | T161 | Sugiyama | RAC3 | QGLAMAREIGSVKyLECsALtQRGLKtVFDEAIRAVLCPPP |
| P60842 | T80 | Sugiyama | EIF4A1 DDX2A EIF4A | QRAILPCIKGyDVIAQAQsGtGKTATFAISILQQIELDLKA |
| P61221 | S186 | Sugiyama | ABCE1 RLI RNASEL1 RNASELI RNS4I OK/SW-cl.40 | AIIKPQYVDQIPKAAKGtVGsILDRKDETKTQAIVCQQLDL |
| P61221 | T183 | Sugiyama | ABCE1 RLI RNASEL1 RNASELI RNS4I OK/SW-cl.40 | DLKAIIKPQYVDQIPKAAKGtVGsILDRKDETKTQAIVCQQ |
| P61247 | S236 | Sugiyama | RPS3A FTE1 MFTL | KMLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGy |
| P61254 | T8 | Sugiyama | RPL26 | _____________MKFNPFVtsDRsKNRKRHFNAPsHIRRK |
| P61254 | T93 | Sugiyama | RPL26 | VYRKKyVIyIERVQREKANGttVHVGIHPSKVVITRLKLDK |
| P61254 | T94 | Sugiyama | RPL26 | YRKKyVIyIERVQREKANGttVHVGIHPSKVVITRLKLDKD |
| P61289 | T99 | Sugiyama | PSME3 | LDGPTYKKRRLDECEEAFQGtKVFVMPNGMLKSNQQLVDII |
| P61604 | S64 | Sugiyama | HSPE1 | AtVVAVGsGsKGKGGEIQPVsVKVGDKVLLPEyGGtKVVLD |
| P61604 | T45 | Sugiyama | HSPE1 | TVTKGGIMLPEKSQGKVLQAtVVAVGsGsKGKGGEIQPVsV |
| P61604 | T79 | Sugiyama | HSPE1 | EIQPVsVKVGDKVLLPEyGGtKVVLDDKDyFLFRDGDILGK |
| P61956 | S28 | Sugiyama | SUMO2 SMT3B SMT3H2 | EGVKtENNDHINLKVAGQDGsVVQFKIKRHTPLSKLMKAYC |
| P61978 | S401 | Sugiyama | HNRNPK HNRPK | GDLGGPIIttQVtIPKDLAGsIIGKGGQRIKQIRHEsGAsI |
| P61978 | S420 | Sugiyama | HNRNPK HNRPK | GsIIGKGGQRIKQIRHEsGAsIKIDEPLEGsEDRIITItGt |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61981 | S46 | Sugiyama | YWHAG | AMKNVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P61981 | T210 | Sugiyama | YWHAG | PEQACHLAKtAFDDAIAELDtLNEDsyKDstLIMQLLRDNL |
| P62081 | T172 | Sugiyama | RPS7 | RLIKVHLDKAQQNNVEHKVEtFsGVyKKLTGKDVNFEFPEF |
| P62241 | S115 | Sugiyama | RPS8 OK/SW-cl.83 | TLVKNCIVLIDStPYRQWyEsHyALPLGRKKGAKLtPEEEE |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S46 | Sugiyama | YWHAE | SMKKVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssI |
| P62263 | S139 | Sugiyama | RPS14 PRO2640 | LARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL________ |
| P62263 | T140 | Sugiyama | RPS14 PRO2640 | ARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL_________ |
| P62266 | S45 | Sugiyama | RPS23 | KQYKKAHLGtALKANPFGGAsHAKGIVLEKVGVEAKQPNSA |
| P62266 | T34 | Sugiyama | RPS23 | RSHRRDQKWHDKQYKKAHLGtALKANPFGGAsHAKGIVLEK |
| P62269 | S96 | Sugiyama | RPS18 D6S218E | QYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLKK |
| P62273 | S9 | Sugiyama | RPS29 | ____________MGHQQLyWsHPRKFGQGSRSCRVCSNRHG |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62280 | T15 | Sugiyama | RPS11 | ______MADIQTERAyQKQPtIFQNKKRVLLGEtGKEKLPR |
| P62280 | T28 | Sugiyama | RPS11 | RAyQKQPtIFQNKKRVLLGEtGKEKLPRYYKNIGLGFKtPK |
| P62280 | T54 | Sugiyama | RPS11 | PRYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILs |
| P62312 | T75 | Sugiyama | LSM6 | QLKNKyGDAFIRGNNVLyIstQKRRM_______________ |
| P62316 | T40 | Sugiyama | SNRPD2 SNRPD1 | EEEEFNtGPLsVLtQsVKNNtQVLINCRNNKKLLGRVKAFD |
| P62424 | T142 | Sugiyama | RPL7A SURF-3 SURF3 | AAGKGDVPTKRPPVLRAGVNtVttLVENKKAQLVVIAHDVD |
| P62424 | T145 | Sugiyama | RPL7A SURF-3 SURF3 | KGDVPTKRPPVLRAGVNtVttLVENKKAQLVVIAHDVDPIE |
| P62424 | T84 | Sugiyama | RPL7A SURF-3 SURF3 | QRQRAILyKRLKVPPAINQFtQALDRQTAtQLLKLAHKYRP |
| P62701 | S204 | Sugiyama | RPS4X CCG2 RPS4 SCAR | tGGANLGRIGVITNRERHPGsFDVVHVKDANGNSFATRLsN |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | S62 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P62736 | T320 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P62736 | T326 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P62736 | Y55 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P62750 | T126 | Sugiyama | RPL23A | KHQIKQAVKKLyDIDVAKVNtLIRPDGEKKAYVRLAPDyDA |
| P62750 | T42 | Sugiyama | RPL23A | LKAKKAVLKGVHSHKKKKIRtsPTFRRPKTLRLRRQPKYPR |
| P62753 | T125 | Sugiyama | RPS6 OK/SW-cl.2 | NLSVLNLVIVKKGEKDIPGLtDttVPRRLGPKRASRIRKLF |
| P62753 | T127 | Sugiyama | RPS6 OK/SW-cl.2 | SVLNLVIVKKGEKDIPGLtDttVPRRLGPKRASRIRKLFNL |
| P62753 | T128 | Sugiyama | RPS6 OK/SW-cl.2 | VLNLVIVKKGEKDIPGLtDttVPRRLGPKRASRIRKLFNLs |
| P62807 | S39 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | VTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKA |
| P62826 | T21 | Sugiyama | RAN ARA24 OK/SW-cl.81 | MAAQGEPQVQFKLVLVGDGGtGKttFVKRHLtGEFEKKyVA |
| P62826 | T66 | Sugiyama | RAN ARA24 OK/SW-cl.81 | EVHPLVFHTNRGPIKFNVWDtAGQEKFGGLRDGYYIQAQCA |
| P62857 | T57 | Sugiyama | RPS28 | DtsRsIIRNVKGPVREGDVLtLLEsEREARRLR________ |
| P62888 | T83 | Sugiyama | RPL30 | yAMLAKtGVHHysGNNIELGtACGKyyRVCtLAIIDPGDsD |
| P62899 | T22 | Sugiyama | RPL31 | APAKKGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRA |
| P62899 | T26 | Sugiyama | RPL31 | KGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRAL |
| P62899 | Y108 | Sugiyama | RPL31 | LSRKRNEDEDsPNKLytLVtyVPVttFKNLQtVNVDEN___ |
| P62899 | Y25 | Sugiyama | RPL31 | KKGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRA |
| P62906 | S64 | Sugiyama | RPL10A NEDD6 | QKDKRFsGTVRLKSTPRPKFsVCVLGDQQHCDEAKAVDIPH |
| P62906 | T9 | Sugiyama | RPL10A NEDD6 | ____________MSSKVsRDtLyEAVREVLHGNQRKRRKFL |
| P62913 | S59 | Sugiyama | RPL11 | VLEQLtGQtPVFsKARyTVRsFGIRRNEKIAVHCTVRGAKA |
| P62913 | Y55 | Sugiyama | RPL11 | RAAKVLEQLtGQtPVFsKARyTVRsFGIRRNEKIAVHCTVR |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | S14 | Sugiyama | RPL8 | _______MGRVIRGQRKGAGsVFRAHVKHRKGAARLRAVDF |
| P62917 | T135 | Sugiyama | RPL8 | CLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSK |
| P62917 | T143 | Sugiyama | RPL8 | RGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSKKVISSANR |
| P62917 | T146 | Sugiyama | RPL8 | LARAsGNyAtVIsHNPEtKKtRVKLPSGSKKVISSANRAVV |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62937 | S51 | Sugiyama | PPIA CYPA | KtAENFRALSTGEKGFGYKGsCFHRIIPGFMCQGGDFtRHN |
| P62937 | T157 | Sugiyama | PPIA CYPA | NIVEAMERFGsRNGKTSKKItIADCGQLE____________ |
| P62942 | T22 | Sugiyama | FKBP1A FKBP1 FKBP12 | GVQVEtIsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRD |
| P62942 | T28 | Sugiyama | FKBP1A FKBP1 FKBP12 | IsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRDRNKPFK |
| P62942 | T7 | Sugiyama | FKBP1A FKBP1 FKBP12 | ______________MGVQVEtIsPGDGRtFPKRGQtCVVHy |
| P62979 | S134 | Sugiyama | RPS27A UBA80 UBCEP1 | IsRLRRECPsDECGAGVFMAsHFDRHyCGKCCLtyCFNKPE |
| P63000 | T161 | Sugiyama | RAC1 TC25 MIG5 | QGLAMAKEIGAVKyLECsALtQRGLKtVFDEAIRAVLCPPP |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63104 | S45 | Sugiyama | YWHAZ | CMKsVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssI |
| P63151 | S409 | Sugiyama | PPP2R2A | RTVLKPRKVCASGKRKKDEIsVDsLDFNKKILHTAWHPKEN |
| P63151 | S412 | Sugiyama | PPP2R2A | LKPRKVCASGKRKKDEIsVDsLDFNKKILHTAWHPKENIIA |
| P63173 | T14 | Sugiyama | RPL38 | _______MPRKIEEIKDFLLtARRKDAKSVKIKKNKDNVKF |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S300 | Sugiyama | ACTG1 ACTG | NSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItAL |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | S60 | Sugiyama | ACTG1 ACTG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P63261 | T201 | Sugiyama | ACTG1 ACTG | AGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVAL |
| P63261 | T202 | Sugiyama | ACTG1 ACTG | GRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALD |
| P63261 | T297 | Sugiyama | ACTG1 ACTG | TTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEI |
| P63261 | T303 | Sugiyama | ACTG1 ACTG | MKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPs |
| P63261 | T304 | Sugiyama | ACTG1 ACTG | KCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPst |
| P63261 | T318 | Sugiyama | ACTG1 ACTG | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P63261 | T324 | Sugiyama | ACTG1 ACTG | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P63261 | Y53 | Sugiyama | ACTG1 ACTG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | S61 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P63267 | T319 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P63267 | T325 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P63267 | Y54 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P67809 | T108 | Sugiyama | YBX1 NSEP1 YB1 | QtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEAANVtGP |
| P67809 | Y99 | Sugiyama | YBX1 NSEP1 YB1 | DtKEDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKG |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | S62 | Sugiyama | ACTC1 ACTC | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68032 | T320 | Sugiyama | ACTC1 ACTC | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68032 | T326 | Sugiyama | ACTC1 ACTC | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68032 | Y55 | Sugiyama | ACTC1 ACTC | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68104 | T22 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | GKEKtHINIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKF |
| P68104 | T261 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | PTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKPGMVVtFA |
| P68104 | T432 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | S62 | Sugiyama | ACTA1 ACTA | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68133 | T320 | Sugiyama | ACTA1 ACTA | VMSGGTTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68133 | T326 | Sugiyama | ACTA1 ACTA | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68133 | Y55 | Sugiyama | ACTA1 ACTA | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68363 | T73 | Sugiyama | TUBA1B | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| P68363 | T80 | Sugiyama | TUBA1B | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| P68363 | T82 | Sugiyama | TUBA1B | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| P68363 | Y83 | Sugiyama | TUBA1B | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| P78371 | S60 | Sugiyama | CCT2 99D8.1 CCTB | KSTLGPKGMDKILLsSGRDAsLMVtNDGAtILKNIGVDNPA |
| P78371 | T69 | Sugiyama | CCT2 99D8.1 CCTB | DKILLsSGRDAsLMVtNDGAtILKNIGVDNPAAKVLVDMSR |
| P78417 | S23 | Sugiyama | GSTO1 GSTTLP28 | GESARsLGKGsAPPGPVPEGsIRIySMRFCPFAERTRLVLK |
| P78417 | Y27 | Sugiyama | GSTO1 GSTTLP28 | RsLGKGsAPPGPVPEGsIRIySMRFCPFAERTRLVLKAKGI |
| P83731 | S38 | Sugiyama | RPL24 | GRRYARTDGKVFQFLNAKCEsAFLSKRNPRQINWtVLyRRK |
| P83731 | S7 | Sugiyama | RPL24 | ______________MKVELCsFsGyKIYPGHGRRYARTDGK |
| P83731 | T52 | Sugiyama | RPL24 | LNAKCEsAFLSKRNPRQINWtVLyRRKHKKGQsEEIQKKRT |
| P83731 | Y55 | Sugiyama | RPL24 | KCEsAFLSKRNPRQINWtVLyRRKHKKGQsEEIQKKRTRRA |
| P84098 | S122 | Sugiyama | RPL19 | LRRLLRRYRESKKIDRHMyHsLyLKVKGNVFKNKRILMEHI |
| P84098 | S13 | Sugiyama | RPL19 | ________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEIA |
| P84098 | T29 | Sugiyama | RPL19 | RLAssVLRCGKKKVWLDPNEtNEIANANsRQQIRKLIKDGL |
| P84103 | S95 | Sugiyama | SRSF3 SFRS3 SRP20 | RVRVELSNGEKRSRNRGPPPsWGRRPRDDYRRRSPPPRRRS |
| P99999 | T50 | Sugiyama | CYCS CYC | GPNLHGLFGRKtGQAPGysytAANKNKGIIWGEDTLMEYLE |
| Q00341 | T729 | Sugiyama | HDLBP HBP VGL | VEKAKKQLLHLAEEKQTKSFtVDIRAKPEYHKFLIGKGGGK |
| Q00526 | T160 | Sugiyama | CDK3 CDKN3 | AIKLADFGLARAFGVPLRtYtHEVVTLWYRAPEILLGSKFY |
| Q00839 | S267 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | KRPREDHGRGyFEyIEENKysRAKsPQPPVEEEDEHFDDtV |
| Q00839 | T530 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | KTTWVTKHAAENPGKyNILGtNtIMDKMMVAGFKKQMADtG |
| Q00839 | T532 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | TWVTKHAAENPGKyNILGtNtIMDKMMVAGFKKQMADtGKL |
| Q01082 | S1388 | Sugiyama | SPTBN1 SPTB2 | TTQTKAQRLFDANKAELFtQsCADLDKWLHGLESQIQSDDy |
| Q01105 | S165 | Sugiyama | SET | PyFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQ |
| Q01518 | T165 | Sugiyama | CAP1 CAP | AMAPKPGPYVKEMNDAAMFytNRVLKEYKDVDKKHVDWVKA |
| Q01546 | S196 | Sugiyama | KRT76 KRT2B KRT2P | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWE |
| Q02543 | T107 | Sugiyama | RPL18A | RSGtHNMYREyRDLttAGAVtQCyRDMGARHRARAHsIQIM |
| Q02543 | Y97 | Sugiyama | RPL18A | NFGIWLRYDsRSGtHNMYREyRDLttAGAVtQCyRDMGARH |
| Q02790 | T278 | Sugiyama | FKBP4 FKBP52 | sWEMNsEEKLEQSTIVKERGtVYFKEGKYKQALLQYKKIVS |
| Q02878 | T235 | Sugiyama | RPL6 TXREB1 | AyFKKKKLRKPRHQEGEIFDtEKEKYEITEQRKIDQKAVDs |
| Q04760 | T35 | Sugiyama | GLO1 | AALSCCSDADPSTKDFLLQQtMLRVKDPKKSLDFyTRVLGM |
| Q04917 | S46 | Sugiyama | YWHAH YWHA1 | AMKAVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSI |
| Q05639 | T22 | Sugiyama | EEF1A2 EEF1AL STN | GKEKtHINIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKF |
| Q05639 | T261 | Sugiyama | EEF1A2 EEF1AL STN | PTDKPLRLPLQDVyKIGGIGtVPVGRVETGILRPGMVVTFA |
| Q05639 | T432 | Sugiyama | EEF1A2 EEF1AL STN | VESFSQYPPLGRFAVRDMRQtVAVGVIKNVEKKSGGAGKVT |
| Q06830 | T143 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | EGIsFRGLFIIDDKGILRQItVNDLPVGRsVDEtLRLVQAF |
| Q07020 | T136 | Sugiyama | RPL18 | AGGKILtFDQLALDsPKGCGtVLLsGPRKGREVYRHFGKAP |
| Q07020 | T39 | Sugiyama | RPL18 | KSQDIyLRLLVKLYRFLARRtNstFNQVVLKRLFMSRtNRP |
| Q07020 | T42 | Sugiyama | RPL18 | DIyLRLLVKLYRFLARRtNstFNQVVLKRLFMSRtNRPPLs |
| Q07020 | T85 | Sugiyama | RPL18 | RMIRKMKLPGRENKtAVVVGtItDDVRVQEVPKLKVCALRV |
| Q07157 | T1167 | Sugiyama | TJP1 ZO1 | EQAPRAsALRHEEQPAPGyDtHGRLRPEAQPHPsAGPKPAE |
| Q13131 | T183 | PSP | PRKAA1 AMPK1 | NAKIADFGLsNMMsDGEFLRtsCGsPNyAAPEVISGRLYAG |
| Q13136 | T572 | Sugiyama | PPFIA1 LIP1 | LRRPQKGRLAALRDEPSKVQtLNEQDWERAQQASVLANVAQ |
| Q13263 | S784 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | DVGRMFKQFNKLTEDKADVQsIIGLQRFFETRMNEAFGDTK |
| Q13283 | T241 | Sugiyama | G3BP1 G3BP | ETAPEDAQKsssPAPADIAQtVQEDLRtFsWAsVtsKNLPP |
| Q13409 | S111 | Sugiyama | DYNC1I2 DNCI2 DNCIC2 | KsVStPsEAGsQDsGDGAVGsRTLHWDTDPSVLQLHSDSDL |
| Q13509 | S75 | Sugiyama | TUBB3 TUBB4 | SSHKYVPRAILVDLEPGtMDsVRSGAFGHLFRPDNFIFGQS |
| Q13561 | T315 | Sugiyama | DCTN2 DCTN50 | KHKASVEDADTQSKVHQLyEtIQRWsPIASTLPELVQRLVT |
| Q13765 | T119 | Sugiyama | NACA HSD48 | SKNILFVITKPDVYKSPAsDtyIVFGEAKIEDLsQQAQLAA |
| Q13885 | S75 | Sugiyama | TUBB2A TUBB2 | AGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q14004 | S389 | Sugiyama | CDK13 CDC2L CDC2L5 CHED KIAA1791 | SYSRHSSYERGGDVsPsPyssSsWRRsRsPysPVLRRSGKS |
| Q14103 | S271 | Sugiyama | HNRNPD AUF1 HNRPD | KCEIKVAMSKEQyQQQQQWGsRGGFAGRARGRGGGPSQNWN |
| Q14103 | T127 | Sugiyama | HNRNPD AUF1 HNRPD | DTTKKDLKDYFSKFGEVVDCtLKLDPITGRSRGFGFVLFKE |
| Q14152 | S1028 | Sugiyama | EIF3A EIF3S10 KIAA0139 | NWRHADDDRPPRRGLDEDRGsWRtADEDRGPRRGMDDDRGP |
| Q14152 | S584 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EHQRILARRQtIEERKERLEsLNIQREKEELEQREAELQKV |
| Q14152 | S988 | Sugiyama | EIF3A EIF3S10 KIAA0139 | PRRGPEEDRFsRRGADDDRPsWRNTDDDRPPRRIADEDRGN |
| Q14152 | T1378 | Sugiyama | EIF3A EIF3S10 KIAA0139 | AEKDREsLRRTKNEtDEDGWttVRR________________ |
| Q14152 | T1379 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EKDREsLRRTKNEtDEDGWttVRR_________________ |
| Q14152 | T898 | Sugiyama | EIF3A EIF3S10 KIAA0139 | LGDssLSRKDSRWGDRDsEGtWRKGPEADsEWRRGPPEKEW |
| Q14157 | S852 | Sugiyama | UBAP2L KIAA0144 NICE4 | LDyysIPFPtPttPLtGRDGsLAsNPysGDLtKFGRGDASS |
| Q14157 | T358 | Sugiyama | UBAP2L KIAA0144 NICE4 | MVsMLGKGFGDVGEAKGGsttGsQFLEQFKTAQALAQLAAQ |
| Q14240 | T81 | Sugiyama | EIF4A2 DDX2B EIF4F | QRAIIPCIKGyDVIAQAQsGtGKTATFAISILQQLEIEFKE |
| Q14247 | S113 | Sugiyama | CTTN EMS1 | DRMDKsAVGHEyQSKLsKHCsQVDsVRGFGGKFGVQMDRVD |
| Q14568 | S165 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | AEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGERMGRGTK |
| Q14568 | T109 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | LTIVDTGIGMTKADLINNLGtIAKSGtKAFMEALQAGADIS |
| Q14677 | T271 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | KDEEETVTTKHIHItQATEttttRHKRTANPsKtIDLGAAA |
| Q14697 | S44 | Sugiyama | GANAB G2AN KIAA0088 | GVCLGITLAVDRSNFKtCEEssFCKRQRsIRPGLsPyRALL |
| Q14697 | T40 | Sugiyama | GANAB G2AN KIAA0088 | LAFLGVCLGITLAVDRSNFKtCEEssFCKRQRsIRPGLsPy |
| Q14974 | T863 | Sugiyama | KPNB1 NTF97 | IHELLTEGRRSKTNKAKtLAtWATKELRKLKNQA_______ |
| Q14978 | T610 | Sugiyama | NOLC1 KIAA0035 NS5ATP13 | EAAKEAEtPQAKKIKLQtPNtFPKRKKGEKRAssPFRRVRE |
| Q14CN4 | S138 | Sugiyama | KRT72 K6IRS2 KB35 KRT6 KRT6IRS2 | IQRVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWN |
| Q15021 | S1310 | Sugiyama | NCAPD2 CAPD2 CNAP1 KIAA0159 | RACHTRGLDGIKELEIGQAGsQRAPsAKKPSTGSRyQPLAs |
| Q15056 | S110 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | DEVDsLKEALtyDGALLGDRsLRVDIAEGRKQDKGGFGFRK |
| Q15056 | S69 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | LPFNTVQGDIDAIFKDLsIRsVRLVRDKDTDKFKGFCyVEF |
| Q15084 | S230 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | QTKGKVKLAAVDAtVNQVLAsRYGIRGFPtIKIFQKGEsPV |
| Q15084 | T223 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | AAsEVKEQTKGKVKLAAVDAtVNQVLAsRYGIRGFPtIKIF |
| Q15185 | S85 | Sugiyama | PTGES3 P23 TEBP | KHKRtDRsILCCLRKGEsGQsWPRLTKERAKLNWLsVDFNN |
| Q15293 | T144 | Sugiyama | RCN1 RCN | WKDYDRDKDDKISWEEyKQAtyGyyLGNPAEFHDssDHHtF |
| Q15293 | T163 | Sugiyama | RCN1 RCN | AtyGyyLGNPAEFHDssDHHtFKKMLPRDERRFKAADLNGD |
| Q15560 | T254 | Sugiyama | TCEA2 | IRKAMTKEAIREHQMARTGGtQTDLFtCGKCRKKNCTYTQV |
| Q15631 | T67 | Sugiyama | TSN | QGAGFQDIPKRCLKAREHFGtVKTHLTSLKTKFPAEQYYRF |
| Q16181 | T318 | Sugiyama | SEPTIN7 CDC10 SEPT7 | KDVTNNVHyENyRSRKLAAVtyNGVDNNKNKGQLtKsPLAQ |
| Q16658 | T239 | Sugiyama | FSCN1 FAN1 HSN SNL | GKVAFRDCEGRyLAPsGPsGtLKAGKATKVGKDELFALEQs |
| Q16775 | T292 | Sugiyama | HAGH GLO2 HAGH1 | FMRVREKTVQQHAGETDPVttMRAVRREKDQFKMPRD____ |
| Q27J81 | T1206 | Sugiyama | INF2 C14orf151 C14orf173 | DtsLDKsFsEDAVtDssGsGtLPRARGRASKGTGKRRKKRP |
| Q2VIR3 | T22 | Sugiyama | EIF2S3B | AGGEAGVtLGQPHLsRQDLttLDVtKLTPLSHEVISRQAtI |
| Q2VIR3 | T41 | Sugiyama | EIF2S3B | ttLDVtKLTPLSHEVISRQAtINIGtIGHVAHGKSTVVKAI |
| Q2VIR3 | T430 | Sugiyama | EIF2S3B | sLstGGRVSAVKADLGKIVLtNPVCtEVGEKIALSRRVEKH |
| Q2VIR3 | T435 | Sugiyama | EIF2S3B | GRVSAVKADLGKIVLtNPVCtEVGEKIALSRRVEKHWRLIG |
| Q2VIR3 | T46 | Sugiyama | EIF2S3B | tKLTPLSHEVISRQAtINIGtIGHVAHGKSTVVKAISGVHT |
| Q2VIR3 | T9 | Sugiyama | EIF2S3B | ____________MAGGEAGVtLGQPHLsRQDLttLDVtKLT |
| Q3SY84 | S143 | Sugiyama | KRT71 K6IRS1 KB34 KRT6IRS1 | IQKVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q3ZCM7 | S75 | Sugiyama | TUBB8 | SGGRYVPRAVLVDLEPGtMDsVRSGPFGQVFRPDNFIFGQC |
| Q3ZCM7 | T72 | Sugiyama | TUBB8 | NEASGGRYVPRAVLVDLEPGtMDsVRSGPFGQVFRPDNFIF |
| Q53EL6 | S49 | Sugiyama | PDCD4 H731 | ENAGTEEIKNEINGNWIsAssINEARINAKAKRRLRKNssR |
| Q58FF7 | T489 | Sugiyama | HSP90AB3P HSP90BC | YGWTANMEQIMKAQALRDNstMGyMMAKKHLEINPDHPIME |
| Q58FF8 | T104 | Sugiyama | HSP90AB2P HSP90BB | LTLVDTGIGMTKADLINNLGtIAKFQDQTEYLEEMQVKEVV |
| Q5QNW6 | S39 | Sugiyama | H2BC18 HIST2H2BF | VTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q5VTE0 | T22 | Sugiyama | EEF1A1P5 EEF1AL3 | GKEKtHINIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKF |
| Q5VTE0 | T261 | Sugiyama | EEF1A1P5 EEF1AL3 | PTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKPGMVVtFA |
| Q5VTE0 | T432 | Sugiyama | EEF1A1P5 EEF1AL3 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| Q5XKE5 | S155 | Sugiyama | KRT79 K6L KB38 KRT6L | IQRVRTQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| Q66LE6 | S415 | Sugiyama | PPP2R2D KIAA1541 | RASLKPRKVCTGGKRRKDEIsVDsLDFNKKILHTAWHPVDN |
| Q66LE6 | S418 | Sugiyama | PPP2R2D KIAA1541 | LKPRKVCTGGKRRKDEIsVDsLDFNKKILHTAWHPVDNVIA |
| Q6EEV6 | S28 | Sugiyama | SUMO4 SMT3H4 | EEVKTENNNHINLKVAGQDGsVVQFKIKRQTPLSKLMKAYC |
| Q6PCE3 | S175 | Sugiyama | PGM2L1 BM32A | PFVPYAVQKLKAVAGVMItAsHNRKEDNGYKVYWETGAQIT |
| Q6PKG0 | S627 | Sugiyama | LARP1 KIAA0731 LARP | FLFDEEMEQMDGRKNtFtAWsDEEsDyEIDDRDVNKILIVt |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q6ZMR3 | S167 | Sugiyama | LDHAL6A LDHL2 | AWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIHSESCHG |
| Q71U36 | T73 | Sugiyama | TUBA1A TUBA3 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q71U36 | T80 | Sugiyama | TUBA1A TUBA3 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q71U36 | T82 | Sugiyama | TUBA1A TUBA3 | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| Q71U36 | Y83 | Sugiyama | TUBA1A TUBA3 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q71UM5 | S78 | Sugiyama | RPS27L | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| Q7RTS7 | S153 | Sugiyama | KRT74 K6IRS4 KB37 KRT5C KRT6IRS4 | IQKVRAQEREQIKVLNDKFAsFIDKVRFLEQQNQVLETKWE |
| Q7Z417 | S655 | Sugiyama | NUFIP2 KIAA1321 PIG1 | LGsAKEQRYQRGLERNDsWGsFDLRAAIVYHTKEMEsIWNL |
| Q7Z739 | T177 | Sugiyama | YTHDF3 | YPPSSLGRAITDGQAGFGNDtLSKVPGISsIEQGMTGLKIG |
| Q7Z794 | S177 | Sugiyama | KRT77 KRT1B | IQRIKTQEREQIMVLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| Q86UE4 | T194 | Sugiyama | MTDH AEG1 LYRIC | KAVQNssRHDGKEVDEGAWEtKISHREKRQQRKRDKVLtDs |
| Q86UE4 | T477 | Sugiyama | MTDH AEG1 LYRIC | stAQDtEELEKEIREDLPVNtsKTRPKQEKAFSLKtIstsD |
| Q86V81 | T148 | Sugiyama | ALYREF ALY BEF THOC4 | EFGtLKKAAVHYDRsGRsLGtADVHFERKADALKAMKQYNG |
| Q86W92 | T968 | Sugiyama | PPFIBP1 KIAA1230 | MRLyEEDDLDRLEQMEDsEGtVRQIGAFSEGINNLTHMLKE |
| Q86Y46 | S145 | Sugiyama | KRT73 K6IRS3 KB36 KRT6IRS3 | IQKVRAQEREQIKVLNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q8IYD1 | T444 | Sugiyama | GSPT2 ERF3B | NRSIDGPIRLPIVDKYKDMGtVVLGKLESGSIFKGQQLVMM |
| Q8TAE6 | T73 | EPSD|PSP | PPP1R14C KEPI | AAAAGQVQQQQQRRHQQGKVtVKYDRKELRKRLVLEEWIVE |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q8TDY4 | T545 | SIGNOR|EPSD|PSP | ASAP3 DDEFL1 UPLC1 | GTRRDYIMAKYVEHRFARRCtPEPQRLWTAICNRDLLSVLE |
| Q8TF09 | T67 | Sugiyama | DYNLRB2 DNCL2B DNLC2B ROBLD2 | HHLTMKAKSTVRDIDPQNDLtFLRIRSKKHEIMVAPDKEYL |
| Q8WXX5 | S215 | Sugiyama | DNAJC9 | EEAKEAEMSRKELGLDEGVDsLKAAIQSRQKDRQKEMDNFL |
| Q92499 | T302 | Sugiyama | DDX1 | FLPNAPKALIVEPSRELAEQtLNNIKQFKKYIDNPKLRELL |
| Q92688 | T105 | Sugiyama | ANP32B APRIL PHAPI2 | EKLPNLTHLNLsGNKLKDIstLEPLKKLECLKsLDLFNCEV |
| Q92890 | S299 | Sugiyama | UFD1 UFD1L | KKVEEDEAGGRFVAFsGEGQsLRKKGRKP____________ |
| Q93079 | S39 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q96AY3 | T200 | Sugiyama | FKBP10 FKBP65 PSEC0056 | HYNGTLLDGTSFDTSYSKGGtyDtyVGsGWLIKGMDQGLLG |
| Q96AY3 | T203 | Sugiyama | FKBP10 FKBP65 PSEC0056 | GTLLDGTSFDTSYSKGGtyDtyVGsGWLIKGMDQGLLGMCP |
| Q96C86 | T318 | Sugiyama | DCPS DCS1 HINT5 HSPC015 | LAEVIENLECDPRHyQQRTLtFALRADDPLLKLLQEAQQS_ |
| Q96C86 | Y312 | Sugiyama | DCPS DCS1 HINT5 HSPC015 | VERAHLLAEVIENLECDPRHyQQRTLtFALRADDPLLKLLQ |
| Q96G46 | T167 | Sugiyama | DUS3L | VGRYLETKPADLGPRCVLFEtFGRCPYGVtCRFAGAHLRPE |
| Q99547 | T124 | Sugiyama | MPHOSPH6 MPP6 | TVELDVsDEEMARRyEtLVGtIGKKFARKRDHANYEEDENG |
| Q99547 | Y118 | Sugiyama | MPHOSPH6 MPP6 | EEVEDETVELDVsDEEMARRyEtLVGtIGKKFARKRDHANY |
| Q99613 | T880 | Sugiyama | EIF3C EIF3S8 | AEKLGsLVENNERVFDHKQGtyGGyFRDQKDGYRKNEGYMR |
| Q99627 | T158 | Sugiyama | COPS8 CSN8 | GLPVEEAVKGILEQGWQADstTRMVLPRKPVAGALDVsFNK |
| Q99733 | T58 | Sugiyama | NAP1L4 NAP2 | LAALQERLDNVPHtPssyIEtLPKAVKRRINALKQLQVRCA |
| Q99733 | Y55 | Sugiyama | NAP1L4 NAP2 | PRVLAALQERLDNVPHtPssyIEtLPKAVKRRINALKQLQV |
| Q99832 | T57 | Sugiyama | CCT7 CCTH NIP7-1 | RTTLGPRGMDKLIVDGRGKAtIsNDGAtILKLLDVVHPAAK |
| Q99832 | T64 | Sugiyama | CCT7 CCTH NIP7-1 | GMDKLIVDGRGKAtIsNDGAtILKLLDVVHPAAKTLVDIAK |
| Q99848 | S270 | Sugiyama | EBNA1BP2 EBP2 | FGGKKKGSKWNtREsyDDVssFRAKTAHGRGLKRPGKKGSN |
| Q99877 | S39 | Sugiyama | H2BC15 H2BFD HIST1H2BN | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99879 | S39 | Sugiyama | H2BC14 H2BFE HIST1H2BM | INKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99880 | S39 | Sugiyama | H2BC13 H2BFC HIST1H2BL | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q9BQE3 | T73 | Sugiyama | TUBA1C TUBA6 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q9BQE3 | T80 | Sugiyama | TUBA1C TUBA6 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q9BQE3 | T82 | Sugiyama | TUBA1C TUBA6 | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| Q9BQE3 | Y83 | Sugiyama | TUBA1C TUBA6 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q9BS26 | T155 | Sugiyama | ERP44 KIAA0573 TXNDC4 UNQ532/PRO1075 | yIRQQKSDPIQEIRDLAEIttLDRSKRNIIGYFEQKDSDNy |
| Q9BUJ2 | S512 | Sugiyama | HNRNPUL1 E1BAP5 HNRPUL1 | IQIAARKKRNyILDQtNVyGsAQRRKMRPFEGFQRKAIVIC |
| Q9BUL8 | S39 | EPSD|PSP | PDCD10 CCM3 TFAR15 | SMPLYAVMYPVFNELERVNLsAAQtLRAAFIKAEKENPGLT |
| Q9BUL8 | T43 | EPSD|PSP | PDCD10 CCM3 TFAR15 | YAVMYPVFNELERVNLsAAQtLRAAFIKAEKENPGLTQDII |
| Q9BVA1 | S75 | Sugiyama | TUBB2B | tGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9C0C2 | T204 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | GSRLTFNHDGssRYGPRTyGtTTAPRDEDGstLFRGWsQEG |
| Q9C0C9 | S115 | Sugiyama | UBE2O KIAA1734 | GRGssGCSEAGGAGHEEGRAsPLRRGYVRVQWYPEGVKQHV |
| Q9C0C9 | S87 | Sugiyama | UBE2O KIAA1734 | SGRYRGsVHFGLVRLIHGEDsDsEGEEEGRGssGCSEAGGA |
| Q9C0C9 | S89 | Sugiyama | UBE2O KIAA1734 | RYRGsVHFGLVRLIHGEDsDsEGEEEGRGssGCSEAGGAGH |
| Q9H0B6 | S539 | Sugiyama | KLC2 | sEsDLEDVGPTAEWNGDGsGsLRRSGsFGKLRDALRRsSEM |
| Q9H0C5 | S273 | Sugiyama | BTBD1 C15orf1 NS5ATP8 | QRQQLPVTFGNKQKVLGKALsLIRFPLMTIEEFAAGPAQSG |
| Q9H173 | T125 | Sugiyama | SIL1 UNQ545/PRO836 | QYEDKFRNNLKGKRLDINtNtytsQDLKSALAKFKEGAEME |
| Q9H444 | T85 | Sugiyama | CHMP4B C20orf178 SHAX1 | ALQALKRKKRYEKQLAQIDGtLstIEFQREALENANtNtEV |
| Q9H444 | T88 | Sugiyama | CHMP4B C20orf178 SHAX1 | ALKRKKRYEKQLAQIDGtLstIEFQREALENANtNtEVLKN |
| Q9H788 | S124 | Sugiyama | SH2D4A PPP1R38 SH2A | LKAEQEAEEPRKTHsEEFTNsLKTKsQyHDLQAPDNQQtKD |
| Q9H788 | S187 | Sugiyama | SH2D4A PPP1R38 SH2A | EEKIRSLSSSSRNIQQMLADsINRMKAYAFHQKKESMKKKQ |
| Q9H788 | T313 | Sugiyama | SH2D4A PPP1R38 SH2A | QFLNSGAYPQKPLRNQGVVRtLsssAQEDIIRWFKEEQLPL |
| Q9HB71 | T209 | Sugiyama | CACYBP S100A6BP SIP PNAS-107 | EGLMNVLKKIyEDGDDDMKRtINKAWVESREKQAKGDTEF_ |
| Q9HCN8 | T199 | Sugiyama | SDF2L1 UNQ1941/PRO4424 | GSPIRGQHEVHGMPSANtHNtWKAMEGIFIKPSVEPSAGHD |
| Q9NP97 | T67 | Sugiyama | DYNLRB1 BITH DNCL2A DNLC2A ROBLD1 HSPC162 | HSFILKARStVRDIDPQNDLtFLRIRsKKNEIMVAPDKDYF |
| Q9NPQ8 | T441 | Sugiyama | RIC8A | AARGLMAGGRPEGQysEDEDtDtDEyKEAKAsINPVTGRVE |
| Q9NQ39 | S157 | Sugiyama | RPS10P5 RPS10L | TYRRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ_ |
| Q9NQW7 | T591 | Sugiyama | XPNPEP1 XPNPEPL XPNPEPL1 | MIDVDSLTDKECDWLNNyHLtCRDVIGKELQKQGRQEALEW |
| Q9NRX4 | T119 | Sugiyama | PHPT1 PHP14 CGI-202 HSPC141 | PAQHAISTEKIKAKyPDyEVtWANDGy______________ |
| Q9NSB2 | S178 | Sugiyama | KRT84 KRTHB4 | AQRVKKDEKEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWS |
| Q9NZZ3 | T23 | Sugiyama | CHMP5 C9orf83 SNF7DC2 CGI-34 HSPC177 PNAS-114 PNAS-2 | RLFGKAKPKAPPPsLtDCIGtVDsRAEsIDKKISRLDAELV |
| Q9P0J1 | T494 | Sugiyama | PDP1 PDP PPM2C | EDQNAATHLIRHAVGNNEFGtVDHERLSKMLSLPEELARMY |
| Q9P258 | T20 | Sugiyama | RCC2 KIAA1470 TD60 | _MPRKKAAAAAWEEPssGNGtARAGPRKRGGPAGRKRERPE |
| Q9P289 | T178 | GPS6|EPSD | STK26 MASK MST4 | VKLADFGVAGQLtDtQIKRNtFVGtPFWMAPEVIQQSAYDS |
| Q9P2E9 | T684 | Sugiyama | RRBP1 KIAA1398 | EGEAQRLIEILSEKAGIIQDtWHKATQKGDPVAILKRQLEE |
| Q9UBR2 | S195 | Sugiyama | CTSZ | EFKECHAIRNYTLWRVGDYGsLSGREKMMAEIYANGPISCG |
| Q9UBR2 | T172 | Sugiyama | CTSZ | ETCNNYQAKDQECDKFNQCGtCNEFKECHAIRNYTLWRVGD |
| Q9UGY1 | S21 | Sugiyama | NOL12 | MGRNKKKKRDGDDRRPRLVLsFDEEKRREyLTGFHKRKVER |
| Q9UHA3 | T64 | Sugiyama | RSL24D1 C15orf15 RPL24L My024 | RNPRKVRWTKAFRKAAGKELtVDNsFEFEKRRNEPIKYQRE |
| Q9UI15 | T190 | Sugiyama | TAGLN3 NP25 | GQNVIGLQMGSNKGAsQAGMtGyGMPRQIM___________ |
| Q9UII2 | S39 | Sugiyama | ATP5IF1 ATPI ATPIF1 | TMQARGFGsDQSENVDRGAGsIREAGGAFGKREQAEEERyF |
| Q9UJ70 | S76 | Sugiyama | NAGK | AKRKAGVDPLVPLRsLGLsLsGGDQEDAGRILIEELRDRFP |
| Q9UNX3 | T8 | Sugiyama | RPL26L1 RPL26P1 | _____________MKFNPFVtsDRsKNRKRHFNAPSHVRRK |
| Q9UNX3 | T93 | Sugiyama | RPL26L1 RPL26P1 | VYRKKyVIyIERVQREKANGttVHVGIHPSKVVITRLKLDK |
| Q9UNX3 | T94 | Sugiyama | RPL26L1 RPL26P1 | YRKKyVIyIERVQREKANGttVHVGIHPSKVVITRLKLDKD |
| Q9UQ35 | S2692 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ERRSRSPRKPIDsLRDsRsLsysPVERRRPsPQPsPRDQQS |
| Q9UQ35 | T848 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | KtPsRQsHSsssPHPKVKsGtPPRQGsItsPQANEQsVtPQ |
| Q9UQ80 | T200 | Sugiyama | PA2G4 EBP1 | TPIEGMLSHQLKQHVIDGEKtIIQNPTDQQKKDHEKAEFEV |
| Q9Y281 | T91 | Sugiyama | CFL2 | FVKLLPLNDCRyALyDAtyEtKESKKEDLVFIFWAPESAPL |
| Q9Y281 | Y89 | Sugiyama | CFL2 | tsFVKLLPLNDCRyALyDAtyEtKESKKEDLVFIFWAPESA |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y2B0 | T100 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | ELLEEICDRMKEyGEQIDPstHRKNYVRVVGRNGEssELDL |
| Q9Y2B0 | T132 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | NGEssELDLQGIRIDsDISGtLKFACEsIVEEyEDELIEFF |
| Q9Y2K2 | T221 | PSP | SIK3 KIAA0999 QSK L19 | NIKIADFGFSNLFTPGQLLKtWCGSPPYAAPELFEGKEYDG |
| Q9Y2T7 | T143 | Sugiyama | YBX2 CSDA3 MSY2 | QtAIKRNNPRKFLRsVGDGEtVEFDVVEGEKGAEATNVTGP |
| Q9Y2W1 | S232 | Sugiyama | THRAP3 BCLAF2 TRAP150 | QDTKAsEssKPWPDAtyGtGsAsRAsAVsELsPRERsPALK |
| Q9Y2W1 | T230 | Sugiyama | THRAP3 BCLAF2 TRAP150 | tsQDTKAsEssKPWPDAtyGtGsAsRAsAVsELsPRERsPA |
| Q9Y3B8 | S203 | Sugiyama | REXO2 SFN SMFN CGI-114 | EYEFAPKKAAsHRALDDIsEsIKELQFyRNNIFKKKIDEKK |
| Q9Y4P1 | S383 | SIGNOR|EPSD|PSP | ATG4B APG4B AUTL1 KIAA0943 | DVLNLSLDSSDVERLERFFDsEDEDFEILsL__________ |
| Q9Y570 | S265 | Sugiyama | PPME1 PME1 PP2593 PRO0750 | EGsKsIVEGIIEEEEEDEEGsESISKRKKEDDMETKKDHPY |
| Q9Y5B9 | S650 | Sugiyama | SUPT16H FACT140 FACTP140 | KRYKTREAEEKEKEGIVKQDsLVINLNRsNPKLKDLYIRPN |
| Q9Y5L4 | S57 | Sugiyama | TIMM13 TIM13B TIMM13A TIMM13B | ELLQRMTDKCFRKCIGKPGGsLDNSEQKCIAMCMDRyMDAW |
| Q9Y5L4 | T79 | Sugiyama | TIMM13 TIM13B TIMM13A TIMM13B | DNSEQKCIAMCMDRyMDAWNtVsRAYNSRLQRERANM____ |
| Q9Y6E0 | S149 | Sugiyama | STK24 MST3 STK3 | DETQIATILREILKGLDYLHsEKKIHRDIKAANVLLSEHGE |
| Q9Y6E0 | S46 | Sugiyama | STK24 MST3 STK3 | TNLKADPEELFTKLEKIGKGsFGEVFKGIDNRTQKVVAIKI |
| Q9Y6E0 | T182 | Sugiyama | STK24 MST3 STK3 | VLLSEHGEVKLADFGVAGQLtDtQIKRNtFVGTPFWMAPEV |
| Q9Y6E0 | T184 | Sugiyama | STK24 MST3 STK3 | LSEHGEVKLADFGVAGQLtDtQIKRNtFVGTPFWMAPEVIK |
| Q9Y6E0 | T297 | Sugiyama | STK24 MST3 STK3 | AKELLKHKFILRNAKKTsyLtELIDRYKRWKAEQSHDDSSS |
| Q9Y6E0 | Y295 | Sugiyama | STK24 MST3 STK3 | PTAKELLKHKFILRNAKKTsyLtELIDRYKRWKAEQSHDDS |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 2.029419e-10 | 9.693 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 3.319205e-09 | 8.479 | 1 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.294109e-08 | 7.888 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.550986e-08 | 7.809 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 4.346442e-07 | 6.362 | 1 | 1 |
| Axon guidance | R-HSA-422475 | 3.993004e-07 | 6.399 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 5.549054e-07 | 6.256 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 8.531743e-07 | 6.069 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.135492e-06 | 5.945 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.135492e-06 | 5.945 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.992776e-06 | 5.701 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.793973e-06 | 5.554 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 4.956706e-06 | 5.305 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 5.660989e-06 | 5.247 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.171190e-05 | 4.931 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.155838e-05 | 4.937 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.274805e-05 | 4.895 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.353152e-05 | 4.869 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.321425e-05 | 4.879 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.328832e-05 | 4.633 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 2.705090e-05 | 4.568 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.665130e-05 | 4.574 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 3.033593e-05 | 4.518 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 3.574909e-05 | 4.447 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 4.007152e-05 | 4.397 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 4.522709e-05 | 4.345 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 5.046830e-05 | 4.297 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 7.174345e-05 | 4.144 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.102994e-04 | 3.957 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.099425e-04 | 3.959 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.194058e-04 | 3.923 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.295762e-04 | 3.887 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.372298e-04 | 3.863 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.561485e-04 | 3.806 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.561814e-04 | 3.806 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.520766e-04 | 3.818 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.685388e-04 | 3.773 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.926542e-04 | 3.715 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.901478e-04 | 3.721 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.183641e-04 | 3.661 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 3.406562e-04 | 3.468 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 3.343401e-04 | 3.476 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 3.697734e-04 | 3.432 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 4.122388e-04 | 3.385 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 4.316548e-04 | 3.365 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 4.511142e-04 | 3.346 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 5.218033e-04 | 3.282 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 5.115441e-04 | 3.291 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 5.108091e-04 | 3.292 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 5.108091e-04 | 3.292 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 6.175601e-04 | 3.209 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 6.324918e-04 | 3.199 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 6.795026e-04 | 3.168 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 6.931220e-04 | 3.159 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 7.143481e-04 | 3.146 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 8.453022e-04 | 3.073 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 8.395870e-04 | 3.076 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 8.234822e-04 | 3.084 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 8.478190e-04 | 3.072 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 8.979516e-04 | 3.047 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 9.264292e-04 | 3.033 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.011255e-03 | 2.995 | 1 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.129754e-03 | 2.947 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.163837e-03 | 2.934 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.166601e-03 | 2.933 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.290293e-03 | 2.889 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.366662e-03 | 2.864 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 1.613555e-03 | 2.792 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.643857e-03 | 2.784 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.932207e-03 | 2.714 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.915429e-03 | 2.718 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.948252e-03 | 2.710 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.961013e-03 | 2.708 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 2.175967e-03 | 2.662 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.155434e-03 | 2.666 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 2.260054e-03 | 2.646 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.263099e-03 | 2.645 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.312933e-03 | 2.636 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 2.578018e-03 | 2.589 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 2.516067e-03 | 2.599 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.583428e-03 | 2.588 | 0 | 0 |
| Kinesins | R-HSA-983189 | 2.711465e-03 | 2.567 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 3.192206e-03 | 2.496 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 3.083786e-03 | 2.511 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 3.297788e-03 | 2.482 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 3.247805e-03 | 2.488 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 3.247805e-03 | 2.488 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 3.247805e-03 | 2.488 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 3.247805e-03 | 2.488 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 3.405816e-03 | 2.468 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 3.440511e-03 | 2.463 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 3.567822e-03 | 2.448 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 3.692269e-03 | 2.433 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 3.692269e-03 | 2.433 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 3.928862e-03 | 2.406 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 3.774179e-03 | 2.423 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 4.061406e-03 | 2.391 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 4.069485e-03 | 2.390 | 1 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 4.085676e-03 | 2.389 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 4.105549e-03 | 2.387 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 4.130997e-03 | 2.384 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 4.484257e-03 | 2.348 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 4.569511e-03 | 2.340 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 4.623464e-03 | 2.335 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 4.686808e-03 | 2.329 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 5.404235e-03 | 2.267 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 5.420370e-03 | 2.266 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 5.535346e-03 | 2.257 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 5.665111e-03 | 2.247 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 5.812080e-03 | 2.236 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 6.162606e-03 | 2.210 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 5.843362e-03 | 2.233 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 6.267075e-03 | 2.203 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 5.843362e-03 | 2.233 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 5.843362e-03 | 2.233 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 6.394869e-03 | 2.194 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 6.394869e-03 | 2.194 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 6.436993e-03 | 2.191 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 6.466783e-03 | 2.189 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 6.466783e-03 | 2.189 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 6.493872e-03 | 2.187 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 6.751781e-03 | 2.171 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 7.418793e-03 | 2.130 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 6.957411e-03 | 2.158 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 7.072680e-03 | 2.150 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 7.033533e-03 | 2.153 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 7.443002e-03 | 2.128 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 7.514994e-03 | 2.124 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 7.621682e-03 | 2.118 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 8.027959e-03 | 2.095 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 8.054906e-03 | 2.094 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 8.313250e-03 | 2.080 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 8.342320e-03 | 2.079 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 8.342320e-03 | 2.079 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 8.881492e-03 | 2.052 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 9.046567e-03 | 2.044 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.018399e-02 | 1.992 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.018559e-02 | 1.992 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 9.911762e-03 | 2.004 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.030584e-02 | 1.987 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.030584e-02 | 1.987 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.069416e-02 | 1.971 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.070375e-02 | 1.970 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.072934e-02 | 1.969 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 1.076926e-02 | 1.968 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 1.081067e-02 | 1.966 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.245772e-02 | 1.905 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.290593e-02 | 1.889 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.223998e-02 | 1.912 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 1.234487e-02 | 1.909 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.174431e-02 | 1.930 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.212726e-02 | 1.916 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.260346e-02 | 1.900 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 1.311236e-02 | 1.882 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.356810e-02 | 1.867 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 1.371440e-02 | 1.863 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.371440e-02 | 1.863 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.382931e-02 | 1.859 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 1.471741e-02 | 1.832 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.508834e-02 | 1.821 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 1.533601e-02 | 1.814 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.540034e-02 | 1.812 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.544163e-02 | 1.811 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.545584e-02 | 1.811 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.725382e-02 | 1.763 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.688295e-02 | 1.773 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 1.726893e-02 | 1.763 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.654153e-02 | 1.781 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 1.555709e-02 | 1.808 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.650982e-02 | 1.782 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 1.734581e-02 | 1.761 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.734581e-02 | 1.761 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 1.734581e-02 | 1.761 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.771621e-02 | 1.752 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 1.771621e-02 | 1.752 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.773558e-02 | 1.751 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.773558e-02 | 1.751 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.815787e-02 | 1.741 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 1.815787e-02 | 1.741 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 1.900416e-02 | 1.721 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.926445e-02 | 1.715 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.932736e-02 | 1.714 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.979094e-02 | 1.704 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 1.979094e-02 | 1.704 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 2.186341e-02 | 1.660 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 2.180841e-02 | 1.661 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 2.180841e-02 | 1.661 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 2.146154e-02 | 1.668 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 2.020135e-02 | 1.695 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 2.087281e-02 | 1.680 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.036439e-02 | 1.691 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 2.033950e-02 | 1.692 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 2.369734e-02 | 1.625 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 2.369734e-02 | 1.625 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 2.382590e-02 | 1.623 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 2.385249e-02 | 1.622 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 2.388241e-02 | 1.622 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 2.405183e-02 | 1.619 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 2.490973e-02 | 1.604 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.574255e-02 | 1.589 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.675075e-02 | 1.573 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 3.009265e-02 | 1.522 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 3.009265e-02 | 1.522 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 3.009265e-02 | 1.522 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 3.009265e-02 | 1.522 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 3.009265e-02 | 1.522 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 3.009265e-02 | 1.522 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 3.009265e-02 | 1.522 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 3.009265e-02 | 1.522 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 3.057702e-02 | 1.515 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.749797e-02 | 1.561 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 2.679268e-02 | 1.572 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 2.679268e-02 | 1.572 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 2.679268e-02 | 1.572 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.942458e-02 | 1.531 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.854486e-02 | 1.544 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 2.893327e-02 | 1.539 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 2.980813e-02 | 1.526 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 3.110048e-02 | 1.507 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 3.110048e-02 | 1.507 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.145229e-02 | 1.502 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 3.231060e-02 | 1.491 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 3.231060e-02 | 1.491 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 3.243839e-02 | 1.489 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 3.332684e-02 | 1.477 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 3.337486e-02 | 1.477 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 3.337486e-02 | 1.477 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 3.337486e-02 | 1.477 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 3.354560e-02 | 1.474 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 3.354560e-02 | 1.474 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 3.398769e-02 | 1.469 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 3.425757e-02 | 1.465 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 3.425757e-02 | 1.465 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 4.060737e-02 | 1.391 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 3.785012e-02 | 1.422 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 3.821715e-02 | 1.418 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 4.060737e-02 | 1.391 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.512695e-02 | 1.454 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 4.060737e-02 | 1.391 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 3.848063e-02 | 1.415 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 3.751325e-02 | 1.426 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 4.060737e-02 | 1.391 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 3.645727e-02 | 1.438 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 3.827792e-02 | 1.417 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 4.070863e-02 | 1.390 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 4.070863e-02 | 1.390 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 4.070863e-02 | 1.390 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 4.209862e-02 | 1.376 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 4.366185e-02 | 1.360 | 0 | 0 |
| Depurination | R-HSA-73927 | 4.366185e-02 | 1.360 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 4.472134e-02 | 1.349 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.488034e-02 | 1.348 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 4.507986e-02 | 1.346 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 4.507986e-02 | 1.346 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 4.520122e-02 | 1.345 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 4.607998e-02 | 1.336 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 4.657562e-02 | 1.332 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 4.664622e-02 | 1.331 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 4.664622e-02 | 1.331 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 4.715021e-02 | 1.327 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 4.715021e-02 | 1.327 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 4.715021e-02 | 1.327 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 4.797789e-02 | 1.319 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 4.922393e-02 | 1.308 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 4.948157e-02 | 1.306 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 4.954398e-02 | 1.305 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 4.954398e-02 | 1.305 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 4.964245e-02 | 1.304 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 4.984349e-02 | 1.302 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 4.984349e-02 | 1.302 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 5.033660e-02 | 1.298 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 5.165667e-02 | 1.287 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 6.208393e-02 | 1.207 | 0 | 0 |
| Transport of glycerol from adipocytes to the liver by Aquaporins | R-HSA-432030 | 6.208393e-02 | 1.207 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 5.349207e-02 | 1.272 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 5.349207e-02 | 1.272 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 5.404108e-02 | 1.267 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 5.326208e-02 | 1.274 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 5.414474e-02 | 1.266 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 5.982814e-02 | 1.223 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 5.326208e-02 | 1.274 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 5.349207e-02 | 1.272 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 5.593940e-02 | 1.252 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 5.193285e-02 | 1.285 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 5.723879e-02 | 1.242 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 5.781613e-02 | 1.238 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 5.191002e-02 | 1.285 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 5.326208e-02 | 1.274 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 5.594844e-02 | 1.252 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 6.237451e-02 | 1.205 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 6.237451e-02 | 1.205 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 6.237451e-02 | 1.205 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 6.237451e-02 | 1.205 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 6.436633e-02 | 1.191 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 6.444754e-02 | 1.191 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 6.541504e-02 | 1.184 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 6.650416e-02 | 1.177 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 6.650416e-02 | 1.177 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 6.650416e-02 | 1.177 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 6.650416e-02 | 1.177 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 6.650416e-02 | 1.177 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 6.650416e-02 | 1.177 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 6.828320e-02 | 1.166 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 6.920205e-02 | 1.160 | 0 | 0 |
| IRS activation | R-HSA-74713 | 6.923291e-02 | 1.160 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 6.923291e-02 | 1.160 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 6.923291e-02 | 1.160 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 7.031821e-02 | 1.153 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 7.193146e-02 | 1.143 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 7.334837e-02 | 1.135 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 7.406079e-02 | 1.130 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 7.587251e-02 | 1.120 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 7.699175e-02 | 1.114 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 7.831903e-02 | 1.106 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 7.924285e-02 | 1.101 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 7.986842e-02 | 1.098 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 7.986842e-02 | 1.098 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 8.012518e-02 | 1.096 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 8.012518e-02 | 1.096 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 8.020061e-02 | 1.096 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 9.398418e-02 | 1.027 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 9.951840e-02 | 1.002 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 9.951840e-02 | 1.002 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 9.951840e-02 | 1.002 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 8.111926e-02 | 1.091 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 8.111926e-02 | 1.091 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 8.111926e-02 | 1.091 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 8.111926e-02 | 1.091 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 9.729520e-02 | 1.012 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 9.729520e-02 | 1.012 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 9.229428e-02 | 1.035 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 8.631784e-02 | 1.064 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 8.363618e-02 | 1.078 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 9.229428e-02 | 1.035 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 9.520508e-02 | 1.021 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 8.724997e-02 | 1.059 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 8.450694e-02 | 1.073 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 9.193879e-02 | 1.037 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 8.454321e-02 | 1.073 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 8.631784e-02 | 1.064 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 8.575293e-02 | 1.067 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 1.005778e-01 | 0.997 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 8.503544e-02 | 1.070 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 9.980725e-02 | 1.001 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 9.608622e-02 | 1.017 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 9.398418e-02 | 1.027 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 9.513842e-02 | 1.022 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 9.951840e-02 | 1.002 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 9.323309e-02 | 1.030 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 9.323309e-02 | 1.030 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 8.100146e-02 | 1.092 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 1.013085e-01 | 0.994 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 1.013085e-01 | 0.994 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 1.013085e-01 | 0.994 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.013442e-01 | 0.994 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 1.028672e-01 | 0.988 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.028672e-01 | 0.988 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.049070e-01 | 0.979 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 1.056134e-01 | 0.976 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.063875e-01 | 0.973 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 1.063875e-01 | 0.973 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 1.064072e-01 | 0.973 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 1.126128e-01 | 0.948 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.126128e-01 | 0.948 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.149661e-01 | 0.939 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.149661e-01 | 0.939 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.149661e-01 | 0.939 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.154540e-01 | 0.938 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.154540e-01 | 0.938 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.165863e-01 | 0.933 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.165892e-01 | 0.933 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.165892e-01 | 0.933 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.170897e-01 | 0.931 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.203654e-01 | 0.919 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.211695e-01 | 0.917 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.211695e-01 | 0.917 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.211695e-01 | 0.917 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.211695e-01 | 0.917 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.211695e-01 | 0.917 | 0 | 0 |
| Leukotriene receptors | R-HSA-391906 | 1.217924e-01 | 0.914 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.226995e-01 | 0.911 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.230942e-01 | 0.910 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 1.230942e-01 | 0.910 | 0 | 0 |
| Drug resistance of KIT mutants | R-HSA-9669937 | 1.254243e-01 | 0.902 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.254243e-01 | 0.902 | 0 | 0 |
| KIT mutants bind TKIs | R-HSA-9669921 | 1.254243e-01 | 0.902 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.254243e-01 | 0.902 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.254243e-01 | 0.902 | 0 | 0 |
| Dasatinib-resistant KIT mutants | R-HSA-9669914 | 1.254243e-01 | 0.902 | 0 | 0 |
| Imatinib-resistant KIT mutants | R-HSA-9669917 | 1.254243e-01 | 0.902 | 0 | 0 |
| Regorafenib-resistant KIT mutants | R-HSA-9669929 | 1.254243e-01 | 0.902 | 0 | 0 |
| Sorafenib-resistant KIT mutants | R-HSA-9669936 | 1.254243e-01 | 0.902 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.254243e-01 | 0.902 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 1.254243e-01 | 0.902 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.254243e-01 | 0.902 | 0 | 0 |
| Nilotinib-resistant KIT mutants | R-HSA-9669926 | 1.254243e-01 | 0.902 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.254243e-01 | 0.902 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 1.254243e-01 | 0.902 | 0 | 0 |
| Sunitinib-resistant KIT mutants | R-HSA-9669934 | 1.254243e-01 | 0.902 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.254243e-01 | 0.902 | 0 | 0 |
| Masitinib-resistant KIT mutants | R-HSA-9669924 | 1.254243e-01 | 0.902 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.254243e-01 | 0.902 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.454502e-01 | 0.837 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 1.454502e-01 | 0.837 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.521768e-01 | 0.818 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.521768e-01 | 0.818 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 1.446353e-01 | 0.840 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.340455e-01 | 0.873 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 1.544300e-01 | 0.811 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 1.544300e-01 | 0.811 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.582536e-01 | 0.801 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 1.426286e-01 | 0.846 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.288275e-01 | 0.890 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.288275e-01 | 0.890 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.578274e-01 | 0.802 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.419790e-01 | 0.848 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.350727e-01 | 0.869 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.575403e-01 | 0.803 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.648958e-01 | 0.783 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.259134e-01 | 0.900 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.252310e-01 | 0.902 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 1.401602e-01 | 0.853 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.648958e-01 | 0.783 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.660079e-01 | 0.780 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.419790e-01 | 0.848 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 1.340455e-01 | 0.873 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 1.340455e-01 | 0.873 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.284601e-01 | 0.891 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.401566e-01 | 0.853 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 1.340455e-01 | 0.873 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.387667e-01 | 0.858 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.403939e-01 | 0.853 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 1.589365e-01 | 0.799 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 1.403939e-01 | 0.853 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.505591e-01 | 0.822 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 1.454502e-01 | 0.837 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 1.586153e-01 | 0.800 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.471673e-01 | 0.832 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 1.578274e-01 | 0.802 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.488771e-01 | 0.827 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 1.377909e-01 | 0.861 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.436135e-01 | 0.843 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.446353e-01 | 0.840 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.446353e-01 | 0.840 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 1.426286e-01 | 0.846 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.575403e-01 | 0.803 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.582536e-01 | 0.801 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.573541e-01 | 0.803 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 1.350727e-01 | 0.869 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.697067e-01 | 0.770 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 1.697067e-01 | 0.770 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 1.697067e-01 | 0.770 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 1.697067e-01 | 0.770 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.697067e-01 | 0.770 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.698444e-01 | 0.770 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.699266e-01 | 0.770 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.733869e-01 | 0.761 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.733869e-01 | 0.761 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 1.760021e-01 | 0.754 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.760021e-01 | 0.754 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 1.760021e-01 | 0.754 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 1.760458e-01 | 0.754 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.797376e-01 | 0.745 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.804518e-01 | 0.744 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.814721e-01 | 0.741 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.817854e-01 | 0.740 | 0 | 0 |
| RSK activation | R-HSA-444257 | 1.846444e-01 | 0.734 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 1.846444e-01 | 0.734 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 1.846444e-01 | 0.734 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.847915e-01 | 0.733 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.878114e-01 | 0.726 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 2.351238e-01 | 0.629 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH3 | R-HSA-5632927 | 2.351238e-01 | 0.629 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.351238e-01 | 0.629 | 0 | 0 |
| Hereditary fructose intolerance | R-HSA-5657560 | 2.351238e-01 | 0.629 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 1.926598e-01 | 0.715 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.926598e-01 | 0.715 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.926598e-01 | 0.715 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 1.926598e-01 | 0.715 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.926598e-01 | 0.715 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 1.926598e-01 | 0.715 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 1.926598e-01 | 0.715 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 1.926598e-01 | 0.715 | 0 | 0 |
| PI and PC transport between ER and Golgi membranes | R-HSA-1483196 | 3.310690e-01 | 0.480 | 0 | 0 |
| Signaling by juxtamembrane domain KIT mutants | R-HSA-9669935 | 3.310690e-01 | 0.480 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 3.310690e-01 | 0.480 | 0 | 0 |
| Signaling by extracellular domain mutants of KIT | R-HSA-9680187 | 3.310690e-01 | 0.480 | 0 | 0 |
| Abasic sugar-phosphate removal via the single-nucleotide replacement pathway | R-HSA-73930 | 3.310690e-01 | 0.480 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 3.310690e-01 | 0.480 | 0 | 0 |
| MPS IIID - Sanfilippo syndrome D | R-HSA-2206305 | 3.310690e-01 | 0.480 | 0 | 0 |
| Signaling by kinase domain mutants of KIT | R-HSA-9669933 | 3.310690e-01 | 0.480 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 3.310690e-01 | 0.480 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 3.310690e-01 | 0.480 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 3.310690e-01 | 0.480 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 3.310690e-01 | 0.480 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5619081 | 3.310690e-01 | 0.480 | 0 | 0 |
| Defective CD320 causes MMATC | R-HSA-3359485 | 3.310690e-01 | 0.480 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5660724 | 3.310690e-01 | 0.480 | 0 | 0 |
| MyD88 deficiency (TLR5) | R-HSA-5602680 | 3.310690e-01 | 0.480 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 3.310690e-01 | 0.480 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 3.310690e-01 | 0.480 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 2.414743e-01 | 0.617 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 2.414743e-01 | 0.617 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.414743e-01 | 0.617 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 2.187113e-01 | 0.660 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 2.187113e-01 | 0.660 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 2.907490e-01 | 0.536 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 4.149838e-01 | 0.382 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 4.149838e-01 | 0.382 | 0 | 0 |
| Interaction between PHLDA1 and AURKA | R-HSA-8854521 | 4.149838e-01 | 0.382 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 4.149838e-01 | 0.382 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 4.149838e-01 | 0.382 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 4.149838e-01 | 0.382 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 4.149838e-01 | 0.382 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 4.149838e-01 | 0.382 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 4.149838e-01 | 0.382 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 4.149838e-01 | 0.382 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 4.149838e-01 | 0.382 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 4.149838e-01 | 0.382 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 4.149838e-01 | 0.382 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 4.149838e-01 | 0.382 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 4.149838e-01 | 0.382 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 2.539176e-01 | 0.595 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 2.539176e-01 | 0.595 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 3.396010e-01 | 0.469 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 3.396010e-01 | 0.469 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 3.396010e-01 | 0.469 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.986340e-01 | 0.702 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 1.986340e-01 | 0.702 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 1.986340e-01 | 0.702 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 2.898366e-01 | 0.538 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 2.522932e-01 | 0.598 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 2.522932e-01 | 0.598 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 2.221908e-01 | 0.653 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.972174e-01 | 0.705 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.179176e-01 | 0.662 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.179176e-01 | 0.662 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 2.465329e-01 | 0.608 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 2.465329e-01 | 0.608 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 2.465329e-01 | 0.608 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 2.465329e-01 | 0.608 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 3.260815e-01 | 0.487 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 3.260815e-01 | 0.487 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 3.260815e-01 | 0.487 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 3.260815e-01 | 0.487 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 3.873613e-01 | 0.412 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 3.873613e-01 | 0.412 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 3.873613e-01 | 0.412 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 3.873613e-01 | 0.412 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 3.873613e-01 | 0.412 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 3.873613e-01 | 0.412 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 4.883761e-01 | 0.311 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 4.883761e-01 | 0.311 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 4.883761e-01 | 0.311 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 4.883761e-01 | 0.311 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 4.883761e-01 | 0.311 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 1.896000e-01 | 0.722 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.124377e-01 | 0.673 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 2.124377e-01 | 0.673 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 2.393079e-01 | 0.621 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 3.112093e-01 | 0.507 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 3.112093e-01 | 0.507 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 3.623075e-01 | 0.441 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 3.623075e-01 | 0.441 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 3.623075e-01 | 0.441 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 3.623075e-01 | 0.441 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 3.623075e-01 | 0.441 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 2.970091e-01 | 0.527 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 3.411723e-01 | 0.467 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 3.411723e-01 | 0.467 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 4.335355e-01 | 0.363 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 4.335355e-01 | 0.363 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 4.335355e-01 | 0.363 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 4.335355e-01 | 0.363 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 4.335355e-01 | 0.363 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 2.325418e-01 | 0.633 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.945347e-01 | 0.711 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.945347e-01 | 0.711 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 2.076768e-01 | 0.683 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 3.066556e-01 | 0.513 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 3.982136e-01 | 0.400 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.298399e-01 | 0.482 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 3.129994e-01 | 0.504 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 3.532325e-01 | 0.452 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 3.751461e-01 | 0.426 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 3.751461e-01 | 0.426 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 4.011418e-01 | 0.397 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 4.335411e-01 | 0.363 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 4.777700e-01 | 0.321 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 5.525648e-01 | 0.258 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 5.525648e-01 | 0.258 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 5.525648e-01 | 0.258 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 5.525648e-01 | 0.258 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 5.525648e-01 | 0.258 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 5.525648e-01 | 0.258 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 5.525648e-01 | 0.258 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 2.690745e-01 | 0.570 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 3.555638e-01 | 0.449 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 3.767415e-01 | 0.424 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 3.767415e-01 | 0.424 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 3.767415e-01 | 0.424 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 4.013236e-01 | 0.397 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 4.308085e-01 | 0.366 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 3.770615e-01 | 0.424 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 4.680725e-01 | 0.330 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 4.273731e-01 | 0.369 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 3.563763e-01 | 0.448 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 3.555742e-01 | 0.449 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 4.237607e-01 | 0.373 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 5.198249e-01 | 0.284 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 5.198249e-01 | 0.284 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 5.198249e-01 | 0.284 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 5.198249e-01 | 0.284 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 5.198249e-01 | 0.284 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 4.531906e-01 | 0.344 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 4.531906e-01 | 0.344 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 5.016282e-01 | 0.300 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 5.016282e-01 | 0.300 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 5.016282e-01 | 0.300 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 5.016282e-01 | 0.300 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 3.850015e-01 | 0.415 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 4.365625e-01 | 0.360 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 4.887828e-01 | 0.311 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 4.564359e-01 | 0.341 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 3.655209e-01 | 0.437 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 4.568922e-01 | 0.340 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 4.840724e-01 | 0.315 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 5.340643e-01 | 0.272 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 5.340643e-01 | 0.272 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 5.340643e-01 | 0.272 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 5.340643e-01 | 0.272 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 5.340643e-01 | 0.272 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 5.595509e-01 | 0.252 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 5.595509e-01 | 0.252 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 5.595509e-01 | 0.252 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 4.875860e-01 | 0.312 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 5.283486e-01 | 0.277 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 4.199181e-01 | 0.377 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 5.441790e-01 | 0.264 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 5.239637e-01 | 0.281 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 5.493699e-01 | 0.260 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 4.901661e-01 | 0.310 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 4.901661e-01 | 0.310 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 2.715192e-01 | 0.566 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 1.971683e-01 | 0.705 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 3.108364e-01 | 0.507 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 5.066328e-01 | 0.295 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 3.369084e-01 | 0.472 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 3.306168e-01 | 0.481 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 5.089832e-01 | 0.293 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 2.221908e-01 | 0.653 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 1.945347e-01 | 0.711 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 3.228648e-01 | 0.491 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 3.766222e-01 | 0.424 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 2.715192e-01 | 0.566 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 3.129994e-01 | 0.504 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 5.523819e-01 | 0.258 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 2.465329e-01 | 0.608 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 3.534267e-01 | 0.452 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 3.172880e-01 | 0.499 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 4.059937e-01 | 0.391 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 2.858792e-01 | 0.544 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 3.260815e-01 | 0.487 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 2.325418e-01 | 0.633 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 3.369084e-01 | 0.472 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 5.037594e-01 | 0.298 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 5.340643e-01 | 0.272 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 5.391003e-01 | 0.268 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 2.393079e-01 | 0.621 | 0 | 0 |
| Extrinsic Pathway of Fibrin Clot Formation | R-HSA-140834 | 5.525648e-01 | 0.258 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 4.013236e-01 | 0.397 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.964780e-01 | 0.528 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 2.024260e-01 | 0.694 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 4.021504e-01 | 0.396 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 4.521435e-01 | 0.345 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 3.260815e-01 | 0.487 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 3.112093e-01 | 0.507 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 4.335411e-01 | 0.363 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 3.050826e-01 | 0.516 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 4.680725e-01 | 0.330 | 0 | 0 |
| Protein folding | R-HSA-391251 | 3.944425e-01 | 0.404 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 2.920741e-01 | 0.535 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 5.377629e-01 | 0.269 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 5.523819e-01 | 0.258 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 2.837743e-01 | 0.547 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 2.187113e-01 | 0.660 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 2.393079e-01 | 0.621 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 2.325418e-01 | 0.633 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 4.237607e-01 | 0.373 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 5.198249e-01 | 0.284 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 4.274863e-01 | 0.369 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 5.340643e-01 | 0.272 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 5.441790e-01 | 0.264 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 1.896000e-01 | 0.722 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 4.976341e-01 | 0.303 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 3.712092e-01 | 0.430 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 2.002070e-01 | 0.699 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 1.926598e-01 | 0.715 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 2.815138e-01 | 0.551 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.873613e-01 | 0.412 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 3.873613e-01 | 0.412 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 2.512988e-01 | 0.600 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 2.714831e-01 | 0.566 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 1.945347e-01 | 0.711 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 4.680725e-01 | 0.330 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 4.600646e-01 | 0.337 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 5.168523e-01 | 0.287 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 1.896000e-01 | 0.722 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 2.612925e-01 | 0.583 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 2.808545e-01 | 0.552 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 4.702472e-01 | 0.328 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 2.221908e-01 | 0.653 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 2.952331e-01 | 0.530 | 0 | 0 |
| S Phase | R-HSA-69242 | 3.822981e-01 | 0.418 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 4.013908e-01 | 0.396 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 4.901661e-01 | 0.310 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.926598e-01 | 0.715 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 2.414743e-01 | 0.617 | 0 | 0 |
| PKA activation | R-HSA-163615 | 1.986340e-01 | 0.702 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 2.715192e-01 | 0.566 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 4.011418e-01 | 0.397 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 4.777700e-01 | 0.321 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 3.767415e-01 | 0.424 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 4.680725e-01 | 0.330 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 5.340643e-01 | 0.272 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 5.529808e-01 | 0.257 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 3.228648e-01 | 0.491 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 5.148583e-01 | 0.288 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.064223e-01 | 0.685 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 3.411723e-01 | 0.467 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 3.592377e-01 | 0.445 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 3.112093e-01 | 0.507 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 2.465728e-01 | 0.608 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 2.984261e-01 | 0.525 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 2.984261e-01 | 0.525 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.939914e-01 | 0.712 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 2.751965e-01 | 0.560 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 3.623075e-01 | 0.441 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 4.840724e-01 | 0.315 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 3.231909e-01 | 0.491 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 2.815138e-01 | 0.551 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 2.666125e-01 | 0.574 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 2.666125e-01 | 0.574 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 5.337508e-01 | 0.273 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 1.961605e-01 | 0.707 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 4.691329e-01 | 0.329 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 4.938749e-01 | 0.306 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 5.156340e-01 | 0.288 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 4.131494e-01 | 0.384 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 4.875860e-01 | 0.312 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 1.961605e-01 | 0.707 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 3.260815e-01 | 0.487 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 2.393079e-01 | 0.621 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 4.335355e-01 | 0.363 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 4.335355e-01 | 0.363 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 3.129994e-01 | 0.504 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 4.777700e-01 | 0.321 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 4.777700e-01 | 0.321 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 4.416096e-01 | 0.355 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 5.675031e-01 | 0.246 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 1.972174e-01 | 0.705 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 4.655976e-01 | 0.332 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 2.932210e-01 | 0.533 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 5.680122e-01 | 0.246 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.216839e-01 | 0.654 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 3.341865e-01 | 0.476 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 5.680122e-01 | 0.246 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 2.187113e-01 | 0.660 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 1.940156e-01 | 0.712 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 4.629362e-01 | 0.334 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 3.931634e-01 | 0.405 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 3.109494e-01 | 0.507 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 1.919254e-01 | 0.717 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 2.539176e-01 | 0.595 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 3.260815e-01 | 0.487 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 2.714831e-01 | 0.566 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 5.525648e-01 | 0.258 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 5.525648e-01 | 0.258 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 4.680725e-01 | 0.330 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 5.595509e-01 | 0.252 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.341865e-01 | 0.476 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 2.854251e-01 | 0.545 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 4.273731e-01 | 0.369 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 4.154668e-01 | 0.381 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 2.414743e-01 | 0.617 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 2.539176e-01 | 0.595 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 3.396010e-01 | 0.469 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 3.260815e-01 | 0.487 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.124377e-01 | 0.673 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.002070e-01 | 0.699 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 3.398417e-01 | 0.469 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 4.786813e-01 | 0.320 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 4.365625e-01 | 0.360 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 3.298399e-01 | 0.482 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 4.416096e-01 | 0.355 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 5.429753e-01 | 0.265 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 5.429753e-01 | 0.265 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 3.532325e-01 | 0.452 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 4.777700e-01 | 0.321 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 3.679859e-01 | 0.434 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 4.895314e-01 | 0.310 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.930549e-01 | 0.714 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 3.982136e-01 | 0.400 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 3.742810e-01 | 0.427 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 4.938749e-01 | 0.306 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 4.938749e-01 | 0.306 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 5.016282e-01 | 0.300 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 2.837743e-01 | 0.547 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 4.938749e-01 | 0.306 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 2.351238e-01 | 0.629 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 3.310690e-01 | 0.480 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 3.310690e-01 | 0.480 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 2.187113e-01 | 0.660 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 4.149838e-01 | 0.382 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 4.149838e-01 | 0.382 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 1.961605e-01 | 0.707 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 3.396010e-01 | 0.469 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 2.898366e-01 | 0.538 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 3.873613e-01 | 0.412 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 4.883761e-01 | 0.311 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 4.883761e-01 | 0.311 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 4.335355e-01 | 0.363 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 2.841911e-01 | 0.546 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 3.751461e-01 | 0.426 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 4.777700e-01 | 0.321 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 4.777700e-01 | 0.321 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 5.525648e-01 | 0.258 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 3.770615e-01 | 0.424 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 3.241098e-01 | 0.489 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 5.198249e-01 | 0.284 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 5.595509e-01 | 0.252 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 4.802545e-01 | 0.319 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 2.863927e-01 | 0.543 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 5.084624e-01 | 0.294 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 5.371385e-01 | 0.270 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 2.905138e-01 | 0.537 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 3.130394e-01 | 0.504 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 2.053752e-01 | 0.687 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 4.887828e-01 | 0.311 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 4.273731e-01 | 0.369 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 5.016282e-01 | 0.300 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 3.103178e-01 | 0.508 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 4.401388e-01 | 0.356 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 3.172880e-01 | 0.499 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 5.484366e-01 | 0.261 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 3.050826e-01 | 0.516 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 2.187113e-01 | 0.660 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 4.335355e-01 | 0.363 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 4.777700e-01 | 0.321 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 5.255703e-01 | 0.279 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 4.627490e-01 | 0.335 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 4.887828e-01 | 0.311 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 5.049665e-01 | 0.297 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 5.016282e-01 | 0.300 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 5.458402e-01 | 0.263 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 3.569097e-01 | 0.447 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 4.249148e-01 | 0.372 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 4.421506e-01 | 0.354 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 3.396010e-01 | 0.469 | 0 | 0 |
| Lipid particle organization | R-HSA-8964572 | 3.396010e-01 | 0.469 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 4.777700e-01 | 0.321 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 4.777700e-01 | 0.321 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 4.777700e-01 | 0.321 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 4.680725e-01 | 0.330 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 4.702839e-01 | 0.328 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.975019e-01 | 0.704 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 4.976341e-01 | 0.303 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.858680e-01 | 0.544 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 4.466467e-01 | 0.350 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 2.907490e-01 | 0.536 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 4.149838e-01 | 0.382 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 2.539176e-01 | 0.595 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 1.986340e-01 | 0.702 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 2.898366e-01 | 0.538 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 4.883761e-01 | 0.311 | 0 | 0 |
| SLC-mediated bile acid transport | R-HSA-9958517 | 4.335355e-01 | 0.363 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 2.714831e-01 | 0.566 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 5.525648e-01 | 0.258 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 4.308085e-01 | 0.366 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 3.104790e-01 | 0.508 | 0 | 0 |
| LTC4-CYSLTR mediated IL4 production | R-HSA-9664535 | 5.198249e-01 | 0.284 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 5.016282e-01 | 0.300 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 4.365625e-01 | 0.360 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.505504e-01 | 0.346 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 5.595509e-01 | 0.252 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 5.156708e-01 | 0.288 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.221908e-01 | 0.653 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 2.179176e-01 | 0.662 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 4.335411e-01 | 0.363 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 4.600646e-01 | 0.337 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 2.416991e-01 | 0.617 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 2.907490e-01 | 0.536 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.522932e-01 | 0.598 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 4.883761e-01 | 0.311 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 5.595509e-01 | 0.252 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 5.212341e-01 | 0.283 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 2.920741e-01 | 0.535 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 3.489530e-01 | 0.457 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 4.531906e-01 | 0.344 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 4.761769e-01 | 0.322 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 3.569097e-01 | 0.447 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 2.414743e-01 | 0.617 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 1.972174e-01 | 0.705 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 3.873613e-01 | 0.412 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 4.883761e-01 | 0.311 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 4.883761e-01 | 0.311 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.970091e-01 | 0.527 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 3.172880e-01 | 0.499 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 5.525648e-01 | 0.258 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.910551e-01 | 0.719 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 2.237664e-01 | 0.650 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 4.857718e-01 | 0.314 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 4.149838e-01 | 0.382 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 3.020721e-01 | 0.520 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 4.680725e-01 | 0.330 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 2.815138e-01 | 0.551 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 2.539176e-01 | 0.595 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 3.984347e-01 | 0.400 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 3.982136e-01 | 0.400 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 4.479685e-01 | 0.349 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 5.652687e-01 | 0.248 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 4.335411e-01 | 0.363 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 5.706840e-01 | 0.244 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 5.707951e-01 | 0.244 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 5.714583e-01 | 0.243 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 5.740948e-01 | 0.241 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 5.744778e-01 | 0.241 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 5.758012e-01 | 0.240 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 5.758012e-01 | 0.240 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 5.758012e-01 | 0.240 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 5.767399e-01 | 0.239 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 5.806381e-01 | 0.236 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 5.812282e-01 | 0.236 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 5.852227e-01 | 0.233 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 5.870519e-01 | 0.231 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 5.937312e-01 | 0.226 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 5.937449e-01 | 0.226 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 5.939480e-01 | 0.226 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 5.947035e-01 | 0.226 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 5.951582e-01 | 0.225 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 5.951582e-01 | 0.225 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 5.951582e-01 | 0.225 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 5.951582e-01 | 0.225 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 5.951582e-01 | 0.225 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 5.951582e-01 | 0.225 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 5.963034e-01 | 0.225 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 5.968705e-01 | 0.224 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 5.968705e-01 | 0.224 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 5.968705e-01 | 0.224 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 5.968705e-01 | 0.224 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 5.968705e-01 | 0.224 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 5.977295e-01 | 0.223 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 5.977295e-01 | 0.223 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 5.985570e-01 | 0.223 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 5.985570e-01 | 0.223 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 6.002765e-01 | 0.222 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 6.013006e-01 | 0.221 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 6.013006e-01 | 0.221 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 6.013006e-01 | 0.221 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 6.013006e-01 | 0.221 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 6.013006e-01 | 0.221 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 6.026704e-01 | 0.220 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 6.042679e-01 | 0.219 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.052387e-01 | 0.218 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 6.073295e-01 | 0.217 | 0 | 0 |
| Activation of AMPA receptors | R-HSA-399710 | 6.087036e-01 | 0.216 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 6.087036e-01 | 0.216 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 6.087036e-01 | 0.216 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 6.087036e-01 | 0.216 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 6.087036e-01 | 0.216 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 6.087036e-01 | 0.216 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 6.087036e-01 | 0.216 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 6.087036e-01 | 0.216 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 6.087036e-01 | 0.216 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 6.087036e-01 | 0.216 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 6.087036e-01 | 0.216 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 6.087036e-01 | 0.216 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 6.087036e-01 | 0.216 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 6.087036e-01 | 0.216 | 0 | 0 |
| Zinc efflux and compartmentalization by the SLC30 family | R-HSA-435368 | 6.087036e-01 | 0.216 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 6.104175e-01 | 0.214 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 6.118886e-01 | 0.213 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 6.195442e-01 | 0.208 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 6.206084e-01 | 0.207 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 6.206084e-01 | 0.207 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 6.209868e-01 | 0.207 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 6.209868e-01 | 0.207 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 6.236748e-01 | 0.205 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 6.236748e-01 | 0.205 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 6.236748e-01 | 0.205 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 6.260180e-01 | 0.203 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 6.317621e-01 | 0.199 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 6.317621e-01 | 0.199 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 6.317621e-01 | 0.199 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 6.317621e-01 | 0.199 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 6.317621e-01 | 0.199 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 6.317621e-01 | 0.199 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 6.317621e-01 | 0.199 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 6.407295e-01 | 0.193 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 6.409274e-01 | 0.193 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 6.409274e-01 | 0.193 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 6.415950e-01 | 0.193 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 6.419223e-01 | 0.193 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 6.431005e-01 | 0.192 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 6.446962e-01 | 0.191 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 6.456481e-01 | 0.190 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 6.467420e-01 | 0.189 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 6.467420e-01 | 0.189 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 6.507830e-01 | 0.187 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 6.507830e-01 | 0.187 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 6.507830e-01 | 0.187 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 6.523919e-01 | 0.185 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 6.529969e-01 | 0.185 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 6.578017e-01 | 0.182 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 6.578017e-01 | 0.182 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.578017e-01 | 0.182 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.578017e-01 | 0.182 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.578017e-01 | 0.182 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 6.578017e-01 | 0.182 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.578017e-01 | 0.182 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 6.578017e-01 | 0.182 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 6.578017e-01 | 0.182 | 0 | 0 |
| Phase 1 - inactivation of fast Na+ channels | R-HSA-5576894 | 6.578017e-01 | 0.182 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 6.578017e-01 | 0.182 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 6.578017e-01 | 0.182 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 6.578017e-01 | 0.182 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 6.578017e-01 | 0.182 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 6.578017e-01 | 0.182 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 6.578017e-01 | 0.182 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 6.578017e-01 | 0.182 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 6.578017e-01 | 0.182 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 6.578017e-01 | 0.182 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 6.578017e-01 | 0.182 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 6.578017e-01 | 0.182 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 6.578017e-01 | 0.182 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 6.578017e-01 | 0.182 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 6.588476e-01 | 0.181 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 6.642475e-01 | 0.178 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 6.642475e-01 | 0.178 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 6.642475e-01 | 0.178 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 6.642475e-01 | 0.178 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 6.642475e-01 | 0.178 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 6.642475e-01 | 0.178 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 6.642475e-01 | 0.178 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 6.655658e-01 | 0.177 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 6.674054e-01 | 0.176 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 6.674054e-01 | 0.176 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 6.732716e-01 | 0.172 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 6.732716e-01 | 0.172 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 6.748317e-01 | 0.171 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 6.764661e-01 | 0.170 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 6.764661e-01 | 0.170 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 6.764661e-01 | 0.170 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 6.764661e-01 | 0.170 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 6.764661e-01 | 0.170 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 6.780400e-01 | 0.169 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 6.822417e-01 | 0.166 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 6.822417e-01 | 0.166 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 6.822417e-01 | 0.166 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 6.890982e-01 | 0.162 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 6.890982e-01 | 0.162 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 6.896617e-01 | 0.161 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 6.896617e-01 | 0.161 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 6.896617e-01 | 0.161 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 6.896617e-01 | 0.161 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 6.896617e-01 | 0.161 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 6.920365e-01 | 0.160 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 6.920365e-01 | 0.160 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 6.925372e-01 | 0.160 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 6.943811e-01 | 0.158 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 6.943811e-01 | 0.158 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 6.943811e-01 | 0.158 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 6.943811e-01 | 0.158 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 6.943811e-01 | 0.158 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 6.943811e-01 | 0.158 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 6.943811e-01 | 0.158 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 6.997633e-01 | 0.155 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 7.002343e-01 | 0.155 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 7.002343e-01 | 0.155 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 7.007242e-01 | 0.154 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 7.007242e-01 | 0.154 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 7.007242e-01 | 0.154 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 7.007416e-01 | 0.154 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 7.007416e-01 | 0.154 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 7.007416e-01 | 0.154 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 7.007416e-01 | 0.154 | 0 | 0 |
| Highly sodium permeable postsynaptic acetylcholine nicotinic receptors | R-HSA-629587 | 7.007416e-01 | 0.154 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 7.007416e-01 | 0.154 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 7.007416e-01 | 0.154 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 7.007416e-01 | 0.154 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 7.007416e-01 | 0.154 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 7.007416e-01 | 0.154 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 7.007416e-01 | 0.154 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 7.007416e-01 | 0.154 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 7.007416e-01 | 0.154 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 7.047439e-01 | 0.152 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 7.047439e-01 | 0.152 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 7.079820e-01 | 0.150 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 7.097677e-01 | 0.149 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 7.097677e-01 | 0.149 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 7.099207e-01 | 0.149 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 7.122941e-01 | 0.147 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 7.122941e-01 | 0.147 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 7.124159e-01 | 0.147 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 7.126390e-01 | 0.147 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 7.129524e-01 | 0.147 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 7.193887e-01 | 0.143 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 7.193887e-01 | 0.143 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 7.193887e-01 | 0.143 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 7.215015e-01 | 0.142 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 7.222414e-01 | 0.141 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 7.222414e-01 | 0.141 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 7.222414e-01 | 0.141 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 7.222414e-01 | 0.141 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 7.222414e-01 | 0.141 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 7.222414e-01 | 0.141 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 7.222414e-01 | 0.141 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 7.222414e-01 | 0.141 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 7.222414e-01 | 0.141 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 7.222414e-01 | 0.141 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 7.235708e-01 | 0.141 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 7.235708e-01 | 0.141 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 7.235708e-01 | 0.141 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 7.289386e-01 | 0.137 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 7.317778e-01 | 0.136 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 7.317778e-01 | 0.136 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 7.367590e-01 | 0.133 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 7.369573e-01 | 0.133 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 7.382955e-01 | 0.132 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 7.382955e-01 | 0.132 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 7.382955e-01 | 0.132 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 7.382955e-01 | 0.132 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 7.382955e-01 | 0.132 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 7.382955e-01 | 0.132 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 7.382955e-01 | 0.132 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 7.382955e-01 | 0.132 | 0 | 0 |
| FGFR3b ligand binding and activation | R-HSA-190371 | 7.382955e-01 | 0.132 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 7.382955e-01 | 0.132 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 7.382955e-01 | 0.132 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 7.382955e-01 | 0.132 | 0 | 0 |
| Cysteine formation from homocysteine | R-HSA-1614603 | 7.382955e-01 | 0.132 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 7.382955e-01 | 0.132 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 7.382955e-01 | 0.132 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 7.382955e-01 | 0.132 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 7.382955e-01 | 0.132 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 7.397665e-01 | 0.131 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 7.407713e-01 | 0.130 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 7.450311e-01 | 0.128 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 7.470668e-01 | 0.127 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 7.479246e-01 | 0.126 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 7.479246e-01 | 0.126 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 7.479246e-01 | 0.126 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 7.479246e-01 | 0.126 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 7.479246e-01 | 0.126 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 7.479246e-01 | 0.126 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 7.480490e-01 | 0.126 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 7.524482e-01 | 0.124 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 7.533299e-01 | 0.123 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 7.533299e-01 | 0.123 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 7.582356e-01 | 0.120 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 7.595523e-01 | 0.119 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 7.651392e-01 | 0.116 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.651392e-01 | 0.116 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 7.656836e-01 | 0.116 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 7.656836e-01 | 0.116 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 7.711387e-01 | 0.113 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 7.711387e-01 | 0.113 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.711387e-01 | 0.113 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 7.711387e-01 | 0.113 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 7.711387e-01 | 0.113 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 7.711387e-01 | 0.113 | 0 | 0 |
| Highly calcium permeable nicotinic acetylcholine receptors | R-HSA-629597 | 7.711387e-01 | 0.113 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 7.711387e-01 | 0.113 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 7.711387e-01 | 0.113 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 7.711387e-01 | 0.113 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 7.711387e-01 | 0.113 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 7.711387e-01 | 0.113 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 7.711387e-01 | 0.113 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 7.711387e-01 | 0.113 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 7.711387e-01 | 0.113 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 7.711387e-01 | 0.113 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 7.715381e-01 | 0.113 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 7.715381e-01 | 0.113 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 7.715381e-01 | 0.113 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 7.715381e-01 | 0.113 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 7.738725e-01 | 0.111 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 7.738725e-01 | 0.111 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 7.794477e-01 | 0.108 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 7.808460e-01 | 0.107 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 7.823387e-01 | 0.107 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 7.831506e-01 | 0.106 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 7.839371e-01 | 0.106 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 7.839371e-01 | 0.106 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 7.839371e-01 | 0.106 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.839371e-01 | 0.106 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 7.839371e-01 | 0.106 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 7.839371e-01 | 0.106 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 7.841068e-01 | 0.106 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 7.841068e-01 | 0.106 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 7.841068e-01 | 0.106 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 7.875436e-01 | 0.104 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 7.931968e-01 | 0.101 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 7.931968e-01 | 0.101 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 7.931968e-01 | 0.101 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 7.931968e-01 | 0.101 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 7.931968e-01 | 0.101 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 7.931968e-01 | 0.101 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 7.966192e-01 | 0.099 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 7.980383e-01 | 0.098 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 7.980383e-01 | 0.098 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 7.980383e-01 | 0.098 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 7.998618e-01 | 0.097 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 7.998618e-01 | 0.097 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 7.998618e-01 | 0.097 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 7.998618e-01 | 0.097 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 7.998618e-01 | 0.097 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 7.998618e-01 | 0.097 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 7.998618e-01 | 0.097 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.998618e-01 | 0.097 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 7.998618e-01 | 0.097 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 7.998618e-01 | 0.097 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 7.998618e-01 | 0.097 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 7.998618e-01 | 0.097 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 8.005752e-01 | 0.097 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 8.014721e-01 | 0.096 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 8.024155e-01 | 0.096 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 8.101088e-01 | 0.091 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 8.117643e-01 | 0.091 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 8.118202e-01 | 0.091 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 8.128101e-01 | 0.090 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 8.130194e-01 | 0.090 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 8.130194e-01 | 0.090 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 8.130194e-01 | 0.090 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 8.130194e-01 | 0.090 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 8.130194e-01 | 0.090 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 8.130194e-01 | 0.090 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 8.130194e-01 | 0.090 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 8.130194e-01 | 0.090 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 8.130194e-01 | 0.090 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 8.153721e-01 | 0.089 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 8.177959e-01 | 0.087 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 8.177959e-01 | 0.087 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 8.177959e-01 | 0.087 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 8.177959e-01 | 0.087 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 8.177959e-01 | 0.087 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 8.177959e-01 | 0.087 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 8.182456e-01 | 0.087 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 8.184989e-01 | 0.087 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 8.184989e-01 | 0.087 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.245719e-01 | 0.084 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 8.249815e-01 | 0.084 | 0 | 0 |
| Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | R-HSA-629594 | 8.249815e-01 | 0.084 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 8.249815e-01 | 0.084 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 8.249815e-01 | 0.084 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 8.249815e-01 | 0.084 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 8.249815e-01 | 0.084 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 8.249815e-01 | 0.084 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 8.249815e-01 | 0.084 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 8.249815e-01 | 0.084 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 8.249815e-01 | 0.084 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 8.255019e-01 | 0.083 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.263322e-01 | 0.083 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 8.266846e-01 | 0.083 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 8.311255e-01 | 0.080 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 8.311255e-01 | 0.080 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 8.311255e-01 | 0.080 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 8.311255e-01 | 0.080 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 8.329634e-01 | 0.079 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 8.329634e-01 | 0.079 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 8.329634e-01 | 0.079 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 8.329634e-01 | 0.079 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 8.329634e-01 | 0.079 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 8.334131e-01 | 0.079 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 8.366147e-01 | 0.077 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 8.366147e-01 | 0.077 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 8.385197e-01 | 0.076 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 8.404077e-01 | 0.076 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 8.404077e-01 | 0.076 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 8.404077e-01 | 0.076 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 8.419773e-01 | 0.075 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 8.430198e-01 | 0.074 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 8.465658e-01 | 0.072 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 8.469496e-01 | 0.072 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 8.469496e-01 | 0.072 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 8.469496e-01 | 0.072 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 8.469496e-01 | 0.072 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 8.469496e-01 | 0.072 | 0 | 0 |
| Cholesterol biosynthesis via desmosterol | R-HSA-6807047 | 8.469496e-01 | 0.072 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 8.469496e-01 | 0.072 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 8.469496e-01 | 0.072 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 8.469496e-01 | 0.072 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 8.469496e-01 | 0.072 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 8.469496e-01 | 0.072 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 8.470311e-01 | 0.072 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 8.470311e-01 | 0.072 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 8.470311e-01 | 0.072 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 8.470311e-01 | 0.072 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 8.470311e-01 | 0.072 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 8.476337e-01 | 0.072 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 8.476337e-01 | 0.072 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 8.476337e-01 | 0.072 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 8.476337e-01 | 0.072 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.479714e-01 | 0.072 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 8.518742e-01 | 0.070 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 8.529056e-01 | 0.069 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 8.566075e-01 | 0.067 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 8.566075e-01 | 0.067 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 8.567568e-01 | 0.067 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 8.575031e-01 | 0.067 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 8.575031e-01 | 0.067 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 8.592941e-01 | 0.066 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 8.600569e-01 | 0.065 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 8.626596e-01 | 0.064 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 8.626596e-01 | 0.064 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 8.626596e-01 | 0.064 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 8.626596e-01 | 0.064 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 8.626596e-01 | 0.064 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 8.626596e-01 | 0.064 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 8.632595e-01 | 0.064 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 8.632595e-01 | 0.064 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 8.661019e-01 | 0.062 | 0 | 0 |
| Presynaptic nicotinic acetylcholine receptors | R-HSA-622323 | 8.661615e-01 | 0.062 | 0 | 0 |
| Endosomal/Vacuolar pathway | R-HSA-1236977 | 8.661615e-01 | 0.062 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 8.661615e-01 | 0.062 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 8.661615e-01 | 0.062 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 8.661615e-01 | 0.062 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 8.661615e-01 | 0.062 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 8.661615e-01 | 0.062 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 8.661615e-01 | 0.062 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.672688e-01 | 0.062 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 8.687234e-01 | 0.061 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 8.705144e-01 | 0.060 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 8.720986e-01 | 0.059 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.720986e-01 | 0.059 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 8.738865e-01 | 0.059 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 8.738865e-01 | 0.059 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 8.738865e-01 | 0.059 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 8.738865e-01 | 0.059 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 8.738865e-01 | 0.059 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 8.763154e-01 | 0.057 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 8.763154e-01 | 0.057 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 8.763154e-01 | 0.057 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 8.763154e-01 | 0.057 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 8.781694e-01 | 0.056 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 8.781694e-01 | 0.056 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 8.809622e-01 | 0.055 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 8.829627e-01 | 0.054 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 8.829627e-01 | 0.054 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 8.829627e-01 | 0.054 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 8.829627e-01 | 0.054 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 8.829627e-01 | 0.054 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.829627e-01 | 0.054 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 8.829627e-01 | 0.054 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.829627e-01 | 0.054 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 8.829627e-01 | 0.054 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 8.829627e-01 | 0.054 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 8.829627e-01 | 0.054 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 8.829627e-01 | 0.054 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 8.829627e-01 | 0.054 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 8.829627e-01 | 0.054 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 8.829627e-01 | 0.054 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 8.829627e-01 | 0.054 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 8.835254e-01 | 0.054 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.849208e-01 | 0.053 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 8.860803e-01 | 0.053 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 8.880057e-01 | 0.052 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 8.882392e-01 | 0.051 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 8.886124e-01 | 0.051 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 8.887080e-01 | 0.051 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 8.887080e-01 | 0.051 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 8.887080e-01 | 0.051 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 8.887080e-01 | 0.051 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 8.887080e-01 | 0.051 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 8.887080e-01 | 0.051 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 8.887080e-01 | 0.051 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 8.896302e-01 | 0.051 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 8.930125e-01 | 0.049 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 8.930125e-01 | 0.049 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 8.930125e-01 | 0.049 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 8.934591e-01 | 0.049 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 8.934591e-01 | 0.049 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 8.946973e-01 | 0.048 | 0 | 0 |
| Acetylcholine binding and downstream events | R-HSA-181431 | 8.976557e-01 | 0.047 | 0 | 0 |
| Postsynaptic nicotinic acetylcholine receptors | R-HSA-622327 | 8.976557e-01 | 0.047 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 8.976557e-01 | 0.047 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 8.976557e-01 | 0.047 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 8.976557e-01 | 0.047 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 8.976557e-01 | 0.047 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 8.976557e-01 | 0.047 | 0 | 0 |
| Mtb iron assimilation by chelation | R-HSA-1222449 | 8.976557e-01 | 0.047 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 8.976557e-01 | 0.047 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 8.976557e-01 | 0.047 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 8.976557e-01 | 0.047 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 8.976557e-01 | 0.047 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 8.999394e-01 | 0.046 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 8.999394e-01 | 0.046 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 8.999394e-01 | 0.046 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 9.015845e-01 | 0.045 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.015845e-01 | 0.045 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 9.016828e-01 | 0.045 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 9.016828e-01 | 0.045 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 9.028897e-01 | 0.044 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.030989e-01 | 0.044 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 9.060431e-01 | 0.043 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.064603e-01 | 0.043 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.065341e-01 | 0.043 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 9.079262e-01 | 0.042 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.095437e-01 | 0.041 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.101058e-01 | 0.041 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 9.103595e-01 | 0.041 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 9.105048e-01 | 0.041 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 9.105048e-01 | 0.041 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 9.105048e-01 | 0.041 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 9.105048e-01 | 0.041 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 9.105048e-01 | 0.041 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 9.105048e-01 | 0.041 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 9.105048e-01 | 0.041 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 9.105048e-01 | 0.041 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 9.105048e-01 | 0.041 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 9.105048e-01 | 0.041 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 9.105048e-01 | 0.041 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 9.115593e-01 | 0.040 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.115593e-01 | 0.040 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.115593e-01 | 0.040 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.123008e-01 | 0.040 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.192974e-01 | 0.037 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.192974e-01 | 0.037 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.195194e-01 | 0.036 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.195194e-01 | 0.036 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.215599e-01 | 0.035 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 9.217414e-01 | 0.035 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 9.217414e-01 | 0.035 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 9.217414e-01 | 0.035 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 9.217414e-01 | 0.035 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 9.217414e-01 | 0.035 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 9.217414e-01 | 0.035 | 0 | 0 |
| Synthesis of 12-eicosatetraenoic acid derivatives | R-HSA-2142712 | 9.217414e-01 | 0.035 | 0 | 0 |
| Dopamine clearance from the synaptic cleft | R-HSA-379401 | 9.217414e-01 | 0.035 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 9.217414e-01 | 0.035 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 9.217414e-01 | 0.035 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 9.217414e-01 | 0.035 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 9.217414e-01 | 0.035 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.227344e-01 | 0.035 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.237632e-01 | 0.034 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.237632e-01 | 0.034 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.237632e-01 | 0.034 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.246984e-01 | 0.034 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 9.266955e-01 | 0.033 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.268149e-01 | 0.033 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.268196e-01 | 0.033 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 9.268196e-01 | 0.033 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 9.275988e-01 | 0.033 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 9.275988e-01 | 0.033 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 9.275988e-01 | 0.033 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.277671e-01 | 0.033 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.277671e-01 | 0.033 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.299378e-01 | 0.032 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.299378e-01 | 0.032 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.311248e-01 | 0.031 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 9.315678e-01 | 0.031 | 0 | 0 |
| Activation of the phototransduction cascade | R-HSA-2485179 | 9.315678e-01 | 0.031 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 9.315678e-01 | 0.031 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 9.315678e-01 | 0.031 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 9.315678e-01 | 0.031 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 9.315678e-01 | 0.031 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 9.315678e-01 | 0.031 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 9.315678e-01 | 0.031 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 9.315678e-01 | 0.031 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 9.335071e-01 | 0.030 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.348357e-01 | 0.029 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.350885e-01 | 0.029 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.350885e-01 | 0.029 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 9.350885e-01 | 0.029 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.359394e-01 | 0.029 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.372400e-01 | 0.028 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.399345e-01 | 0.027 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 9.401608e-01 | 0.027 | 0 | 0 |
| Vitamin B6 activation to pyridoxal phosphate | R-HSA-964975 | 9.401608e-01 | 0.027 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 9.401608e-01 | 0.027 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 9.401608e-01 | 0.027 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.413404e-01 | 0.026 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 9.418394e-01 | 0.026 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 9.418394e-01 | 0.026 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.418394e-01 | 0.026 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.418394e-01 | 0.026 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.446713e-01 | 0.025 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.452212e-01 | 0.024 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.460642e-01 | 0.024 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 9.476753e-01 | 0.023 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 9.476753e-01 | 0.023 | 0 | 0 |
| Synthesis of 15-eicosatetraenoic acid derivatives | R-HSA-2142770 | 9.476753e-01 | 0.023 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 9.476753e-01 | 0.023 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 9.476753e-01 | 0.023 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.501297e-01 | 0.022 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.503304e-01 | 0.022 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.503304e-01 | 0.022 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 9.509149e-01 | 0.022 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 9.515020e-01 | 0.022 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.524927e-01 | 0.021 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.531449e-01 | 0.021 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 9.533893e-01 | 0.021 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.533893e-01 | 0.021 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 9.542465e-01 | 0.020 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 9.542465e-01 | 0.020 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 9.542465e-01 | 0.020 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.542465e-01 | 0.020 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 9.542465e-01 | 0.020 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 9.542465e-01 | 0.020 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.547030e-01 | 0.020 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.547030e-01 | 0.020 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.549922e-01 | 0.020 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 9.551433e-01 | 0.020 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.569862e-01 | 0.019 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.583075e-01 | 0.018 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 9.590333e-01 | 0.018 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.592419e-01 | 0.018 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.592419e-01 | 0.018 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.592419e-01 | 0.018 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 9.594553e-01 | 0.018 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.598764e-01 | 0.018 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 9.599927e-01 | 0.018 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 9.599927e-01 | 0.018 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 9.599927e-01 | 0.018 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 9.599927e-01 | 0.018 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.599927e-01 | 0.018 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 9.599927e-01 | 0.018 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 9.599927e-01 | 0.018 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 9.599927e-01 | 0.018 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.599927e-01 | 0.018 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 9.599927e-01 | 0.018 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 9.636544e-01 | 0.016 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.650176e-01 | 0.015 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.650176e-01 | 0.015 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 9.650176e-01 | 0.015 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 9.650176e-01 | 0.015 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 9.650176e-01 | 0.015 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 9.650176e-01 | 0.015 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 9.650176e-01 | 0.015 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.650176e-01 | 0.015 | 0 | 0 |
| Keratan sulfate degradation | R-HSA-2022857 | 9.650176e-01 | 0.015 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.650176e-01 | 0.015 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.650176e-01 | 0.015 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.650176e-01 | 0.015 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 9.666352e-01 | 0.015 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.666352e-01 | 0.015 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 9.666925e-01 | 0.015 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 9.694116e-01 | 0.013 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 9.694116e-01 | 0.013 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.694116e-01 | 0.013 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 9.694116e-01 | 0.013 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 9.694116e-01 | 0.013 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.694116e-01 | 0.013 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 9.694116e-01 | 0.013 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 9.694116e-01 | 0.013 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.698385e-01 | 0.013 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.698385e-01 | 0.013 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.698385e-01 | 0.013 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.702510e-01 | 0.013 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.702510e-01 | 0.013 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.719543e-01 | 0.012 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 9.732540e-01 | 0.012 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 9.732540e-01 | 0.012 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.732540e-01 | 0.012 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.732540e-01 | 0.012 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.734413e-01 | 0.012 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.734413e-01 | 0.012 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 9.734413e-01 | 0.012 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.734413e-01 | 0.012 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 9.743045e-01 | 0.011 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.751353e-01 | 0.011 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.762998e-01 | 0.010 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.762998e-01 | 0.010 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 9.762998e-01 | 0.010 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 9.766138e-01 | 0.010 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.766138e-01 | 0.010 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 9.766138e-01 | 0.010 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 9.766138e-01 | 0.010 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.766138e-01 | 0.010 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 9.766138e-01 | 0.010 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 9.777900e-01 | 0.010 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.777900e-01 | 0.010 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.779037e-01 | 0.010 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 9.784648e-01 | 0.009 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.788594e-01 | 0.009 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 9.788594e-01 | 0.009 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 9.788594e-01 | 0.009 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.788594e-01 | 0.009 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.793155e-01 | 0.009 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 9.795518e-01 | 0.009 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.795518e-01 | 0.009 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.795518e-01 | 0.009 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.799908e-01 | 0.009 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.805824e-01 | 0.009 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 9.821208e-01 | 0.008 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.821208e-01 | 0.008 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.821208e-01 | 0.008 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.821208e-01 | 0.008 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.821713e-01 | 0.008 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.823549e-01 | 0.008 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.823825e-01 | 0.008 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.831992e-01 | 0.007 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 9.834143e-01 | 0.007 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.839734e-01 | 0.007 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.839734e-01 | 0.007 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.843672e-01 | 0.007 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.843672e-01 | 0.007 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.843672e-01 | 0.007 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 9.843672e-01 | 0.007 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 9.843672e-01 | 0.007 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 9.843672e-01 | 0.007 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.849652e-01 | 0.007 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.850311e-01 | 0.007 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.850311e-01 | 0.007 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.853333e-01 | 0.006 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.853333e-01 | 0.006 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.863315e-01 | 0.006 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.863315e-01 | 0.006 | 0 | 0 |
| Linoleic acid (LA) metabolism | R-HSA-2046105 | 9.863315e-01 | 0.006 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.863315e-01 | 0.006 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.864523e-01 | 0.006 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 9.866680e-01 | 0.006 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.877950e-01 | 0.005 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.878735e-01 | 0.005 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.880490e-01 | 0.005 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 9.880490e-01 | 0.005 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.880490e-01 | 0.005 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.880490e-01 | 0.005 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.880490e-01 | 0.005 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.880490e-01 | 0.005 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.881300e-01 | 0.005 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.881300e-01 | 0.005 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.885740e-01 | 0.005 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.895509e-01 | 0.005 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.895509e-01 | 0.005 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.895509e-01 | 0.005 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 9.895509e-01 | 0.005 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.895824e-01 | 0.005 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.895824e-01 | 0.005 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.903193e-01 | 0.004 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 9.903834e-01 | 0.004 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.905999e-01 | 0.004 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.908372e-01 | 0.004 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.908640e-01 | 0.004 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 9.908640e-01 | 0.004 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.908640e-01 | 0.004 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 9.908640e-01 | 0.004 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 9.908640e-01 | 0.004 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.908640e-01 | 0.004 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.911389e-01 | 0.004 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.916388e-01 | 0.004 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.916388e-01 | 0.004 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.920122e-01 | 0.003 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 9.920122e-01 | 0.003 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.920122e-01 | 0.003 | 0 | 0 |
| Mucopolysaccharidoses | R-HSA-2206281 | 9.920122e-01 | 0.003 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.926973e-01 | 0.003 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.930162e-01 | 0.003 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 9.930162e-01 | 0.003 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.930162e-01 | 0.003 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.930162e-01 | 0.003 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.930533e-01 | 0.003 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.932210e-01 | 0.003 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.933907e-01 | 0.003 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.933907e-01 | 0.003 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.933907e-01 | 0.003 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 9.933907e-01 | 0.003 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.934782e-01 | 0.003 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.934823e-01 | 0.003 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 9.938940e-01 | 0.003 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.941263e-01 | 0.003 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.941263e-01 | 0.003 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.941263e-01 | 0.003 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.943409e-01 | 0.002 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.943762e-01 | 0.002 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.943762e-01 | 0.002 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.946615e-01 | 0.002 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.946615e-01 | 0.002 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.946615e-01 | 0.002 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.947449e-01 | 0.002 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.947815e-01 | 0.002 | 0 | 0 |
| Translation | R-HSA-72766 | 9.950309e-01 | 0.002 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.951189e-01 | 0.002 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.953326e-01 | 0.002 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.953326e-01 | 0.002 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 9.953326e-01 | 0.002 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.954738e-01 | 0.002 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.955319e-01 | 0.002 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.955907e-01 | 0.002 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.958208e-01 | 0.002 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.959194e-01 | 0.002 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.959194e-01 | 0.002 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.963459e-01 | 0.002 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.964324e-01 | 0.002 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.964324e-01 | 0.002 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.964324e-01 | 0.002 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.967566e-01 | 0.001 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.968810e-01 | 0.001 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 9.968810e-01 | 0.001 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.970795e-01 | 0.001 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.971221e-01 | 0.001 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.972732e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.972732e-01 | 0.001 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.972732e-01 | 0.001 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.972732e-01 | 0.001 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.972732e-01 | 0.001 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.973846e-01 | 0.001 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.974469e-01 | 0.001 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.974469e-01 | 0.001 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.976160e-01 | 0.001 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.976160e-01 | 0.001 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.976160e-01 | 0.001 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.977355e-01 | 0.001 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.979158e-01 | 0.001 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.979609e-01 | 0.001 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.980688e-01 | 0.001 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.981247e-01 | 0.001 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 9.981779e-01 | 0.001 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.981779e-01 | 0.001 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.984071e-01 | 0.001 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.984219e-01 | 0.001 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.984998e-01 | 0.001 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.985904e-01 | 0.001 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.986015e-01 | 0.001 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.986074e-01 | 0.001 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.987609e-01 | 0.001 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.987609e-01 | 0.001 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.989023e-01 | 0.000 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.989357e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.989607e-01 | 0.000 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.990277e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.990277e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.990277e-01 | 0.000 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.990696e-01 | 0.000 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.990696e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.991635e-01 | 0.000 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.991867e-01 | 0.000 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.991867e-01 | 0.000 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.991891e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.992367e-01 | 0.000 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 9.992890e-01 | 0.000 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.993784e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.994567e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.994724e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.994724e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.995153e-01 | 0.000 | 0 | 0 |
| Keratan sulfate/keratin metabolism | R-HSA-1638074 | 9.995250e-01 | 0.000 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.995250e-01 | 0.000 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.995250e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.995323e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.995323e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.995671e-01 | 0.000 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.995730e-01 | 0.000 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.995848e-01 | 0.000 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.995862e-01 | 0.000 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.996371e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.996371e-01 | 0.000 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.996371e-01 | 0.000 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.996827e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.997138e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.997138e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.997138e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.997272e-01 | 0.000 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.997469e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.997569e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.997606e-01 | 0.000 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.997738e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.997763e-01 | 0.000 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.997881e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.997888e-01 | 0.000 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.998148e-01 | 0.000 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.998148e-01 | 0.000 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.998282e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.998371e-01 | 0.000 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.998763e-01 | 0.000 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.998763e-01 | 0.000 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.998794e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.999278e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.999278e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999325e-01 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.999330e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.999369e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.999369e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999377e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999428e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999440e-01 | 0.000 | 0 | 0 |
| Latent infection - Other responses of Mtb to phagocytosis | R-HSA-1222499 | 9.999448e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999511e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999526e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.999579e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.999607e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999677e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.999694e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.999719e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999753e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.999754e-01 | 0.000 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.999759e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999762e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999856e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.999857e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999870e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999877e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999886e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999916e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999961e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999976e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999983e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999989e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999991e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999992e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999992e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999994e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999996e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999998e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999998e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 1.000000e+00 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 1.000000e+00 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 1.000000e+00 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 1.110223e-16 | 15.955 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 1.110223e-16 | 15.955 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.110223e-16 | 15.955 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 1.110223e-16 | 15.955 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 1.110223e-16 | 15.955 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.110223e-16 | 15.955 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.110223e-16 | 15.955 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.110223e-16 | 15.955 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.110223e-16 | 15.955 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.110223e-16 | 15.955 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.110223e-16 | 15.955 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.110223e-16 | 15.955 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.110223e-16 | 15.955 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.110223e-16 | 15.955 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.110223e-16 | 15.955 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.110223e-16 | 15.955 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.110223e-16 | 15.955 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 2.220446e-16 | 15.654 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 4.440892e-16 | 15.353 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 5.551115e-16 | 15.256 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 6.661338e-16 | 15.176 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 8.881784e-16 | 15.051 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 8.881784e-16 | 15.051 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 8.881784e-16 | 15.051 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 1.221245e-15 | 14.913 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 1.443290e-15 | 14.841 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.220446e-15 | 14.654 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.331468e-15 | 14.632 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 2.553513e-15 | 14.593 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 2.997602e-15 | 14.523 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 3.219647e-15 | 14.492 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 3.885781e-15 | 14.411 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 4.884981e-15 | 14.311 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 7.660539e-15 | 14.116 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 7.882583e-15 | 14.103 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 9.547918e-15 | 14.020 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.842970e-14 | 13.734 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 2.531308e-14 | 13.597 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 3.652634e-14 | 13.437 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 2.227107e-13 | 12.652 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.476908e-13 | 12.606 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.599032e-13 | 12.585 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 2.763345e-13 | 12.559 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 3.246292e-13 | 12.489 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 3.553824e-13 | 12.449 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 3.802514e-13 | 12.420 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 4.197753e-13 | 12.377 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 4.447553e-13 | 12.352 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 5.000445e-13 | 12.301 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 5.309087e-13 | 12.275 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 6.559198e-13 | 12.183 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 8.197887e-13 | 12.086 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 8.300027e-13 | 12.081 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.433076e-12 | 11.844 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.464162e-12 | 11.834 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.529776e-12 | 11.815 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.544431e-12 | 11.811 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 1.753264e-12 | 11.756 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 4.887646e-12 | 11.311 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 4.909406e-12 | 11.309 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 5.141998e-12 | 11.289 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 6.526668e-12 | 11.185 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 7.294387e-12 | 11.137 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 7.294387e-12 | 11.137 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.175127e-11 | 10.930 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.194478e-11 | 10.923 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.313361e-11 | 10.882 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.291545e-11 | 10.889 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.321687e-11 | 10.879 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 1.566791e-11 | 10.805 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 2.235989e-11 | 10.651 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 2.491451e-11 | 10.604 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 2.492451e-11 | 10.603 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 2.492506e-11 | 10.603 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 2.819978e-11 | 10.550 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 3.391742e-11 | 10.470 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.434175e-11 | 10.464 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 4.150624e-11 | 10.382 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 4.272638e-11 | 10.369 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 4.547618e-11 | 10.342 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 4.826017e-11 | 10.316 | 0 | 0 |
| Translation | R-HSA-72766 | 5.868905e-11 | 10.231 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 6.308110e-11 | 10.200 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 7.684842e-11 | 10.114 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 8.570722e-11 | 10.067 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.204171e-10 | 9.919 | 1 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.213534e-10 | 9.916 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.383720e-10 | 9.859 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.565225e-10 | 9.805 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 1.621692e-10 | 9.790 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 2.074911e-10 | 9.683 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 2.323258e-10 | 9.634 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.736389e-10 | 9.563 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 2.738774e-10 | 9.562 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 3.680345e-10 | 9.434 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 3.680345e-10 | 9.434 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 3.680345e-10 | 9.434 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 3.680345e-10 | 9.434 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 3.612207e-10 | 9.442 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 3.680345e-10 | 9.434 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 3.680345e-10 | 9.434 | 1 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 3.943967e-10 | 9.404 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 4.601728e-10 | 9.337 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 4.601728e-10 | 9.337 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 5.366751e-10 | 9.270 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 7.211194e-10 | 9.142 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 7.389725e-10 | 9.131 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 7.786858e-10 | 9.109 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 1.032369e-09 | 8.986 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.203657e-09 | 8.919 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.257928e-09 | 8.900 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.330484e-09 | 8.876 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 1.378191e-09 | 8.861 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 1.365300e-09 | 8.865 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.391902e-09 | 8.856 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.466340e-09 | 8.834 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.634782e-09 | 8.787 | 1 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.670735e-09 | 8.777 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.747551e-09 | 8.758 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.862562e-09 | 8.730 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 2.548556e-09 | 8.594 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 2.604258e-09 | 8.584 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 2.823264e-09 | 8.549 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 2.915458e-09 | 8.535 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 3.175778e-09 | 8.498 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 3.300443e-09 | 8.481 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 3.564524e-09 | 8.448 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 3.694120e-09 | 8.432 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 3.712772e-09 | 8.430 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 4.064479e-09 | 8.391 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 4.354340e-09 | 8.361 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 4.354340e-09 | 8.361 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 4.505095e-09 | 8.346 | 0 | 0 |
| Immune System | R-HSA-168256 | 4.544429e-09 | 8.343 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 4.912923e-09 | 8.309 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 4.925682e-09 | 8.308 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 5.143411e-09 | 8.289 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 5.677261e-09 | 8.246 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 6.059710e-09 | 8.218 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 6.995646e-09 | 8.155 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 7.074438e-09 | 8.150 | 0 | 0 |
| Disease | R-HSA-1643685 | 7.868543e-09 | 8.104 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 8.496231e-09 | 8.071 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 9.340649e-09 | 8.030 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.137600e-08 | 7.944 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.137603e-08 | 7.944 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.148619e-08 | 7.940 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.239292e-08 | 7.907 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.337731e-08 | 7.874 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.618280e-08 | 7.791 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.628407e-08 | 7.788 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 1.640330e-08 | 7.785 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 1.801630e-08 | 7.744 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 1.856303e-08 | 7.731 | 0 | 0 |
| Protein folding | R-HSA-391251 | 3.026060e-08 | 7.519 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.408529e-08 | 7.467 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 3.554191e-08 | 7.449 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 3.554191e-08 | 7.449 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 3.925693e-08 | 7.406 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 3.925693e-08 | 7.406 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 4.072420e-08 | 7.390 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 4.175768e-08 | 7.379 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 4.233764e-08 | 7.373 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 5.587550e-08 | 7.253 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 5.671204e-08 | 7.246 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 6.533105e-08 | 7.185 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 5.912124e-08 | 7.228 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 6.480482e-08 | 7.188 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 7.951049e-08 | 7.100 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 8.762344e-08 | 7.057 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 8.974686e-08 | 7.047 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 9.372862e-08 | 7.028 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 9.595085e-08 | 7.018 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.061859e-07 | 6.974 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.088816e-07 | 6.963 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.088816e-07 | 6.963 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.102388e-07 | 6.958 | 0 | 0 |
| Depurination | R-HSA-73927 | 1.129382e-07 | 6.947 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.155791e-07 | 6.937 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.304757e-07 | 6.884 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.444914e-07 | 6.840 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.648754e-07 | 6.783 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.915476e-07 | 6.718 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.096944e-07 | 6.678 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 2.131780e-07 | 6.671 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.131780e-07 | 6.671 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.188661e-07 | 6.660 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.531547e-07 | 6.597 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.307816e-07 | 6.637 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 3.278803e-07 | 6.484 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 3.640252e-07 | 6.439 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 3.668173e-07 | 6.436 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 3.668173e-07 | 6.436 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 4.452401e-07 | 6.351 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 4.732791e-07 | 6.325 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 5.463959e-07 | 6.262 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 5.506333e-07 | 6.259 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 6.359200e-07 | 6.197 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 6.359200e-07 | 6.197 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 6.734332e-07 | 6.172 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 7.460872e-07 | 6.127 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 7.546047e-07 | 6.122 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 7.602719e-07 | 6.119 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 8.333596e-07 | 6.079 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 8.823245e-07 | 6.054 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 9.671486e-07 | 6.015 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 9.671486e-07 | 6.015 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.036105e-06 | 5.985 | 1 | 1 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 1.045678e-06 | 5.981 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 1.045678e-06 | 5.981 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 1.046443e-06 | 5.980 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.268495e-06 | 5.897 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.300714e-06 | 5.886 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.456941e-06 | 5.837 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 1.734183e-06 | 5.761 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.775442e-06 | 5.751 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.852358e-06 | 5.732 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 2.091928e-06 | 5.679 | 0 | 0 |
| Kinesins | R-HSA-983189 | 2.003479e-06 | 5.698 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.120045e-06 | 5.674 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 2.136805e-06 | 5.670 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 3.155437e-06 | 5.501 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 3.797503e-06 | 5.421 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 4.155385e-06 | 5.381 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 4.465304e-06 | 5.350 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 4.763303e-06 | 5.322 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 4.800158e-06 | 5.319 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 5.269993e-06 | 5.278 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 5.269993e-06 | 5.278 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 5.578012e-06 | 5.254 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 5.938763e-06 | 5.226 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 6.049825e-06 | 5.218 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 6.817397e-06 | 5.166 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 8.253030e-06 | 5.083 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 8.253030e-06 | 5.083 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 8.321735e-06 | 5.080 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 8.425881e-06 | 5.074 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 9.442115e-06 | 5.025 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 9.844296e-06 | 5.007 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.095390e-05 | 4.960 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 1.127376e-05 | 4.948 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.178381e-05 | 4.929 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.230445e-05 | 4.910 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.346599e-05 | 4.871 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.381315e-05 | 4.860 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.471719e-05 | 4.832 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.506458e-05 | 4.822 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.568635e-05 | 4.804 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 1.657125e-05 | 4.781 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.773800e-05 | 4.751 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 2.120990e-05 | 4.673 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 2.282477e-05 | 4.642 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 2.120990e-05 | 4.673 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 2.106060e-05 | 4.677 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 2.120990e-05 | 4.673 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.120990e-05 | 4.673 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.242943e-05 | 4.649 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 2.395227e-05 | 4.621 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.589997e-05 | 4.587 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.064647e-05 | 4.514 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 3.064647e-05 | 4.514 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 3.548722e-05 | 4.450 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 3.605449e-05 | 4.443 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 3.763400e-05 | 4.424 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 4.057720e-05 | 4.392 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 4.158661e-05 | 4.381 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 4.158661e-05 | 4.381 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 4.513238e-05 | 4.346 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 4.513238e-05 | 4.346 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 4.513238e-05 | 4.346 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 4.860561e-05 | 4.313 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 4.914159e-05 | 4.309 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 5.086089e-05 | 4.294 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 5.158556e-05 | 4.287 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 5.263267e-05 | 4.279 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 5.301948e-05 | 4.276 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 6.751636e-05 | 4.171 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 6.861498e-05 | 4.164 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 6.867580e-05 | 4.163 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 6.987343e-05 | 4.156 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 7.001352e-05 | 4.155 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 7.001352e-05 | 4.155 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 7.199666e-05 | 4.143 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 7.771747e-05 | 4.109 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 8.205064e-05 | 4.086 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 8.454176e-05 | 4.073 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.639645e-05 | 4.064 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 8.778801e-05 | 4.057 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 9.009360e-05 | 4.045 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 9.077348e-05 | 4.042 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.026943e-04 | 3.988 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.034521e-04 | 3.985 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.106011e-04 | 3.956 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.169607e-04 | 3.932 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 1.169607e-04 | 3.932 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.200476e-04 | 3.921 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 1.232452e-04 | 3.909 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.260527e-04 | 3.899 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.386636e-04 | 3.858 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 1.416088e-04 | 3.849 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.660607e-04 | 3.780 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.845614e-04 | 3.734 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.885468e-04 | 3.725 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 1.787012e-04 | 3.748 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 2.091088e-04 | 3.680 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 2.090409e-04 | 3.680 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.827210e-04 | 3.738 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.788460e-04 | 3.748 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 2.275659e-04 | 3.643 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.331740e-04 | 3.632 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.331740e-04 | 3.632 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.382338e-04 | 3.623 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.897410e-04 | 3.538 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.897410e-04 | 3.538 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 2.897410e-04 | 3.538 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.949176e-04 | 3.530 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 3.034946e-04 | 3.518 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 3.159983e-04 | 3.500 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 3.201719e-04 | 3.495 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 3.311599e-04 | 3.480 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 3.484341e-04 | 3.458 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 3.484341e-04 | 3.458 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 3.722155e-04 | 3.429 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 4.075064e-04 | 3.390 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 4.075064e-04 | 3.390 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 4.228035e-04 | 3.374 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 4.382157e-04 | 3.358 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 4.546694e-04 | 3.342 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 6.080731e-04 | 3.216 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 6.576974e-04 | 3.182 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 6.839945e-04 | 3.165 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 8.385824e-04 | 3.076 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 8.561072e-04 | 3.067 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 8.561072e-04 | 3.067 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 9.661768e-04 | 3.015 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 9.661768e-04 | 3.015 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.005906e-03 | 2.997 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.005906e-03 | 2.997 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.027724e-03 | 2.988 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.136087e-03 | 2.945 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 1.139069e-03 | 2.943 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.354185e-03 | 2.868 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 1.354185e-03 | 2.868 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 1.388888e-03 | 2.857 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 1.388888e-03 | 2.857 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 1.388888e-03 | 2.857 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.400529e-03 | 2.854 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 1.404482e-03 | 2.852 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 1.404482e-03 | 2.852 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.442132e-03 | 2.841 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.442132e-03 | 2.841 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.581695e-03 | 2.801 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 1.673600e-03 | 2.776 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.800748e-03 | 2.745 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.800748e-03 | 2.745 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.821892e-03 | 2.739 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.821892e-03 | 2.739 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.855329e-03 | 2.732 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.965441e-03 | 2.707 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.093645e-03 | 2.679 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.093645e-03 | 2.679 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 2.472176e-03 | 2.607 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 2.472176e-03 | 2.607 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 2.594353e-03 | 2.586 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 3.396397e-03 | 2.469 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 3.216994e-03 | 2.493 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.707693e-03 | 2.567 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.718520e-03 | 2.566 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 3.474737e-03 | 2.459 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 3.417632e-03 | 2.466 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 3.075761e-03 | 2.512 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 3.484973e-03 | 2.458 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 3.484973e-03 | 2.458 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 3.659237e-03 | 2.437 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 3.910570e-03 | 2.408 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 4.285173e-03 | 2.368 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 4.362345e-03 | 2.360 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 4.362345e-03 | 2.360 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 4.386648e-03 | 2.358 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 4.630084e-03 | 2.334 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 4.905247e-03 | 2.309 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 5.009825e-03 | 2.300 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 5.009825e-03 | 2.300 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 5.042424e-03 | 2.297 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 5.042424e-03 | 2.297 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 5.451739e-03 | 2.263 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 5.451739e-03 | 2.263 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 5.451739e-03 | 2.263 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 6.276094e-03 | 2.202 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 6.335242e-03 | 2.198 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 6.354235e-03 | 2.197 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 6.354235e-03 | 2.197 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 6.354235e-03 | 2.197 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 6.354235e-03 | 2.197 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 6.646900e-03 | 2.177 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 6.704921e-03 | 2.174 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 6.734949e-03 | 2.172 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 6.828425e-03 | 2.166 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 6.972181e-03 | 2.157 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 6.972181e-03 | 2.157 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 7.244215e-03 | 2.140 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 7.366122e-03 | 2.133 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 7.431285e-03 | 2.129 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 7.431521e-03 | 2.129 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 7.450768e-03 | 2.128 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 7.450971e-03 | 2.128 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 7.458196e-03 | 2.127 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 7.705110e-03 | 2.113 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 7.837740e-03 | 2.106 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 8.024983e-03 | 2.096 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 8.216847e-03 | 2.085 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 8.485177e-03 | 2.071 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 8.666022e-03 | 2.062 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 8.755097e-03 | 2.058 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 8.778059e-03 | 2.057 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 8.778059e-03 | 2.057 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 9.038585e-03 | 2.044 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 9.039145e-03 | 2.044 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 9.255244e-03 | 2.034 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 9.256510e-03 | 2.034 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 9.256510e-03 | 2.034 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 9.319382e-03 | 2.031 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 9.716667e-03 | 2.012 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 9.716667e-03 | 2.012 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.718897e-03 | 2.012 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 9.796486e-03 | 2.009 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 9.796486e-03 | 2.009 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.030751e-02 | 1.987 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.086221e-02 | 1.964 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 1.089631e-02 | 1.963 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 1.089631e-02 | 1.963 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 1.089631e-02 | 1.963 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.089631e-02 | 1.963 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.089631e-02 | 1.963 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 1.098965e-02 | 1.959 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 1.098965e-02 | 1.959 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.106567e-02 | 1.956 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.158059e-02 | 1.936 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 1.194320e-02 | 1.923 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.194320e-02 | 1.923 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 1.194320e-02 | 1.923 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.194320e-02 | 1.923 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.194320e-02 | 1.923 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 1.194320e-02 | 1.923 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.208074e-02 | 1.918 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.284836e-02 | 1.891 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.284836e-02 | 1.891 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.284836e-02 | 1.891 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.284836e-02 | 1.891 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.284836e-02 | 1.891 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.284836e-02 | 1.891 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.284836e-02 | 1.891 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.284836e-02 | 1.891 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.284836e-02 | 1.891 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.284836e-02 | 1.891 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.284836e-02 | 1.891 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.284836e-02 | 1.891 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 1.293799e-02 | 1.888 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.293799e-02 | 1.888 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 1.952619e-02 | 1.709 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.508321e-02 | 1.822 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.508321e-02 | 1.822 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 1.508321e-02 | 1.822 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.744018e-02 | 1.758 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.973555e-02 | 1.705 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.471593e-02 | 1.832 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.617269e-02 | 1.791 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.528532e-02 | 1.816 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.772606e-02 | 1.751 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 1.413547e-02 | 1.850 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 1.853424e-02 | 1.732 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 1.744018e-02 | 1.758 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 1.503391e-02 | 1.823 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 1.773071e-02 | 1.751 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 1.973555e-02 | 1.705 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 1.853424e-02 | 1.732 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 1.937879e-02 | 1.713 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.413547e-02 | 1.850 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 1.413547e-02 | 1.850 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 1.937879e-02 | 1.713 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 1.937879e-02 | 1.713 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 1.586531e-02 | 1.800 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 1.773071e-02 | 1.751 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.617269e-02 | 1.791 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 1.481057e-02 | 1.829 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.508321e-02 | 1.822 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 1.765540e-02 | 1.753 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 1.413547e-02 | 1.850 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.471593e-02 | 1.832 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.590359e-02 | 1.799 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.747526e-02 | 1.758 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.487470e-02 | 1.828 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.786367e-02 | 1.748 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 1.381762e-02 | 1.860 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 1.973927e-02 | 1.705 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 2.001450e-02 | 1.699 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 2.113348e-02 | 1.675 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.120553e-02 | 1.674 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 2.188341e-02 | 1.660 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 2.188341e-02 | 1.660 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 2.188341e-02 | 1.660 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 2.244794e-02 | 1.649 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.281096e-02 | 1.642 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.281096e-02 | 1.642 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.281096e-02 | 1.642 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 2.299262e-02 | 1.638 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 2.299262e-02 | 1.638 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 2.354155e-02 | 1.628 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 2.495857e-02 | 1.603 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 2.495857e-02 | 1.603 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 2.495857e-02 | 1.603 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 2.510690e-02 | 1.600 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.662110e-02 | 1.575 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 2.662110e-02 | 1.575 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 2.662110e-02 | 1.575 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 2.677596e-02 | 1.572 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 2.677596e-02 | 1.572 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 2.677596e-02 | 1.572 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 2.703355e-02 | 1.568 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 2.703355e-02 | 1.568 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 2.735103e-02 | 1.563 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.735103e-02 | 1.563 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 2.735103e-02 | 1.563 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.739736e-02 | 1.562 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 2.762521e-02 | 1.559 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.908561e-02 | 1.536 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.908561e-02 | 1.536 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 2.921663e-02 | 1.534 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 2.921963e-02 | 1.534 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 2.963496e-02 | 1.528 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 3.061561e-02 | 1.514 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 3.151677e-02 | 1.501 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 3.151677e-02 | 1.501 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 3.151677e-02 | 1.501 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 3.151677e-02 | 1.501 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 3.151677e-02 | 1.501 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 3.151677e-02 | 1.501 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 3.151677e-02 | 1.501 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 3.151872e-02 | 1.501 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 3.170047e-02 | 1.499 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 3.196657e-02 | 1.495 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 3.196657e-02 | 1.495 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 3.256951e-02 | 1.487 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.256951e-02 | 1.487 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 3.256951e-02 | 1.487 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 3.577921e-02 | 1.446 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 3.621638e-02 | 1.441 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 3.621638e-02 | 1.441 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 3.666660e-02 | 1.436 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 3.666660e-02 | 1.436 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 3.666660e-02 | 1.436 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 4.023921e-02 | 1.395 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 4.023921e-02 | 1.395 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 4.023921e-02 | 1.395 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 4.050803e-02 | 1.392 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 4.109959e-02 | 1.386 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 4.116213e-02 | 1.386 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 4.221974e-02 | 1.374 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 4.221974e-02 | 1.374 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 4.454744e-02 | 1.351 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 4.565513e-02 | 1.341 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 4.602258e-02 | 1.337 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 4.602258e-02 | 1.337 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 4.602258e-02 | 1.337 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 4.602258e-02 | 1.337 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 4.602258e-02 | 1.337 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.777473e-02 | 1.321 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 4.809448e-02 | 1.318 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 4.809448e-02 | 1.318 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 4.816873e-02 | 1.317 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 4.816873e-02 | 1.317 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 4.816873e-02 | 1.317 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 4.816873e-02 | 1.317 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 4.832079e-02 | 1.316 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 4.884821e-02 | 1.311 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 4.884821e-02 | 1.311 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.108344e-02 | 1.292 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 5.108344e-02 | 1.292 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 5.158933e-02 | 1.287 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 5.180378e-02 | 1.286 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 5.180378e-02 | 1.286 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 5.236743e-02 | 1.281 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 5.350375e-02 | 1.272 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 5.450459e-02 | 1.264 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 5.450459e-02 | 1.264 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 5.450459e-02 | 1.264 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 5.450459e-02 | 1.264 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 5.450459e-02 | 1.264 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 5.567559e-02 | 1.254 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 5.567559e-02 | 1.254 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 5.667643e-02 | 1.247 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.667643e-02 | 1.247 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 5.667643e-02 | 1.247 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 5.667643e-02 | 1.247 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 5.753596e-02 | 1.240 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 5.753596e-02 | 1.240 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 5.753596e-02 | 1.240 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 5.839142e-02 | 1.234 | 0 | 0 |
| Hereditary fructose intolerance | R-HSA-5657560 | 8.133540e-02 | 1.090 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 8.133540e-02 | 1.090 | 0 | 0 |
| SARS-CoV-1 targets PDZ proteins in cell-cell junction | R-HSA-9692912 | 8.133540e-02 | 1.090 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 6.809085e-02 | 1.167 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 6.809085e-02 | 1.167 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 6.809085e-02 | 1.167 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 6.809085e-02 | 1.167 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 9.288142e-02 | 1.032 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 9.288142e-02 | 1.032 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 1.061109e-01 | 0.974 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 1.061109e-01 | 0.974 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 1.061109e-01 | 0.974 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 8.349481e-02 | 1.078 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 8.349481e-02 | 1.078 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 1.086999e-01 | 0.964 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 7.746069e-02 | 1.111 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 6.840752e-02 | 1.165 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 6.840752e-02 | 1.165 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 9.999695e-02 | 1.000 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 6.121703e-02 | 1.213 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 6.121703e-02 | 1.213 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.031849e-01 | 0.986 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 9.773551e-02 | 1.010 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 6.809085e-02 | 1.167 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 7.442316e-02 | 1.128 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.176304e-01 | 0.929 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 8.021271e-02 | 1.096 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 6.809085e-02 | 1.167 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 8.018448e-02 | 1.096 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 6.390626e-02 | 1.194 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 6.121703e-02 | 1.213 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 1.087819e-01 | 0.963 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 9.999695e-02 | 1.000 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 8.349481e-02 | 1.078 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 1.003343e-01 | 0.999 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 1.176839e-01 | 0.929 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 8.621858e-02 | 1.064 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 8.133540e-02 | 1.090 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 6.809085e-02 | 1.167 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 8.018448e-02 | 1.096 | 0 | 0 |
| PKA activation | R-HSA-163615 | 7.572495e-02 | 1.121 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 7.572495e-02 | 1.121 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 6.350908e-02 | 1.197 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.243616e-02 | 1.034 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 7.627247e-02 | 1.118 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 1.078991e-01 | 0.967 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 6.121703e-02 | 1.213 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.054870e-01 | 0.977 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 9.433958e-02 | 1.025 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 1.171183e-01 | 0.931 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 1.171183e-01 | 0.931 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 6.328512e-02 | 1.199 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 6.390626e-02 | 1.194 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 6.809085e-02 | 1.167 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 9.288142e-02 | 1.032 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 7.227844e-02 | 1.141 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 1.087819e-01 | 0.963 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 8.908792e-02 | 1.050 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 7.630080e-02 | 1.117 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 9.636706e-02 | 1.016 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 9.636706e-02 | 1.016 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 9.636706e-02 | 1.016 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 7.278270e-02 | 1.138 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 9.773551e-02 | 1.010 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 9.773551e-02 | 1.010 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 8.877419e-02 | 1.052 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 9.887609e-02 | 1.005 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 9.288142e-02 | 1.032 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 9.999695e-02 | 1.000 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 9.243626e-02 | 1.034 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 8.018448e-02 | 1.096 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 9.999695e-02 | 1.000 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 7.336063e-02 | 1.135 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 8.018448e-02 | 1.096 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 9.288142e-02 | 1.032 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 8.621858e-02 | 1.064 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 8.038912e-02 | 1.095 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 8.755966e-02 | 1.058 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 5.972332e-02 | 1.224 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 1.061109e-01 | 0.974 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 1.086999e-01 | 0.964 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 1.086999e-01 | 0.964 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 6.390626e-02 | 1.194 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 1.145236e-01 | 0.941 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 8.104017e-02 | 1.091 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 8.414031e-02 | 1.075 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 6.809085e-02 | 1.167 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 8.018448e-02 | 1.096 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 9.288142e-02 | 1.032 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 9.159029e-02 | 1.038 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.086999e-01 | 0.964 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 1.086999e-01 | 0.964 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 1.123092e-01 | 0.950 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 8.018448e-02 | 1.096 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 7.572495e-02 | 1.121 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 6.979324e-02 | 1.156 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 1.061109e-01 | 0.974 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 8.301454e-02 | 1.081 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 6.768466e-02 | 1.170 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 7.599877e-02 | 1.119 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.076184e-01 | 0.968 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.159029e-02 | 1.038 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 9.243616e-02 | 1.034 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.123092e-01 | 0.950 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 1.194911e-01 | 0.923 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 1.194911e-01 | 0.923 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 1.194911e-01 | 0.923 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 1.194911e-01 | 0.923 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 1.198069e-01 | 0.922 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.198069e-01 | 0.922 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.198069e-01 | 0.922 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 1.212621e-01 | 0.916 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 1.212621e-01 | 0.916 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.265179e-01 | 0.898 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 1.269908e-01 | 0.896 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.280897e-01 | 0.892 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.287183e-01 | 0.890 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 1.288899e-01 | 0.890 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 1.288899e-01 | 0.890 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 1.318080e-01 | 0.880 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 1.325873e-01 | 0.877 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 1.338919e-01 | 0.873 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.338919e-01 | 0.873 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 1.338919e-01 | 0.873 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.339080e-01 | 0.873 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 1.339080e-01 | 0.873 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 1.339080e-01 | 0.873 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 1.339080e-01 | 0.873 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 1.339080e-01 | 0.873 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 1.339080e-01 | 0.873 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 1.364331e-01 | 0.865 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.388772e-01 | 0.857 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 1.388772e-01 | 0.857 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 1.389813e-01 | 0.857 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 1.414370e-01 | 0.849 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 1.414370e-01 | 0.849 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 1.414370e-01 | 0.849 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 1.414370e-01 | 0.849 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 1.414370e-01 | 0.849 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 1.414370e-01 | 0.849 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.452956e-01 | 0.838 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.461671e-01 | 0.835 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.461671e-01 | 0.835 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.461671e-01 | 0.835 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 1.461671e-01 | 0.835 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 1.461671e-01 | 0.835 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 1.467152e-01 | 0.834 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.483570e-01 | 0.829 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.483570e-01 | 0.829 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 1.483570e-01 | 0.829 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 1.483570e-01 | 0.829 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 1.483570e-01 | 0.829 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 1.483570e-01 | 0.829 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 1.483570e-01 | 0.829 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 1.483570e-01 | 0.829 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.483570e-01 | 0.829 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 1.491463e-01 | 0.826 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 1.491463e-01 | 0.826 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 1.491463e-01 | 0.826 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 1.512012e-01 | 0.820 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.514532e-01 | 0.820 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.514532e-01 | 0.820 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 1.518615e-01 | 0.819 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 1.560642e-01 | 0.807 | 0 | 0 |
| Defective AHCY causes HMAHCHD | R-HSA-5578997 | 1.560642e-01 | 0.807 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 1.560642e-01 | 0.807 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 1.560642e-01 | 0.807 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 1.560642e-01 | 0.807 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 1.560642e-01 | 0.807 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 1.560642e-01 | 0.807 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 1.560642e-01 | 0.807 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.561196e-01 | 0.807 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 1.561196e-01 | 0.807 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 1.561196e-01 | 0.807 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.631010e-01 | 0.788 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 1.631010e-01 | 0.788 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 1.631010e-01 | 0.788 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.631010e-01 | 0.788 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 1.631010e-01 | 0.788 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 1.631010e-01 | 0.788 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 1.652847e-01 | 0.782 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 1.662753e-01 | 0.779 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.679877e-01 | 0.775 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 1.702971e-01 | 0.769 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 1.731905e-01 | 0.761 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 1.731905e-01 | 0.761 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 1.766184e-01 | 0.753 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 1.766184e-01 | 0.753 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 1.766184e-01 | 0.753 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.780905e-01 | 0.749 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 1.780905e-01 | 0.749 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 1.780905e-01 | 0.749 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 1.780905e-01 | 0.749 | 0 | 0 |
| Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA | R-HSA-77310 | 1.780905e-01 | 0.749 | 0 | 0 |
| Beta oxidation of hexanoyl-CoA to butanoyl-CoA | R-HSA-77350 | 1.780905e-01 | 0.749 | 0 | 0 |
| Beta oxidation of octanoyl-CoA to hexanoyl-CoA | R-HSA-77348 | 1.780905e-01 | 0.749 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 1.780905e-01 | 0.749 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 1.780905e-01 | 0.749 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 1.780905e-01 | 0.749 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 1.780905e-01 | 0.749 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.780905e-01 | 0.749 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.788045e-01 | 0.748 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 1.791829e-01 | 0.747 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 1.791829e-01 | 0.747 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 1.791829e-01 | 0.747 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 1.802505e-01 | 0.744 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 1.814341e-01 | 0.741 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 1.814868e-01 | 0.741 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 1.844230e-01 | 0.734 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 1.862913e-01 | 0.730 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.862913e-01 | 0.730 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 1.871338e-01 | 0.728 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 1.871338e-01 | 0.728 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 1.899118e-01 | 0.721 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 1.899118e-01 | 0.721 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 1.904488e-01 | 0.720 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 1.911204e-01 | 0.719 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 1.911204e-01 | 0.719 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 1.911204e-01 | 0.719 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 1.911204e-01 | 0.719 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.911204e-01 | 0.719 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.932798e-01 | 0.714 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 1.932798e-01 | 0.714 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 1.932798e-01 | 0.714 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 1.932798e-01 | 0.714 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.932798e-01 | 0.714 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.932798e-01 | 0.714 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 1.935003e-01 | 0.713 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 1.935003e-01 | 0.713 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 1.967761e-01 | 0.706 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.984581e-01 | 0.702 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 2.063133e-01 | 0.685 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 2.086209e-01 | 0.681 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 2.086209e-01 | 0.681 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 2.086266e-01 | 0.681 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 2.086266e-01 | 0.681 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.086266e-01 | 0.681 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 2.086266e-01 | 0.681 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 2.158854e-01 | 0.666 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.190240e-01 | 0.660 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 2.216461e-01 | 0.654 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 2.240917e-01 | 0.650 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.240917e-01 | 0.650 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 2.240917e-01 | 0.650 | 0 | 0 |
| Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA | R-HSA-77346 | 2.240917e-01 | 0.650 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 2.240917e-01 | 0.650 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 2.240917e-01 | 0.650 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 2.247224e-01 | 0.648 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 2.247224e-01 | 0.648 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 2.247224e-01 | 0.648 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 2.247224e-01 | 0.648 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.247224e-01 | 0.648 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 2.247224e-01 | 0.648 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 2.247224e-01 | 0.648 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 2.247224e-01 | 0.648 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.247224e-01 | 0.648 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 2.247224e-01 | 0.648 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 2.257455e-01 | 0.646 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 2.306189e-01 | 0.637 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 2.306189e-01 | 0.637 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 2.379504e-01 | 0.624 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 2.396387e-01 | 0.620 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 2.396387e-01 | 0.620 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 2.396387e-01 | 0.620 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 2.396387e-01 | 0.620 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 2.396387e-01 | 0.620 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.417740e-01 | 0.617 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 2.417740e-01 | 0.617 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 2.417740e-01 | 0.617 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 2.464112e-01 | 0.608 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 2.464112e-01 | 0.608 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 2.464112e-01 | 0.608 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 2.468988e-01 | 0.607 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 2.505440e-01 | 0.601 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 2.518729e-01 | 0.599 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 2.518729e-01 | 0.599 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 2.518729e-01 | 0.599 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 2.530151e-01 | 0.597 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 2.530151e-01 | 0.597 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 2.530151e-01 | 0.597 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 2.542662e-01 | 0.595 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 2.552344e-01 | 0.593 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 2.552344e-01 | 0.593 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 2.552344e-01 | 0.593 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.552344e-01 | 0.593 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.552344e-01 | 0.593 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.569305e-01 | 0.590 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 2.569305e-01 | 0.590 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.569305e-01 | 0.590 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 2.569305e-01 | 0.590 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 2.569305e-01 | 0.590 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 2.569305e-01 | 0.590 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 2.569305e-01 | 0.590 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 2.569305e-01 | 0.590 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 2.569305e-01 | 0.590 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 2.569305e-01 | 0.590 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 2.569305e-01 | 0.590 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 2.569305e-01 | 0.590 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 2.610635e-01 | 0.583 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 2.621818e-01 | 0.581 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.621818e-01 | 0.581 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 2.643289e-01 | 0.578 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 2.643289e-01 | 0.578 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 2.643289e-01 | 0.578 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 2.703173e-01 | 0.568 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 2.708479e-01 | 0.567 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.708479e-01 | 0.567 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 2.744755e-01 | 0.561 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 2.757026e-01 | 0.560 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 2.757026e-01 | 0.560 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 2.757026e-01 | 0.560 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 2.796273e-01 | 0.553 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 2.796273e-01 | 0.553 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 2.816398e-01 | 0.550 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 2.822008e-01 | 0.549 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 2.862476e-01 | 0.543 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.864509e-01 | 0.543 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.864509e-01 | 0.543 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 2.864509e-01 | 0.543 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.864509e-01 | 0.543 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 2.871239e-01 | 0.542 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 2.871239e-01 | 0.542 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 2.871239e-01 | 0.542 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 2.871239e-01 | 0.542 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 2.871239e-01 | 0.542 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 2.878025e-01 | 0.541 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 2.878025e-01 | 0.541 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 2.878025e-01 | 0.541 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 2.878025e-01 | 0.541 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 2.878025e-01 | 0.541 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 2.878025e-01 | 0.541 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 2.878025e-01 | 0.541 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 2.878025e-01 | 0.541 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 2.878025e-01 | 0.541 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 2.878025e-01 | 0.541 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 2.878025e-01 | 0.541 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 2.878025e-01 | 0.541 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 2.878025e-01 | 0.541 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 2.878025e-01 | 0.541 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 2.888455e-01 | 0.539 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 2.889867e-01 | 0.539 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 2.958729e-01 | 0.529 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 2.981673e-01 | 0.526 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 2.985808e-01 | 0.525 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 3.020173e-01 | 0.520 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 3.020173e-01 | 0.520 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 3.020173e-01 | 0.520 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 3.020173e-01 | 0.520 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 3.020173e-01 | 0.520 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 3.020173e-01 | 0.520 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.020173e-01 | 0.520 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 3.025131e-01 | 0.519 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 3.038833e-01 | 0.517 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 3.096251e-01 | 0.509 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 3.100619e-01 | 0.509 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 3.100619e-01 | 0.509 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 3.100619e-01 | 0.509 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 3.172942e-01 | 0.499 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 3.172942e-01 | 0.499 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 3.172942e-01 | 0.499 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 3.173936e-01 | 0.498 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 3.173936e-01 | 0.498 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 3.173936e-01 | 0.498 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 3.173936e-01 | 0.498 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 3.173936e-01 | 0.498 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 3.173936e-01 | 0.498 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 3.173936e-01 | 0.498 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 3.173936e-01 | 0.498 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 3.173936e-01 | 0.498 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 3.175234e-01 | 0.498 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 3.175234e-01 | 0.498 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 3.175234e-01 | 0.498 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 3.180206e-01 | 0.498 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 3.215559e-01 | 0.493 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 3.215559e-01 | 0.493 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 3.267848e-01 | 0.486 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 3.329472e-01 | 0.478 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 3.329472e-01 | 0.478 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 3.330523e-01 | 0.477 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 3.332612e-01 | 0.477 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 3.360273e-01 | 0.474 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 3.362922e-01 | 0.473 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 3.445408e-01 | 0.463 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 3.457569e-01 | 0.461 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 3.457569e-01 | 0.461 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 3.457569e-01 | 0.461 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.457569e-01 | 0.461 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 3.457569e-01 | 0.461 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 3.457569e-01 | 0.461 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 3.457569e-01 | 0.461 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 3.457569e-01 | 0.461 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 3.457569e-01 | 0.461 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 3.457569e-01 | 0.461 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 3.458104e-01 | 0.461 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 3.482690e-01 | 0.458 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 3.482690e-01 | 0.458 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 3.519949e-01 | 0.453 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 3.560117e-01 | 0.449 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 3.634705e-01 | 0.440 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 3.634705e-01 | 0.440 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 3.634705e-01 | 0.440 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 3.686073e-01 | 0.433 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 3.686073e-01 | 0.433 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 3.686073e-01 | 0.433 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 3.729434e-01 | 0.428 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 3.729434e-01 | 0.428 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 3.729434e-01 | 0.428 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 3.729434e-01 | 0.428 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 3.729434e-01 | 0.428 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 3.729434e-01 | 0.428 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 3.729434e-01 | 0.428 | 0 | 0 |
| Fructose biosynthesis | R-HSA-5652227 | 3.729434e-01 | 0.428 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 3.729434e-01 | 0.428 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 3.729434e-01 | 0.428 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 3.729434e-01 | 0.428 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 3.774333e-01 | 0.423 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 3.785354e-01 | 0.422 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 3.785354e-01 | 0.422 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 3.785354e-01 | 0.422 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 3.785354e-01 | 0.422 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 3.902270e-01 | 0.409 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 3.902270e-01 | 0.409 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 3.902270e-01 | 0.409 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 3.902270e-01 | 0.409 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 3.902270e-01 | 0.409 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 3.902270e-01 | 0.409 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 3.934488e-01 | 0.405 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 3.934488e-01 | 0.405 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 3.934488e-01 | 0.405 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 3.990017e-01 | 0.399 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 3.990017e-01 | 0.399 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 3.990017e-01 | 0.399 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 3.990017e-01 | 0.399 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 3.990017e-01 | 0.399 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 3.990017e-01 | 0.399 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 3.990017e-01 | 0.399 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.990017e-01 | 0.399 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 3.990017e-01 | 0.399 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 3.990017e-01 | 0.399 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 3.990017e-01 | 0.399 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 3.990017e-01 | 0.399 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 3.990017e-01 | 0.399 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 4.015381e-01 | 0.396 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 4.015381e-01 | 0.396 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 4.015381e-01 | 0.396 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 4.015381e-01 | 0.396 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 4.028247e-01 | 0.395 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 4.058859e-01 | 0.392 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 4.081973e-01 | 0.389 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 4.081973e-01 | 0.389 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 4.081973e-01 | 0.389 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 4.081973e-01 | 0.389 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 4.081973e-01 | 0.389 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 4.081973e-01 | 0.389 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 4.127890e-01 | 0.384 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 4.127890e-01 | 0.384 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 4.216658e-01 | 0.375 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 4.227689e-01 | 0.374 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 4.227689e-01 | 0.374 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 4.227689e-01 | 0.374 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 4.227689e-01 | 0.374 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 4.239787e-01 | 0.373 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 4.239787e-01 | 0.373 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 4.239787e-01 | 0.373 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 4.239787e-01 | 0.373 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 4.239787e-01 | 0.373 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 4.239787e-01 | 0.373 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 4.239787e-01 | 0.373 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 4.239787e-01 | 0.373 | 0 | 0 |
| Sperm Motility And Taxes | R-HSA-1300642 | 4.239787e-01 | 0.373 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 4.239787e-01 | 0.373 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 4.239787e-01 | 0.373 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 4.239787e-01 | 0.373 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.239787e-01 | 0.373 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 4.315465e-01 | 0.365 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 4.350818e-01 | 0.361 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 4.371528e-01 | 0.359 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 4.371528e-01 | 0.359 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 4.383553e-01 | 0.358 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 4.403603e-01 | 0.356 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 4.461104e-01 | 0.351 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 4.479191e-01 | 0.349 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 4.479191e-01 | 0.349 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 4.479191e-01 | 0.349 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 4.479191e-01 | 0.349 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 4.479191e-01 | 0.349 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 4.496416e-01 | 0.347 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 4.513395e-01 | 0.345 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 4.570523e-01 | 0.340 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 4.570523e-01 | 0.340 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 4.653205e-01 | 0.332 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 4.653205e-01 | 0.332 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 4.653205e-01 | 0.332 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 4.679018e-01 | 0.330 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 4.680521e-01 | 0.330 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.708659e-01 | 0.327 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 4.708659e-01 | 0.327 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 4.708659e-01 | 0.327 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 4.708659e-01 | 0.327 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 4.708659e-01 | 0.327 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 4.708659e-01 | 0.327 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 4.708659e-01 | 0.327 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 4.754981e-01 | 0.323 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 4.786535e-01 | 0.320 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.786535e-01 | 0.320 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 4.786535e-01 | 0.320 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 4.790885e-01 | 0.320 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 4.790885e-01 | 0.320 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 4.790885e-01 | 0.320 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 4.928603e-01 | 0.307 | 0 | 0 |
| Beta oxidation of myristoyl-CoA to lauroyl-CoA | R-HSA-77285 | 4.928603e-01 | 0.307 | 0 | 0 |
| Beta oxidation of palmitoyl-CoA to myristoyl-CoA | R-HSA-77305 | 4.928603e-01 | 0.307 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 4.928603e-01 | 0.307 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 4.928603e-01 | 0.307 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 4.928603e-01 | 0.307 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 4.928603e-01 | 0.307 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 4.994358e-01 | 0.302 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 4.994358e-01 | 0.302 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 5.059605e-01 | 0.296 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 5.059605e-01 | 0.296 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 5.073229e-01 | 0.295 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 5.073229e-01 | 0.295 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 5.102742e-01 | 0.292 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 5.102742e-01 | 0.292 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 5.139417e-01 | 0.289 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 5.139417e-01 | 0.289 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 5.139417e-01 | 0.289 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 5.139417e-01 | 0.289 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 5.139417e-01 | 0.289 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 5.139417e-01 | 0.289 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 5.151600e-01 | 0.288 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 5.190542e-01 | 0.285 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 5.190542e-01 | 0.285 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 5.190542e-01 | 0.285 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 5.190542e-01 | 0.285 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 5.190542e-01 | 0.285 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 5.190542e-01 | 0.285 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 5.190542e-01 | 0.285 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 5.205886e-01 | 0.284 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 5.214192e-01 | 0.283 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 5.290558e-01 | 0.276 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 5.307837e-01 | 0.275 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 5.307837e-01 | 0.275 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 5.319143e-01 | 0.274 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 5.319143e-01 | 0.274 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 5.341480e-01 | 0.272 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 5.341480e-01 | 0.272 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 5.341480e-01 | 0.272 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 5.341480e-01 | 0.272 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 5.341480e-01 | 0.272 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 5.341480e-01 | 0.272 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 5.341480e-01 | 0.272 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 5.341480e-01 | 0.272 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 5.445376e-01 | 0.264 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 5.445376e-01 | 0.264 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 5.459655e-01 | 0.263 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 5.535155e-01 | 0.257 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 5.535155e-01 | 0.257 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 5.535155e-01 | 0.257 | 0 | 0 |
| Beta oxidation of butanoyl-CoA to acetyl-CoA | R-HSA-77352 | 5.535155e-01 | 0.257 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 5.535155e-01 | 0.257 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 5.535155e-01 | 0.257 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 5.535155e-01 | 0.257 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 5.535155e-01 | 0.257 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 5.569215e-01 | 0.254 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 5.569215e-01 | 0.254 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 5.606218e-01 | 0.251 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 5.606218e-01 | 0.251 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 5.606218e-01 | 0.251 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 5.690641e-01 | 0.245 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 5.690641e-01 | 0.245 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 5.696988e-01 | 0.244 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 5.720789e-01 | 0.243 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 5.720789e-01 | 0.243 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 5.720789e-01 | 0.243 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 5.720789e-01 | 0.243 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 5.720789e-01 | 0.243 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 5.720789e-01 | 0.243 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 5.720789e-01 | 0.243 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 5.720789e-01 | 0.243 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 5.720789e-01 | 0.243 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 5.720789e-01 | 0.243 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 5.795281e-01 | 0.237 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 5.809641e-01 | 0.236 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 5.898716e-01 | 0.229 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 5.898716e-01 | 0.229 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 5.898716e-01 | 0.229 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of unsaturated fatty acids | R-HSA-77288 | 5.898716e-01 | 0.229 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 5.898716e-01 | 0.229 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 5.898716e-01 | 0.229 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 5.926206e-01 | 0.227 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 5.926206e-01 | 0.227 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 5.926206e-01 | 0.227 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 5.926206e-01 | 0.227 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 5.926206e-01 | 0.227 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 5.985656e-01 | 0.223 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 6.045918e-01 | 0.219 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 6.069255e-01 | 0.217 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 6.069255e-01 | 0.217 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 6.069255e-01 | 0.217 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 6.152025e-01 | 0.211 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 6.232713e-01 | 0.205 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 6.232713e-01 | 0.205 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 6.232713e-01 | 0.205 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 6.232713e-01 | 0.205 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 6.232713e-01 | 0.205 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 6.297828e-01 | 0.201 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 6.389383e-01 | 0.195 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.389383e-01 | 0.195 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.389383e-01 | 0.195 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 6.389383e-01 | 0.195 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 6.389383e-01 | 0.195 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 6.389383e-01 | 0.195 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 6.389480e-01 | 0.195 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 6.428791e-01 | 0.192 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 6.513158e-01 | 0.186 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 6.539546e-01 | 0.184 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 6.539546e-01 | 0.184 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 6.539546e-01 | 0.184 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 6.539546e-01 | 0.184 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 6.539546e-01 | 0.184 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 6.539546e-01 | 0.184 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 6.539546e-01 | 0.184 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of saturated fatty acids | R-HSA-77286 | 6.574583e-01 | 0.182 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 6.574583e-01 | 0.182 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 6.674240e-01 | 0.176 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 6.674240e-01 | 0.176 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 6.677594e-01 | 0.175 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 6.683474e-01 | 0.175 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 6.683474e-01 | 0.175 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 6.683474e-01 | 0.175 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 6.683474e-01 | 0.175 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 6.683474e-01 | 0.175 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 6.720192e-01 | 0.173 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 6.757662e-01 | 0.170 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 6.821423e-01 | 0.166 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 6.821423e-01 | 0.166 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 6.821423e-01 | 0.166 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 6.821423e-01 | 0.166 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 6.836297e-01 | 0.165 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 6.837854e-01 | 0.165 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 6.866514e-01 | 0.163 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 6.900650e-01 | 0.161 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 6.913502e-01 | 0.160 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 6.953643e-01 | 0.158 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 6.953643e-01 | 0.158 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 6.953643e-01 | 0.158 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 6.953643e-01 | 0.158 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 6.953643e-01 | 0.158 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 6.953643e-01 | 0.158 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 6.953643e-01 | 0.158 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 6.959179e-01 | 0.157 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 6.959326e-01 | 0.157 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 6.989282e-01 | 0.156 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 7.049566e-01 | 0.152 | 0 | 0 |
| S Phase | R-HSA-69242 | 7.058071e-01 | 0.151 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 7.063641e-01 | 0.151 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 7.063641e-01 | 0.151 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 7.080370e-01 | 0.150 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 7.080370e-01 | 0.150 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 7.080370e-01 | 0.150 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 7.080370e-01 | 0.150 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 7.080370e-01 | 0.150 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 7.136586e-01 | 0.147 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 7.201833e-01 | 0.143 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 7.201833e-01 | 0.143 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 7.201833e-01 | 0.143 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 7.201833e-01 | 0.143 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 7.201833e-01 | 0.143 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 7.223623e-01 | 0.141 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 7.223623e-01 | 0.141 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 7.285009e-01 | 0.138 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 7.318250e-01 | 0.136 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 7.318250e-01 | 0.136 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 7.318250e-01 | 0.136 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.318250e-01 | 0.136 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 7.318250e-01 | 0.136 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 7.318250e-01 | 0.136 | 0 | 0 |
| Fertilization | R-HSA-1187000 | 7.318250e-01 | 0.136 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.366947e-01 | 0.133 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 7.414394e-01 | 0.130 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 7.425993e-01 | 0.129 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 7.429830e-01 | 0.129 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 7.429830e-01 | 0.129 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 7.429830e-01 | 0.129 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 7.429830e-01 | 0.129 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 7.464237e-01 | 0.127 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.484027e-01 | 0.126 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 7.536774e-01 | 0.123 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 7.536774e-01 | 0.123 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 7.536774e-01 | 0.123 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 7.536774e-01 | 0.123 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 7.545768e-01 | 0.122 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 7.608370e-01 | 0.119 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 7.608787e-01 | 0.119 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.621094e-01 | 0.118 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 7.639182e-01 | 0.117 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 7.639274e-01 | 0.117 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 7.639274e-01 | 0.117 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 7.639274e-01 | 0.117 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 7.706167e-01 | 0.113 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 7.737516e-01 | 0.111 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 7.737516e-01 | 0.111 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 7.737516e-01 | 0.111 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 7.737516e-01 | 0.111 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 7.737516e-01 | 0.111 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 7.765747e-01 | 0.110 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.765747e-01 | 0.110 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 7.831674e-01 | 0.106 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 7.831674e-01 | 0.106 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 7.831674e-01 | 0.106 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 7.831674e-01 | 0.106 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 7.831674e-01 | 0.106 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 7.831674e-01 | 0.106 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 7.831674e-01 | 0.106 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 7.831674e-01 | 0.106 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 7.835148e-01 | 0.106 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 7.835148e-01 | 0.106 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 7.835148e-01 | 0.106 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 7.835148e-01 | 0.106 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 7.835148e-01 | 0.106 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 7.902649e-01 | 0.102 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 7.959045e-01 | 0.099 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 7.961862e-01 | 0.099 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 8.008415e-01 | 0.096 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 8.008415e-01 | 0.096 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 8.032101e-01 | 0.095 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 8.068315e-01 | 0.093 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 8.091314e-01 | 0.092 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 8.091314e-01 | 0.092 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 8.091314e-01 | 0.092 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 8.091314e-01 | 0.092 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 8.091314e-01 | 0.092 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 8.094129e-01 | 0.092 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 8.094129e-01 | 0.092 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 8.154408e-01 | 0.089 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 8.157106e-01 | 0.088 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.170768e-01 | 0.088 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 8.170768e-01 | 0.088 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 8.170768e-01 | 0.088 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 8.170768e-01 | 0.088 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 8.237847e-01 | 0.084 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.246919e-01 | 0.084 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 8.246919e-01 | 0.084 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 8.246919e-01 | 0.084 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 8.269874e-01 | 0.083 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 8.316199e-01 | 0.080 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.319904e-01 | 0.080 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 8.319904e-01 | 0.080 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 8.319904e-01 | 0.080 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 8.319904e-01 | 0.080 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 8.319904e-01 | 0.080 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 8.325136e-01 | 0.080 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 8.358773e-01 | 0.078 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 8.380220e-01 | 0.077 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.389855e-01 | 0.076 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.389855e-01 | 0.076 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 8.582736e-01 | 0.066 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 8.582736e-01 | 0.066 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 8.582736e-01 | 0.066 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 8.582736e-01 | 0.066 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 8.624448e-01 | 0.064 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 8.624448e-01 | 0.064 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 8.641759e-01 | 0.063 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 8.641759e-01 | 0.063 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 8.669296e-01 | 0.062 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 8.698326e-01 | 0.061 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 8.698326e-01 | 0.061 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 8.752542e-01 | 0.058 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 8.752542e-01 | 0.058 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 8.752542e-01 | 0.058 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 8.752542e-01 | 0.058 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 8.752542e-01 | 0.058 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 8.754988e-01 | 0.058 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 8.795900e-01 | 0.056 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 8.795900e-01 | 0.056 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 8.804502e-01 | 0.055 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 8.804502e-01 | 0.055 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 8.804502e-01 | 0.055 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 8.854301e-01 | 0.053 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 8.854301e-01 | 0.053 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 8.902028e-01 | 0.051 | 0 | 0 |
| Methylation | R-HSA-156581 | 8.902028e-01 | 0.051 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.902028e-01 | 0.051 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 8.947770e-01 | 0.048 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 8.991609e-01 | 0.046 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.073892e-01 | 0.042 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.111910e-01 | 0.040 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.112483e-01 | 0.040 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 9.149469e-01 | 0.039 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 9.159049e-01 | 0.038 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 9.218887e-01 | 0.035 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.251444e-01 | 0.034 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.251444e-01 | 0.034 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.302068e-01 | 0.031 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.312550e-01 | 0.031 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.368675e-01 | 0.028 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.371180e-01 | 0.028 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.413595e-01 | 0.026 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.421786e-01 | 0.026 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.444399e-01 | 0.025 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.444399e-01 | 0.025 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.444399e-01 | 0.025 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.467568e-01 | 0.024 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 9.489773e-01 | 0.023 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 9.489773e-01 | 0.023 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.511052e-01 | 0.022 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.526020e-01 | 0.021 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.531446e-01 | 0.021 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.531446e-01 | 0.021 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.535373e-01 | 0.021 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.558493e-01 | 0.020 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.569720e-01 | 0.019 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.587670e-01 | 0.018 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.587670e-01 | 0.018 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.602991e-01 | 0.018 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.628060e-01 | 0.016 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.637156e-01 | 0.016 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.637156e-01 | 0.016 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.652296e-01 | 0.015 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.674874e-01 | 0.014 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.680710e-01 | 0.014 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.706805e-01 | 0.013 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.708993e-01 | 0.013 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.750696e-01 | 0.011 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.752780e-01 | 0.011 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.772992e-01 | 0.010 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.791554e-01 | 0.009 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.805627e-01 | 0.009 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 9.808601e-01 | 0.008 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 9.824255e-01 | 0.008 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.824255e-01 | 0.008 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.851832e-01 | 0.006 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.884204e-01 | 0.005 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.907250e-01 | 0.004 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.908439e-01 | 0.004 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.918499e-01 | 0.004 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.923155e-01 | 0.003 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.947373e-01 | 0.002 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.951200e-01 | 0.002 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.979601e-01 | 0.001 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.981753e-01 | 0.001 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.989312e-01 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.989543e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.991958e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.992253e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.992890e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.996263e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.998275e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.998518e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.998828e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999169e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.999600e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.999680e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999772e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999791e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999813e-01 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.999845e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.999870e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999988e-01 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | 0.000 | 0 | 0 |